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Summary	  
	  Time	   is	   the	  main	  character	  of	   this	   thesis,	  and	   it	  has	  been	  used	   in	  many	  ways.	  Starting	  from	  molecular	   dynamics	   simulations	   to	   biological	   networks,	   time	   has	   been	   analysed	  under	   different	   light	   and	   roles.	   The	   main	   subjects	   characterizing	   this	   work	   are	   Von	  Hippel-­‐Lindau	   syndrome	   and	   circadian	   rhythm,	   although	   a	   method	   for	   molecular	  dynamics	   simulations	   trajectory	   analysis	   is	   presented	   at	   the	   end.	   Several	   works	   are	  presented	   here,	   analysing	   different	   aspects	   of	   protein	   dynamics	   as	   well	   as	   pathway	  alterations	  depending	  on	   the	   time	  coordinate.	   	  The	   first	  work	  analyses	   the	   interaction	  between	  protein	  Von	  Hippel-­‐Lindau	   (pVHL)	  and	   its	  main	   interactor,	  Hipoxya	   Inducibe	  Factor	   1α	   by	   means	   of	   molecular	   dynamics	   simulations,	   investigating	   on	   a	   non-­‐conventional	   proline	   hydroxylation	   event.	   As	   a	   result,	   we	   obtained	   that	   a	   specific	  hydrogen	   bond	   network	   rearrangement	   and	   improved	   electrostatic	   energy	   for	  hydroxylated	  P567	  appear	  to	  be	  compatible	  with	  an	  increase	  in	  HIF-­‐1α	  binding	  affinity.	  Sequence	   analysis	   also	   confirms	   P567	   to	   be	   vastly	   conserved	   during	   evolution,	  indicating	   a	   possible	   role	   for	   this	   alternative,	   PHD-­‐3	   driven,	   post	   translational	  modification	  in	  pVHL–HIF-­‐1α	  complex	  formation.	  The	  second	  work	  dealt	  with	  the	  same	  main	  subject,	  but	  investigated	  through	  biological	  network	  simulations,	  particularly	  with	  Petri	  net	  models.	   In	   this	  work,	  we	  presented	  a	  novel	  manually	   curated	  Petri	  Net	   (PN)	  model	   of	   the	   main	   pVHL	   functional	   pathways.	   The	   model	   was	   built	   using	   functional	  information	  derived	  from	  the	  literature.	  It	  includes	  all	  major	  pVHL	  functions	  and	  is	  able	  to	   credibly	   reproduce	   VHL	   syndrome	   at	   the	  molecular	   level.	   The	   reliability	   of	   the	   PN	  model	  also	  allowed	  in	  silico	  knockout	  experiments,	  driven	  by	  previous	  model	  analysis.	  Interestingly,	  PN	  analysis	  suggests	  that	  the	  variability	  of	  different	  VHL	  manifestations	  is	  correlated	   with	   the	   concomitant	   inactivation	   of	   different	   metabolic	   pathways.	   In	   the	  third	   work,	   investigating	   the	   structural	   role	   of	   flavin-­‐adenine-­‐dinucleotide	   (FAD)	  through	   molecular	   dynamics	   simulations,	   we	   analyzed	   the	   Drosophila	   melanogaster	  Cryptochrome	  crystal	  structure,	  elucidating	  how	  this	  large	  co-­‐factor	  within	  the	  receptor	  could	   be	   crucial	   for	   CRY	   structural	   stability.	   The	   co-­‐factor	   appears	   indeed	   to	   improve	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receptor	  motility,	  providing	   steric	  hindrance.	  Moreover,	  multiple	   sequence	  alignments	  revealed	   that	  conserved	  motifs	   in	   the	  C-­‐terminal	   tail	  could	  be	  necessary	   for	   functional	  stability.	   The	   fourth	   work	   focused	   on	   the	   sequence	   impact	   on	   the	   modern	   folds.	   We	  shuffled	  the	  sequences	  of	  10	  natural	  proteins	  and	  obtained	  40	  different	  and	  apparently	  unrelated	   folds.	  Our	   results	   suggest	   that	   shuffled	  sequences	  are	  sufficiently	   stable	  and	  may	   act	   as	   a	   basis	   to	   evolve	   functional	   proteins.	   The	   common	   secondary	   structure	   of	  modern	  proteins	  is	  well	  represented	  by	  a	  small	  set	  of	  permuted	  sequences,	  which	  also	  show	   the	   emergence	   of	   intrinsic	   disorder	   and	   aggregation-­‐prone	   stretches	   of	   the	  polypeptide	   chain.	   The	   last	   work	   presented	   here	   is	   a	   method	   to	   quickly	   analyse	  molecular	   dynamics	   simulations	   trajectories.	   The	   complexity	   related	   to	   their	  interpretation	   and	   analysis	   is	   still	   one	   of	   the	  major	   challenges	   for	  most	   users.	   In	   this	  work	  we	  introduce	  RING	  MD,	  which	  is	  able	  to	  identify	  the	  most	  important	  frames	  (PDB	  structures)	   and	   key	   residues	   that	   cause	   different	   conformers	   transitions,	   providing	   a	  simple	  interpretation	  useful	  for	  non-­‐expert	  users.	  Comparison	  with	  the	  classical	  analysis	  of	  three	  MD	  simulations,	  Ubiquitin,	  T4	  Lysozyme	  and	  T4	  Glutaredoxin,	  confirmed	  RING	  MD	  results	  and	  effectiveness.	  	  At	   the	   end,	   time	   should	   not	   be	   considered	   simply	   as	   something	   entraining	   the	  environment,	   it	   is	   what	   indeed	  modifies	   systems	   and	   environment.	   Different	   systems	  simply	  change	  in	  different	  ways,	  because	  of	  different	  mechanisms,	  but	  the	  main	  driving	  force	  should	  always	  be	  considered	  time.	  	  
Riassunto	  
	  Il	  tempo	  è	  soggetto	  principale	  di	  questa	  tesi,	  ed	  è	  stato	  utilizzato	  in	  molti	  modi.	  A	  partire	  da	   simulazioni	   di	   dinamica	  molecolare	   a	   reti	   biologiche,	   il	   tempo	  è	   stato	   analizzato	   in	  diversi	  modi	  e	  con	  diversi	  ruoli.	  I	  principali	  temi	  che	  caratterizzano	  questo	  lavoro	  sono	  la	  sindrome	  di	  Von	  Hippel-­‐Lindau	  e	  il	  ritmo	  circadiano,	  anche	  se	  un	  metodo	  di	  analisi	  di	  traiettorie	   di	   simulazioni	   di	   dinamica	  molecolare	   è	   presentato	   alla	   fine.	   Diversi	   lavori	  sono	   presentati	   qui,	   analizzando	   diversi	   aspetti	   della	   dinamica	   delle	   proteine,	   nonché	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alterazioni	  di	  pathway	  dipendenti	  dalla	  coordinata	   temporale.	   Il	  primo	   lavoro	  analizza	  l'interazione	   tra	   proteina	   Von	   Hippel-­‐Lindau	   (pVHL)	   e	   il	   suo	   interattore	   principale,	  Hipoxya	  Inducibe	  Factor	  1α	  mediante	  simulazioni	  di	  dinamica	  molecolare,	  indagando	  su	  un	  evento	  di	   idrossilazione	  di	  una	  prolina	  non	  convenzionale.	  Come	  risultato,	  abbiamo	  ottenuto	   che	   uno	   specifico	   riarrangiamento	   di	   una	   rete	   di	   legami	   a	   idrogeno	   e	   un	  incremento	   di	   affinità	   elettrostatica	   nel	   sistema	   contenente	   la	   P567	   idrossilata	  sembrano	  essere	  compatibili	  con	  un	  aumento	  di	  affinità	  di	  legame	  per	  HIF-­‐1α.	  Analisi	  di	  sequenza	  confermano	  anche	  che	  P567	  è	  notevolmente	  conservata	  durante	  l'evoluzione,	  indicando	   un	   possibile	   ruolo	   per	   questa	  modificazione	   post	   trasduzionale	   dipendente	  dalla	  PHD-­‐3,	  nella	  formazione	  del	  complesso	  pVHL-­‐HIF-­‐1α.	  Il	  secondo	  lavoro	  affronta	  lo	  stesso	   soggetto	   principale,	   ma	   studiato	   attraverso	   simulazioni	   di	   reti	   biologiche,	   in	  particolare	  con	  reti	  di	  Petri.	  In	  questo	  lavoro,	  abbiamo	  presentato	  in	  un	  modello	  curato	  manualmente	   di	   Petri	   Net	   (PN)	   I	   principali	   pathway	   funzionali	   di	   pVHL.	   Il	   modello	   è	  stato	   costruito	   utilizzando	   informazioni	   funzionali	   derivate	   dalla	   letteratura.	   Include	  tutte	   le	   funzioni	   principali	   pVHL	   ed	   è	   in	   grado	   di	   riprodurre	   in	   modo	   credibile	   la	  sindrome	   VHL	   a	   livello	   molecolare.	   L'affidabilità	   del	   modello	   PN	   ha	   permesso	   anche	  esperimenti	   di	   knockout	   in	   silico,	   guidata	   da	   precedenti	   analisi	   del	   modello.	   È	  interessante	   notare	   che	   l’analisi	   della	   PN	   suggerisce	   che	   la	   variabilità	   delle	   diverse	  manifestazioni	   VHL	   è	   correlata	   con	   l'inattivazione	   concomitante	   di	   diverse	   vie	  metaboliche.	   Nel	   terzo	   lavoro,	   concernente	   il	   ruolo	   strutturale	   del	   flavin-­‐adenina-­‐dinucleotide	   (FAD)	  attraverso	  simulazioni	  di	  dinamica	  molecolare,	   abbiamo	  analizzato	  la	   struttura	   cristallografica	   di	   Criptocromo	   di	   Drosophila	   melanogaster,	   per	   chiarire	  come	  questo	  co-­‐fattore	  nei	  recettore	  potrebbe	  essere	  cruciale	  per	  la	  stabilità	  strutturale	  della	   proteina.	   Il	   co-­‐fattore	   sembra	  promuovere	   la	  motilità	   del	   recettore,	   fornendo	  un	  effetto	   sterico.	   Inoltre,	   allineamenti	   multipli	   di	   sequenza	   hanno	   rivelato	   che	   i	   motivi	  conservati	   nella	   coda	   C-­‐terminale	   potrebbero	   essere	   necessari	   per	   la	   stabilità	  funzionale.	   Il	   quarto	   lavoro	   concerne	   l'impatto	   che	   diverse	   sequenze	   hanno	   sui	   fold	  moderni.	  Abbiamo	  mischiato	  le	  sequenze	  di	  10	  proteine	  naturali	  e	  ottenuto	  40	  diversi	  e	  apparentemente	   non	   collegati	   fold.	   I	   nostri	   risultati	   suggeriscono	   che	   le	   sequenze	  ottenute	  sono	  sufficientemente	  stabili	  e	  possono	  fungere	  da	  base	  per	  evolvere	  proteine	  funzionali.	  La	  struttura	  secondaria	  comune	  di	  proteine	  moderne	  è	  ben	  rappresentata	  da	  un	   piccolo	   insieme	   di	   sequenze	   permutate	   che	   sottolineano	   anche	   l'emergere	   di	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disordine	  intrinseco	  e	  tratti	  di	  segmenti	  peptidici	  pro-­‐aggregazione.	  L'ultimo	  lavoro	  qui	  presentato	   è	   un	   metodo	   per	   analizzare	   rapidamente	   traiettorie	   di	   simulazioni	   di	  dinamica	   molecolare.	   La	   complessità	   legata	   alla	   loro	   interpretazione	   e	   l'analisi	   sono	  ancora	   tra	   le	   principali	   sfide	   per	   la	   maggior	   parte	   degli	   utenti.	   In	   questo	   lavoro	  introduciamo	  RING	  MD,	  che	  è	  in	  grado	  di	   identificare	  i	   frame	  più	  importanti	  (strutture	  PDB)	   e	   residui	   chiave	   che	   causano	   transazioni	   tra	   diversi	   conformeri,	   fornendo	   una	  fonte	   di	   semplice	   interpretazione	   utile	   per	   gli	   utenti	   non	   esperti.	   Il	   confronto	   con	  l'analisi	  classica	  di	  tre	  simulazioni,	  ubiquitina,	  lisozima	  e	  glutaredossina	  di	  batteriofago	  T4,	  conferma	  l’efficacia	  di	  RING	  MD.	  Alla	  fine,	  il	  tempo	  non	  dovrebbe	  essere	  considerato	  semplicemente	  come	  spettatore	  passivo,	  ma	  effettivamente	  parte	  attiva	  nella	  modifica	  di	  sistemi	   e	   dell'ambiente.	   Diversi	   sistemi	  mutano	   in	  maniera	   diversa,	   a	   causa	   di	   diversi	  meccanismi,	  ma	   la	   principale	   forza	  motrice	   deve	   sempre	   essere	   considerata	   il	   tempo.	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1.	  Introduction	  	  	  	  	  	  	  Time	  is	  the	  name	  given	  to	  that	  dimension	  through	  which	  we	  are	  allowed	  to	  sort	  events	  by	  chronological	  order	  and	  measure	  the	  duration	  of	  intervals	  between	  them.	  Whether	  it	  had	  a	  beginning	  or	  not,	  Time	  has	  the	  absolute	  value	  of	  embedding	  physical	  changes,	  as	  it	  contains	   itself	   the	  concept	  of	  motion	   in	   space.	  No	  changes	  would	  be	  admitted	  without	  Time,	   and	   this	   mutual	   relationship,	   although	   appearing	   taken	   from	   granted,	   is	  nonetheless	  probably	  the	  strongest	  requirement	  for	  the	  existence	  of	  Life.	  The	  need	  for	  a	  measure	   of	   Time	   brought	   it	   to	   be	   part	   of	   the	   seven	   fundamental	   measures	   in	   the	  International	  System	  of	  Units,	  and	  the	  majority	  of	  the	  derived	  units	  are	  based	  on	  a	  Time	  scale.	   In	  biology,	   its	  strict	   importance	  can	  be	  found,	   firstly,	   in	  the	  concept	  of	  Life	   itself.	  Every	  organism	  is	  born,	  lives	  and	  dies	  in	  a	  Time	  interval.	  At	  a	  more	  deep	  view,	  we	  can	  find	   infinite	   possibilities	   to	   evaluate	   its	   role	   in	   biological	   events.	   The	   duration	   of	   a	  human	   being	   life	   is	   usually	   measured	   in	   years,	   the	   duration	   of	   a	   seasonal	   change	   in	  months,	   the	   life	   duration	   of	   a	   butterfly	   in	   days,	   and	   so	   on	   with	   faster	   events	   within	  smaller	   intervals.	   In	   my	   work,	   the	   concept	   of	   Time	   is	   recurring	   in	   many	   ways.	  Undeniably,	   molecular	   dynamics	   simulations	   are	   inseparable	   from	   Time,	   but	   several	  other	  roles	  can	  be	  found	  in	  my	  works.	  The	  day/night	  cycles	  light	  entrainment	  of	  a	  fly,	  the	  impact	  of	  evolution,	  which	  in	  turn	  subtends	  Time,	  on	  protein	  folds,	  the	  steps	  of	  a	  Petri	  net	   evolution	   are	   some	   of	   the	   examples	   of	   the	   Time	   impact	   and	   presence	   during	  my	  entire	  Ph.D.	  experience.	  My	  relationship	  with	  Time	  has	  been	  characterized	  by	  the	  usage	  of	   this	   dimension	   “as	   a	   tool	   and	   not	   as	   a	   couch”(1).	   The	   main	   subjects	   I	   have	   been	  working	  on	  are	  Von	  Hippel-­‐Lindau	  syndrome	  and	  circadian	  rhythms,	  exploiting	  state-­‐of-­‐the-­‐art	   in	   silico	   methodologies	   such	   as	   molecular	   dynamics	   simulations	   and	   different	  types	  of	  biological	  networks.	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1.1	  Von	  Hippel-­‐Lindau	  syndrome	  	  Critical	  deregulation	  of	  cellular	  pathways,	  when	  undergoing	  without	   thorough	  control,	  often	   gives	   rise	   to	   a	   cluster	   of	   related	   diseased	   commonly	   termed	   cancer	   (2).	  Particularly,	   Von	   Hippel-­‐Lindau	   (VHL)	   syndrome	   is	   a	   dominantly	   inherited	   familiar	  cancer	  syndrome	  with	  variable	  expression	  and	  age-­‐dependent	  penetrance	  (3).	  The	  main	  character	  behind	  this	  syndrome	  is	  the	  Von	  Hippel-­‐Lindau	  protein	  (pVHL).	  This	  protein	  is	  the	   product	   of	   the	   von	   Hippel-­‐Lindau	   gene,	   located	   in	   the	   short	   arm	   of	   the	   third	  chromosome	  and	  transcribed	  in	  both	  fetal	  and	  adult	  tissues	  (4).	  pVHL	  is	  a	  multipurpose	  adaptor	  (Fig.	  1)(5),	  engaging	  in	  multiple	  protein-­‐protein	  interactions	  and	  can	  be	  found	  in	   two	   isoforms,	   VHL30	   (213	   AA)	   and	   VHL19	   (160	   AA),	   derived	   from	   two	   alternate	  translational	   start	   sites	   (5).	   Neither	   VHL30	   nor	   VHL19	   isoforms	   contain	   enzymatic	  domains	   (5).	   The	  best	   characterized	  protein	  Von	  Hippel-­‐Lindau	   (pVHL)	   function	   is	   its	  role	   as	   target	   recognition	   component	   of	   the	   E3	   ubiquitin	   ligase	   which	   targets	   the	   α	  subunits	  of	  the	  hypoxia-­‐inducible	  factor-­‐1	  (HIF-­‐1α)	  and	  hypoxia-­‐inducible	  factor-­‐2	  (HIF-­‐2)	   for	  degradation	   in	   the	  presence	  of	  oxygen.	  Protein	  pVHL	  binds	   the	  HIF-­‐1α	  subunits	  and	   the	  elongin-­‐C	  (ELO-­‐C)	  protein,	  which	   interact	  with	  elongin-­‐B	  (ELO-­‐B)	  and	  cullin-­‐2	  forming	   the	   VCB	   complex.	   The	   interaction	   between	   HIF-­‐1α	   and	   pVHL	   is	   driven	   by	  proline	  hydroxylation	  events	  on	  this	  protein,	  carried	  out	  by	  prolylhydroxylases	  (PHDs).	  PHDs	  are	  a	  heterogeneous	  enzyme	  family	  composed	  of	  three	  different	  proteins	  (PHD-­‐1	  to	   -­‐3).	  While	   PHD-­‐1	   and	   -­‐2	   require	   a	   specific	   target	   sequence	   (LxxLAP	  motif)	   PHD-­‐3	  seems	  to	  be	  less	  sequence	  specific	  and	  able	  to	  carry	  out	  its	  hydroxylation	  activity	  with	  the	  only	  requirement	  of	  a	  proline	  residue	  in	  the	  linear	  motif	  (6,7).	  Specific	  interactions	  of	  VHL	  have	  been	  studied	  and	   the	   involvement	  of	  VHL	   in	  different	  signaling	  pathways	  has	  been	  proved,	   such	  as	  microtubule	  dynamics,	   cell	  proliferation,	  neuronal	   apoptosis	  and	  responses	  to	  DNA	  damage.	  Several	  oncosuppressors	  and	  oncogenes	  interacting	  with	  pVHL	  were	  already	   identified	   such	  as	  p53	   (8)	  and	  p14ARF	   (9).	  p14ARF	  regulates	  p53	  degradation	   binding	   the	  MDM2	  protein	   (murine	   double	  minute	   clone	   2),	  which	   is	   the	  main	  effector	  of	  p53	  degradation	  (10).	  Recently,	  an	  interaction	  between	  full	  lenght	  pVHL	  and	  p14ARF	  was	  demonstrated,	  with	  pVHL30	  binding	  p14ARF	  and	  pVHL19	  (missing	  the	  N-­‐terminal	  acidic	  region)	  lacking	  this	  interaction	  (11).	  VHL	  syndrome,	  the	  pathological	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outcome	   overlying	   mutation,	   truncation	   or	   complete	   deletion	   events	   on	   pVHL,	   is	  characterized	   by	   cysts	   and	   tumors	   (3,12)	   such	   as	   retinal	   and	   central	   nervous	   system	  hemangioblastomas,	  pheochromocytomas,	  clear	  cell	  renal	  carcinomas	  (CCRCs),	  islet	  cell	  tumors	   of	   the	   pancreas,	   as	   well	   as	   cysts	   and	   cystadenomas	   in	   the	   kidney,	   pancreas,	  epididymis,	  and	  broad	  ligament	  (13).	  Several	  specific	  phenotypes	  characterize	  the	  main	  clinical	  manifestations.	   Central	   nervous	   system	   haemangioblastomas	   are	   found	   in	   60-­‐80%	  of	  the	  cases,	  and	  appear	  to	  be	  one	  of	  the	  most	  occurring	  presenting	  features	  of	  the	  syndrome	   and	   jointed	   with	   retinal	   angiomas	   or	   haemangioblastomas	   are	   the	   most	  common	   clinical	   symptoms	   driving	   towards	   the	   syndrome	   diagnosis	   (14).	   One	   of	   the	  most	   important	   causes	   of	   death	   linked	   to	   VHL	   syndrome	   is	   CCRS	   (14).	  Pheochromocytomas	   are	   adrenal	   gland	   tumors	   bringing	   to	   unbalanced	   adrenergic	  activation.	   Less	   frequent	  within	   the	   overall	   VHL	  population	   but	   characterized	   by	   high	  penetrance	   in	  elderly	  patients	  are	  pancreatic	   islet	   cells	   tumors	   (14).	  VHL	  syndrome	   is	  considered	  a	  severe	  autosomal	  dominant	  genetic	  disease	  with	  inheritance	  of	  one	  person	  over	   35,000	   (15,16),	   and	   being	   a	   genetic	   disorder	   it	   follows	   the	   Knudson’s	   two	   hit	  principle.	   A	   copy	   of	   the	   gene	   is	   mutated	   in	   the	   germ	   line,	   but	   the	   other	   copy	   still	  produces	  a	  functional	  protein.	  Complete	  pVHL	  inactivation	  appears	  during	  life,	  as	  main	  consequence	  of	  somatic	  inactivation	  of	  the	  functional	  copy	  (17).	  Mutations	  occurring	  in	  early	   fetal	   formation	   yield	   to	   embryonic	   lethality	   (18).	   In	   this	   work,	   I	   investigated	  molecular	  details	  driving	  pVHL	  complex	   formation,	  as	  well	  as	   its	  behaviour	  within	   the	  hypoxia	  regulation	  pathway,	  exploiting	  bioinformatics	  and	  molecular	  modelling	  tools.	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Figure	   	  1:	  (Frew	  IJ	  and	  Krek	  W.,	  Sci.Signal.,	  2008)	  Summary	  of	   the	  diverse	  adaptor	  protein	   functions	  of	  pVHL	  that	  regulate	  
both	  transcription-­‐dependent	  and	  transcription-­‐independent	  cellular	  responses.	  pVHL	  functions	  as	  the	  recognition	  subunit	  of	  
the	  VCB	  E3	  ubiquitin	   ligase	  complex	  composed	   of	  Cul2,	   Elongin	  B	   and	  C	   (EloB	  and	  EloC),	  and	  Rbx1	   that	   targets	  HIF-­‐α	  and	  
Rbp1.	  pVHL	  also	  interacts	  with	  and	  inhibits	  aPKC,	  which	  may	  be	  partly	  mediated	  by	  the	  VCB	  complex	  or	  may	  be	  mediated	  by	  a	  
separate	   complex.	   As	  a	   consequence	  of	   the	   inhibition	   of	  aPKC	  activity,	   the	   activity	   of	   JunB	   in	  antagonizing	   c-­‐Jun–mediated	  
apoptosis	  is	  decreased.	  pVHL	  acts	  as	  a	   linker	  to	  bring	  CKII	   into	  contact	  with	  the	  substrate	  CARD9,	  thereby	  inhibiting	  NF-­‐κB	  
signaling.	   pVHL	   interacts	   with	   p53,	   ATM,	   and	   p300	   to	   nucleate	   a	  multimeric	   complex	   that	   leads	   to	   p53	   activation.	   pVHL	  
participates	   in	   an	   unidentified	   protein	   complex	   through	  which	   pVHL	   posttranscriptionally	   stimulates	   the	   accumulation	   of	  
p400	  and	  inhibits	  cellular	  senescence.	  The	  interaction	  of	  pVHL	  with	  collagen	  IV	  (Col	  IV)	  and	  fibronectin	  (FN)	  likely	  underlies	  
its	  function	  in	  ensuring	  the	  correct	  formation	  of	  the	  ECM.	  pVHL	  promotes	  MT	  stabilization	  and	  associates	  with	  the	  MT	  motor	  
protein	   kinesin-­‐2	   and	   the	   polarity	   proteins	   Par3	   and	   Par6,	   as	   well	   as	   aPKC.	   Note	   that	   with	   the	   exception	   of	   the	   VCB	   E3	  
ubiquitin	   ligase	   complex,	   the	   topology	   and	  binding	  domains	  of	   the	   protein-­‐protein	   interactions	   in	   pVHL-­‐associated	   protein	  
complexes	   have	   not	   been	   fully	   characterized.	   An	   arrow	   (↓)	   represents	   a	   stimulatory	   or	   activating	   effect	   on	   a	   protein	   or	  
cellular	  response;	  a	  blunted	  arrow	  (⊥)	  represents	  an	  inhibitory	  effect;	  a	  question	  mark	  (?)	  represents	  an	  unknown	  subunit	  of	  
a	  pVHL	  complex.	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1.2	  Drosophila	  melanogaster	  cryptochrome	  and	  circadian	  rhythm	  
entrainment	  	  Light	  sensing	  is	  a	  crucial	  component	  of	  living	  organisms,	  which	  have	  evolved	  as	  answer	  to	  a	  rhythmic	  environment	  characterized	  by	  endless	  light–dark	  cycles.	  It	  is	  present	  in	  all	  kingdoms	  of	   life,	  and	  this	  function	  is	  achieved	  by	  several	  different	  mechanisms.	  One	  of	  these	  is	  light	  sensing	  by	  means	  of	  a	  class	  of	  proteins	  termed	  photoreceptors	  (19).	  These	  proteins	  are	  optimally	  suited	  for	  studying	  fold	  changes	  due	  to	  light	  activation	  (19).	  The	  main	   classes	   into	   which	   these	   proteins	   can	   be	   divided	   are	   six	   (see	   Fig.	   2),	   each	   one	  characterized	   by	   a	   different	   photochemical	  mechanism	  driving	   receptor	   activation.	   	   A	  mechanism	   of	   activation	   clustering	   three	   of	   these	   six	   classes	   exploits	   a	   cis/trans	  transition	   of	   different	   cofactors.	   The	   photoreceptors	   belonging	   to	   the	   first	   class	   are	  Phytochromes,	   which	   are	   activated	   by	   a	   cis/trans	   transition	   of	   the	   tetrapyrrole	  chromophore	  (19,20).	  The	  second	  class	  photoreceptors	  are	  Rhodopsins,	  which	  share	  the	  activation	  mechanism	  of	  phytochromes	  but	  exploit	  a	  different	  cofactor,	  retinal	  (19,21).	  The	   third	   class	   is	   characterized	   by	   Xanthopsins,	   sharing	   in	   turn	   a	   cis/trans	   transition	  driven	   activation	  mechanism	  provided	   in	   this	   case	   by	   coumaric	   acid	   and	   activated	   by	  blue	   light	   (19,22).	   The	   last	   three	   classes	   also	   share	   a	   common	   cofactor,	   flavin	   adenin	  dinucleotide	  (FAD).	  The	   fourth	  class,	  activated	  by	  a	  FAD	  mediated	  electron	  transfer,	   is	  gathered	  under	  the	  name	  of	  Cryptochromes	  (CRYs),	  and	  are,	  like	  Xanthopsins,	  activated	  by	  blue	  light	  (19,23).	  These	  photoreceptors	  were	  first	  identified	  in	  Arabidopsis	  thaliana	  in	   1993	   (23).	   The	   fifth	   class	   has	   a	   peculiar	   activation	  mechanism	  which	   requires	   the	  formation	  of	  cysteinil	  adducts,	  and	  the	  photoreceptors	  belonging	  to	  this	  class	  are	  termed	  Phototropins	  (19,24).	  The	  last	  class	  has	  been	  found	  in	  photophobic	  responses	  of	  Euglena	  
gracilis	   (19).	   It	   is	  called	  BLUF	  (sensors	   for	  Blue	  Light	  Using	  FAD)	  and	  differently	   from	  CRYs,	   which	   are	   activated	   by	   electron	   transfer	   following	   blue	   light	   absorption,	   the	  members	   of	   this	   photoreceptor	   family	   are	  believed	   to	  be	   activated	  by	  proton	   transfer	  following	  blue	  light	  absorption	  (19,25).	  In	  my	  structural	  biology	  work,	  I	  focused	  mainly	  on	  Cryptochromes.	  Indeed,	  in	  2011	  Zoltowksi	  et	  al	  published	  the	  first	  crystal	  structure	  of	   the	  dark	  state	  Drosophila	  melanogaster	  Cryptochrome	  (dCRY)	  (26),	   later	  updated	   in	  2013	   (27)	   (PDB	   ID:	   4GU5).	   This	   photoreceptor	   is	   known	   to	   share	   the	   same	   tertiary	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structure	  with	  Drosophila	  melanogaster	   (6-­‐4)	   Photolyase	   (dPL),	   a	   DNA	   repair	   enzyme	  reverting	  purine	  DNA	  bases	  dimerization,	  but	  showing	  a	   longer	  C-­‐Terminal	  Tail	   (CTT)	  (28).	  CRYs,	  differently	   from	  PLs,	  do	  not	  show	  DNA	  repair	  activity	   in	  animals	  (29).	  The	  main	  function	  of	  dCRY	  is	  the	  maintenance,	  in	  specific	  subsets	  of	  the	  clock	  neurons	  and	  in	  the	  compound	  eyes	  of	  the	  flies,	  of	  day/night	  cycles	  sensing	  light	  entrainment	  pathway,	  and	  it	  is	  carried	  out	  by	  its	  interaction	  with	  TIMELESS	  (TIM),	  subsequent	  to	  CTT	  opening	  brought	   by	   FAD	   reduction	  upon	  blue	   light	   exposure	   (30–33).	   	   In	   darkness	   conditions,	  PERIOD	   (PER)	   binds	   to	   TIM	   to	   form	   a	   dimer.	   The	   PER-­‐TIM	   heterodimer	   enters	   the	  nucleus	  and	  inhibits	   the	  CLOCK	  and	  CYCLE	  protein	   interaction	  (34,35).	  Light	  exposure	  causes	  dCRY	  activation	  and	  subsequent	  TIM	  binding,	  avoiding	  its	  interaction	  with	  PER.	  This	  interaction,	  in	  turn,	  allows	  CLOCK	  and	  CYCLE	  interacting	  with	  a	  specific	  E-­‐box	  DNA	  segment	  promoting	  the	  transcription	  of	  clock	  genes	  (33,36).	  The	  absorption	  by	  FAD	  of	  a	  photon	  and	  the	  subsequent	  reduction	  towards	  semiquinone	  state	  allow	  CTT	  to	  expose	  plenty	   of	   linear	   motifs,	   particularly	   PDZ	   domains,	   driving	   several	   protein-­‐protein	  interactions	  (29).	  	  
	  
Figure	   2:	   Van	   der	   Horst	   et	   al.	   Acc.	   Chem.	   Res.,	   2004.	   	   The	   curved	   arrow	   identifies	   the	   vinyl	   bond	   subject	   to	  
photoisomerization.	   In	   retinal,	   both	   the	   11,12-­‐	   and	   the	   13,14-­‐vinyl	   bonds	   can	   undergo	   isomerization,	   like	   in	  
mammalian	  and	  in	  bacterial	  sensory	  rhodopsins,	  respectively	  (17).	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1.2	  Protein	  fold	  evolution	  during	  time	  	  20	   is	   the	   number	   of	   the	   building	   blocks	   of	   proteins,	   amino	   acids.	   As	   for	   a	   language,	  composed	   by	   20	   letters,	   the	   potential	   number	   of	  words	   and	  meanings	   is	   infinite.	   The	  same	  could	  be	  stated	  for	  proteins.	  In	  fact,	  what	  is	  observed	  in	  nature	  is	  slightly	  different.	  Plenty	  of	  protein	  sequences	  and	  structures	  are	  conserved,	  highlighting	  a	  relatively	  small	  number	  of	  folds	  if	  compared	  to	  the	  potential	  infinite	  number	  of	  polypeptides	  chains	  that	  could	   be	   obtained	   from	   the	   amino	   acidic	   alphabet.	   Starting	   from	   the	   formation	   of	   the	  primordial	   broth	   and	   the	   first	   peptides,	   proteins	   and	   their	   fold	   underwent	   several	  modification	   processes	   rising	   from	   function	   pressure	   or	   providing	   function	  specialization.	  Same	  catalytic	  activities	  are	  found	  in	  proteins	  not	  sharing	  the	  same	  fold,	  and	  vice	  versa,	  proteins	  sharing	  the	  same	  fold	  are	  not	  always	  sharing	  the	  same	  function.	  A	   stable	   fold	   is	   more	   favourable	   to	   be	   conserved	   during	   evolution,	   and	   proteins	  autonomously	   evolved	   maintaining	   the	   most	   stable	   folds.	   Starting	   from	   these	  assumptions,	   the	  question	  whether	  the	  modern	  folds	  are	  an	  exquisite	  result	  of	  natural	  selection	   or	   rather	   random	   sequences	   slightly	   improved	   by	   evolution	   arises	   (37).	  Considering	  a	  prebiotic	  scenario,	  it	  is	  plausible	  that	  modern	  protein	  folds	  are	  the	  result	  of	  small	  proto-­‐protein	  folds.	  In	  this	  work,	  we	  investigated	  through	  ab	  initio	  predictions	  of	  non-­‐natural	  proteins	  on	  this	  subject,	  trying	  to	  provide	  clues	  on	  the	  origins	  of	  modern	  folds.	  	  
1.4	  Methodologies	  	  
1.4.1	  Molecular	  dynamics	  simulations	  In	   2013,	   the	   Nobel	   Prize	   for	   chemistry	   has	   been	   awarded	   to	   the	   developers	   of	   a	  molecular	   force	   field	   for	   the	   simulation	   of	   biological	   systems	   (38).	   This	   framework	  provides	   the	  possibility	  of	   investigating	   the	  behaviour	  of	  molecular	   structures	   coming	  from	   the	   Protein	   Data	   Bank(39)	   or	   from	   structure	   prediction	   methods	   during	   time.	  Indeed,	  Molecular	  Dynamics	  (MD)	  simulations	  are	  the	  study	  of	  successive	  configurations	  of	  the	  system	  generated	  by	  integration	  of	  the	  Newton’s	  law	  of	  motion	  (40).	  This	  law	  is	  formed	  by	  three	  rules:	  (i)	  a	  body	  continues	  to	  move	  in	  a	  straight	  line	  at	  constant	  velocity	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unless	  a	  force	  acts	  upon	  it,	  (ii)	  force	  equals	  the	  rate	  of	  change	  of	  momentum	  and	  (iii)	  to	  every	   action	   there	   is	   an	   equal	   and	   opposite	   reaction	   (40).	   Molecular	   dynamics	  simulations	  were	   first	   introduced	   by	   Alder	   and	  Wainwright	   in	   1957	   (41),	   and	   during	  years	   have	   been	   increasingly	   used,	   due	   to	   the	   computational	   power	   improvement	  characterizing	  the	  last	  thirty	  years.	  This	  improvement	  allowed	  passing	  from	  simulations	  of	  few	  femtoseconds	  to	  the	  state-­‐of-­‐the-­‐art	  micro	  and	  also	  milliseconds	  long	  simulations	  (42,43).	  In	  classical	  MD	  simulations,	  atoms	  are	  considered	  as	  charged	  spheres	  owning	  a	  mass,	  and	  bonds	  are	   treated	  as	  springs	  obeying	  to	   the	  Morse	  potential.	  The	   force	   field	  contains	   all	   charges	   and	   masses,	   bonds,	   angles,	   dihedrals	   and	   improper	   torsions	  parameters.	   The	   integrator	   performs	   the	   calculations	   of	   Newton’s	   laws	   based	   on	   the	  force	  field.	  Before	  the	  simulation	  starts,	  the	  system	  is	  placed	  within	  a	  box	  of	  water	  or	  in	  a	  lipidic	  bilayer,	  which	  can	  be	  cubic,	  spherical	  or	  octahedral.	  The	  used	  water	  model	  for	  all	  simulations	  in	  this	  work	  was	  TIP3p	  (44,45).	  The	  following	  step	  consists	  in	  global	  charge	  neutralization	  by	  means	  of	  Na+	  or	  K+	  positive	  ions	  and	  Cl-­‐	  negative	  ion	  addition	  whether	  the	  charge	  to	  neutralize	  is	  negative	  or	  positive.	  Finally,	  the	  system	  is	  added	  of	  a	  number	  of	   the	   previously	  mentioned	   ions	   to	   reach	   physiological	   concentrations.	   The	   solvated	  system	   undergoes	   the	   equilibration	   phase,	   which	   consists	   in	   structure	   relaxation	   and	  incremental	   heating	   steps	   followed	   by	   two	   short	   integrations	   first	   in	   NVT	   conditions	  (constant	   number	   of	  molecules,	   volume	   and	   temperature)	   and	   then	   in	   NPT	   (constant	  number	   of	   molecules,	   pressure	   and	   temperature)	   conditions.	   Once	   the	   system	   is	  equilibrated,	  the	  production	  run	  is	  carried	  out.	  	  The	  main	  integration	  software	  packages	  used	  in	  this	  work	  are	  GROMACS	  (46)	  and	  NAMD	  (47).	  The	  former	  was	  set	  to	   integrate	  Newton’s	  laws	  following	  the	  leap-­‐frog	  scheme,	  while	  the	  latter	  using	  the	  Verlet	  method	  (40).	  The	   leap-­‐frog	   scheme	   is	  a	  variation	  of	   the	   classic	  Verlet	   integration	  method.	  The	  classic	  Verlet	  method	  uses	  the	  positions	  and	  accelerations	  at	  time	  t,	  and	  the	  positions	  of	  the	  previous	  step	  to	  calculate	  the	  new	  positions	  in	  the	  following	  timestep	  as	  follows:	  	   𝑟 𝑡 + 𝛿𝑡 = 2𝑟 𝑡 − 𝑟 𝑡 − 𝛿𝑡 + 𝛿𝑡!𝑎(𝑡)	  	  	  	  	  	  	  	  	  	  	  	  	  being	  a	  the	  acceleration	  and	  t	  the	  time.	  The	  leap-­‐frog	  algorithm	  calculates	  the	  velocities	  𝑣(𝑡 + !! 𝑡)	  from	  the	  velocities	  at	  time	  𝑡 − !! 𝑡	  and	  the	  accelerations	  at	  time	  t.	  The	  positions	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are	  deduced	  by	  the	  velocities	  using	  the	  following	  𝑟 𝑡 + 𝛿𝑡 = 𝑟 𝑡 + 𝛿𝑡𝑣 𝑡 + !! 𝛿𝑡 	  (40).	  Using	   these	   integration	   software	   packages,	   the	   result	   is	   a	   trajectory,	   which	   is	   then	  analysed	   in	   terms	   of	   root	   mean	   square	   deviation	   (RMSD)	   and	   root	   mean	   square	  fluctuation	  (RMSF).	  The	  RMSD	  is	  an	  average	  distance	  between	  a	  set	  of	  atom	  pairs	  and	  is	  usually	  stated	  as	  follows:	  	  
𝑅𝑀𝑆𝐷 =    1𝑁 𝛿!!!!!! 	  	  being	  𝛿	  the	  distance	  between	  N	  pairs	  of	  atoms.	  The	  RMSF	  can	  be	  stated	  as	  the	  mean	  per	  residue	   RMSD.	   These	   data,	   joint	   with	   visual	   inspection,	   allow	   obtaining	   molecular	  information	  on	  the	  behaviour	  of	  the	  analysed	  system.	  	  
1.4.2	  Petri	  net	  simulation	  networks	  Networks	   are	   commonly	   defined	   as	   clusters	   of	   objects	   sharing	   connections	   between	  each	  other.	  Several	  systems	  have	  been	  represented	  with	  networks,	  including	  biological	  systems.	  All	   pathways	  occurring	   to	   satisfy	   that	   fundamental	   condition	  of	   life,	  which	   is	  called	   homeostasis,	   can	   be	   represented	   as	   networks.	  Mathematical	   laws	   usually	   drive	  biological	  interconnections	  between	  different	  interactors.	  Starting	  from	  this	  assumption,	  we	  can	  build	  a	  model	  of	  a	  biological	  network	  obeying	  these	  laws	  (48).	  Petri	  Nets	  (PNs)	  are	   mathematical	   representations	   of	   distributed	   systems	   depicting	   discrete	   and	  concurrent	  processes	  in	  a	  clear	  way,	  immediately	  highlighting	  the	  order	  of	  occurrence	  of	  several	   biochemical	   reactions	   belonging	   to	   a	   defined	   pathway	   (49).	   They	   were	   first	  introduced	  by	  Petri	  C.A.	   in	  1962	   to	  describe	   technical	   systems	   (50),	   but	   the	   impact	  of	  these	   kinds	   of	   representations	   for	   biological	   systems	   is	   growing	   (16,51),	   given	   that	  different	  kinds	  of	  networks	  are	  increasingly	  being	  used	  in	  biology	  (52).	  The	  structure	  of	  PNs	  is	  simple,	  but	  it	  allows	  representations	  of	  huge	  and	  cross-­‐linked	  biological	  pathways	  by	   means	   of	   simple	   structural	   objects.	   These	   objects	   are	   circle/places,	  squares/transitions,	   directed	   arcs	   and	   tokens.	   The	   nodes	   of	   the	   networks	   are	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constituted	   by	   places	   and	   transitions,	   while	   directed	   arcs	   represent	   the	   edges	   (53).	  Places	   are	   the	   characters	   of	   the	  pathway,	   such	   as	   ions,	  molecules,	   proteins	   or	   cellular	  components,	  while	   transitions	   represent	   chemical	   or	  biochemical	   reactions,	  molecular	  modifications	   or	   location/state	   modifications,	   post	   translational	   modifications	   or	  synthesis/degradation.	  Directed	  arcs	  drive	  the	  way	  nodes	  interact	  each	  others,	  starting	  from	  the	  assumption	  that	  one	  places	  can	  only	  link	  to	  transitions	  and	  vice	  versa.	  The	  last	  components,	   tokens,	  are	  dots	   representing	   the	  unity	   inside	  a	  place	   (pre-­‐place	  or	  post-­‐place).	   The	  move	   from	  pre-­‐places	   to	  post-­‐places	   through	   transitions,	   representing	   the	  possibility	   of	   occurrence	   of	   a	   given	   transition.	   If	   the	   number	   of	   tokens	   satisfies	   the	  required	   pre-­‐conditions,	   or	   stoichiometry,	   thus	   the	   transition	   is	   allowed	   to	   occur	   and	  tokens	  move	  from	  pre-­‐places	  to	  post-­‐places.	  In	  this	  work,	  we	  used	  Standard	  PNs,	  that	  do	  not	  consider	  the	  timing	  variable.	  Despite	  this,	  several	  types	  of	  PNs	  are	  commonly	  used	  such	  as	  Extended	  PNs,	  Time	  PNs,	  Coloured	  PNs,	  and	  Hybrid	  PNs	  just	  to	  cite	  few	  of	  them.	  These	   several	   types	   allow	   the	   user	   to	   include	   several	   different	   variables	   in	   respect	   to	  Standard	   PNs.	   In	   order	   to	   simplify	   the	   final	   representation	   of	   the	   networks,	   smaller	  pathways	  embedded	  in	  the	  biggest	  ones	  can	  be	  represented	  as	  Macronodes.	  Macronodes	  are	  represented	  by	  boxed	  nodes,	  and	  can	  be	  arbitrary	  nested	  in	  multiple	  layers	  to	  keep	  the	  represented	  network	  clear.	  	  	  	  
1.5	  Aim	  of	  the	  thesis	  	  	  The	  possibility	  offered	  by	  the	  modern	  computational	  power	  to	  perform	  fast	  calculations	  on	  huge	  systems	  provided	  a	  useful	  framework	  to	  investigate	  the	  time	  impact	  on	  several	  biological	   aspects.	   The	   usage	   of	   modern	   techniques	   such	   as	   molecular	   dynamics	  simulations	   of	   biological	   systems	   or	   Petri	   net	   simulations	   of	   biochemical	   pathways	  allowed	   me	   to	   investigate,	   sometimes	   provide	   explanation,	   and	   formulate	   hypothesis	  towards	   several	   biological	   and	   biochemical	   issues.	   The	   growing	   impact	   and	   reliability	  that	   bioinformatics	   and	   molecular	   modelling	   tools	   are	   having	   nowadays	   were	   at	   the	  basis	   of	   my	   Ph.D.	   and	   scientific	   experience	   so	   far.	   In	   spite	   of	   providing	   some	  merely	  theoretical	  answers,	   the	  capability	  of	   in	  silico	  predictions	  of	   simulating	   real	   systems	   is	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gaining	   light.	  With	   this	  work,	   I	   provided	   some	   insights	   on	   several	   time	   related	   issues,	  such	  as	  the	  cruel	  impact	  of	  time	  in	  cancer	  related	  diseases,	  as	  well	  as	  the	  more	  lenient	  impact	   it	   has	   on	   protein	   fold	   evolution,	   and	   on	   day/night	   cycles.	   Both	   cancer	   and	  circadian	   rhythm	   entrainment	   are	   important	   scientific	   topics,	   involving	   a	   huge	  community	  of	  scientist	  investigating	  on	  them.	  	  	  The	   aim	   of	   this	  work	  was	   to	   use	  modern	   computational	   approaches	   to	   provide	   some	  clues	  on	  both	  pure	  biochemical	   and	  more	  applied	  biomedical	   issues,	   as	   answer	   to	   the	  previously	  mentioned	  resources	  availability.	  Under	   this	   light,	  each	  hypothesis	   for	  each	  system	   was	   investigated	   by	   several	   and	   different	   computational	   approaches,	   ranging	  from	   sequence	   analysis	   to	   the	   simulation	   of	   peculiar	   molecular	   interactions,	   passing	  through	   a	   huger	   analysis	   of	   an	   entire	   pathway.	   The	   main	   variable,	   which	   was	   also	  chosen	  to	  be	  part	  of	  the	  title	  of	  the	  present	  work,	  is	  time.	  The	  latter	  allowed	  seeing	  the	  changes	  occurring	  during	  the	  several	  dynamic	  processes	  I	  worked	  on.	  	  	  	  
1.6	  Outline	  	  The	   following	   chapters	   represent	   all	   the	   tasks	   I	   have	   been	   working	   during	   my	   Ph.D.	  experience.	  	  Chapters	  2	  to	  5	  are	  published	  works,	  particularly:	  Chapter	   2	   is	   published	   in	   Minervini	   G,	   Masiero	   A,	   Moro	   S,	   Tosatto	   SCE.	   In	   silico	  
investigation	   of	   PHD-­‐3	   specific	   HIF1-­‐α	   proline	   567	   hydroxylation:	   A	   new	   player	   in	   the	  
VHL/HIF-­‐1α	  interaction	  pathway?	  FEBS	  Lett.	  2013	  Sep	  17;587(18):2996–3001.	  Chapter	  3	  is	  published	  in	  Minervini	  G,	  Panizzoni	  E,	  Giollo	  M,	  Masiero	  A,	  Ferrari	  C,	  Tosatto	  
SCE.	   Design	   and	   Analysis	   of	   a	   Petri	   Net	   Model	   of	   the	   Von	   Hippel-­‐Lindau	   (VHL)	   Tumor	  
Suppressor	  Interaction	  Network.	  PloS	  One.	  2014;9(6):e96986.	  Chapter	  4	  is	  published	  in	  Masiero	  A,	  Aufiero	  S,	  Minervini	  G,	  Moro	  S,	  Costa	  R,	  Tosatto	  SCE.	  
Evaluation	  of	  the	  steric	  impact	  of	  flavin	  adenine	  dinucleotide	  in	  Drosophila	  melanogaster	  
cryptochrome	  function.	  Biochem	  Biophys	  Res	  Commun.	  2014	  Aug	  8;450(4):1606–11.	  Chapter	   5	   is	   published	   in	   Minervini	   G,	   Masiero	   A,	   Potenza	   E,	   Tosatto	   SCE.	   Structural	  
protein	   reorganization	   and	   fold	   emergence	   investigated	   through	   amino	   acid	   sequence	  
permutations.	  Amino	  Acids.	  2015	  Jan;47(1):147–52.	  Chapter	  6	  represents	  the	   last	   task	  I	  performed	  during	  my	  Ph.D.	  experience,	  and	   is	  still	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unpublished,	   while	   Chapter	   8	   contains	   all	   supplementary	   information	   attached	   to	  published	  papers,	  to	  facilitate	  the	  reader	  in	  finding	  what	  is	  mentioned	  in	  the	  main	  texts.	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2.	   In	   silico	   investigation	   of	   PHD-­‐3	   specific	   HIF1-­‐α	  
proline	   567	   hydroxylation:	   a	   new	   player	   in	   the	  
VHL/HIF-­‐1α	  interaction	  pathway?	  	  This	   chapter	  has	  been	  published	   in	   (54)	  Minervini	  G,	  Masiero	  A,	  Moro	  S,	  Tosatto	  SCE.	   In	  silico	   investigation	  of	  PHD-­‐3	  specific	  HIF1-­‐α	  proline	  567	  hydroxylation:	  A	  new	   player	   in	   the	   VHL/HIF-­‐1α	   interaction	   pathway?	   FEBS	   Lett.	   2013	   Sep	  17;587(18):2996–3001.	  
2.1	  Summary	  	  Hypoxia	   inducible	   factor	   1α	   (HIF-­‐1α)	   regulates	   oxygen	   homeostasis	   in	   the	   cell	  through	   a	   sensing	  mechanism	   involving	   its	   hydroxylation	   and	  binding	   to	   the	   von	  Hippel-­‐Lindau	   (VHL)	   tumor	   suppressor.	   This	   mechanism	   is	   mediated	   through	  hydroxylation	  of	  HIF-­‐1α	  proline	  564,	  although	  in	  vitro	  tests	  have	  previously	  shown	  an	   alternative	   hydroxylation	   at	   proline	   567	   by	   PHD-­‐3.	  Here,	  molecular	   dynamics	  simulations	   were	   used	   to	   investigate	   the	   structural	   effect	   of	   this	   alternative	  hydroxylation.	   A	   specific	   hydrogen	   bond	   network	   rearrangement	   and	   improved	  electrostatic	  energy	  for	  hydroxylated	  P567	  are	  compatible	  with	  an	  increase	  in	  HIF-­‐1α	  binding	   affinity.	   Sequence	   analysis	   also	   confirms	  P567	   to	   be	   vastly	   conserved	  during	  evolution,	  indicating	  a	  possible	  role	  for	  this	  alternative,	  PHD-­‐3	  driven,	  post	  translational	   modification	   in	   pVHL-­‐HIF-­‐1α	   complex	   formation.	   The	   analyzed	  systems	  were	   four:	   (i)	  the	   complex	  with	   hydroxylation	   on	  P564,	   (ii)	   the	   complex	  with	  hydroxylation	  on	  P567,	  (iii)	  the	  complex	  with	  hydroxylation	  on	  both	  P564	  and	  P567	  and	  (iv)	  the	  complex	  with	  no	  hydroxylation.	  All	  simulations	  were	  carried	  out	  with	  Gromacs,	   using	   the	  CHARMM	  27	   force	   field.	  HYP567	  was	  generated	  keeping	  the	  same	  stereoisomer	  as	  HYP564,	  and	  both	  4-­‐hydroxyl	  moieties	  were	  placed	  in	  the	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(R)	   conformation.	   Here,	   we	   tested	   the	   structural	   compatibility	   of	   P567	  hydroxylation	   through	   MD	   simulations	   of	   the	   effect	   of	   this	   non-­‐conventional	  hydroxylation	   on	   the	   interaction	   interface	   between	   pVHL	   and	   the	   HIF-­‐1α	   linear	  motif.	   Our	   results	   suggest	   that	   a	   previously	   not	   described	   reorganization	   of	  hydrogen	   bond	   network	   between	   pVHL	   and	   HIF-­‐1α	   appears	   around	   the	   HIF-­‐1α	  P567	  linear	  motif	  when	  hydroxylated.	  HYP	  in	  position	  567	  is	  able	  to	  promote	  a	  new	  hydrogen	  bond	  network	  localized	  around	  HYP567,	  involving	  the	  pVHL	  H110,	  Q73,	  R108	   and	   HIF-­‐1α	   D569	   residues.	   My	   contribution	   to	   this	   work	   ranged	   from	   the	  calculation	   and	   implementation	   of	   the	   force	   field	   parameters	   for	   HYP,	   being	   it	   a	  nonstandard	   residue	   and	   thus	   not	   contained	   in	   the	   force	   field,	   ending	   with	   the	  analysis	   of	   the	   trajectory	   and	   the	   electrostatic	   analysis	   to	   obtain	   the	   provided	  results.	  	  	  
2.2	  Abstract	  	  Hypoxia	   inducible	   factor	   1α	   (HIF-­‐1α)	   regulates	   oxygen	   homeostasis	   in	   the	   cell	  through	   a	   sensing	  mechanism	   involving	   its	   hydroxylation	   and	  binding	   to	   the	   von	  Hippel–Lindau	   (VHL)	   tumor	   suppressor.	   This	   mechanism	   is	   mediated	   through	  hydroxylation	  of	  HIF-­‐1	  α	  proline	  564,	  although	  in	  vitro	  tests	  have	  previously	  shown	  an	   alternative	   hydroxylation	   at	   proline	   567	   by	   PHD-­‐3.	  Here,	  molecular	   dynamics	  simulations	   were	   used	   to	   investigate	   the	   structural	   effect	   of	   this	   alternative	  hydroxylation.	   A	   specific	   hydrogen	   bond	   network	   rearrangement	   and	   improved	  electrostatic	  energy	  for	  hydroxylated	  P567	  are	  compatible	  with	  an	  increase	  in	  HIF-­‐1α	  binding	   affinity.	   Sequence	   analysis	   also	   confirms	  P567	   to	   be	   vastly	   conserved	  during	  evolution,	  indicating	  a	  possible	  role	  for	  this	  alternative,	  PHD-­‐3	  driven,	  post	  translational	  modification	  in	  pVHL–HIF-­‐1α	  complex	  formation.	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2.3	  Introduction	  	  Hypoxia	   is	   a	   pathological	   condition	   commonly	   present	   in	   tissue	   tumor	   growth.	  Hypoxia	   inducible	   factor	   1α	   (HIF-­‐1α)	   is	   a	   key	   transcription	   factor	   of	   oxygen	  homeostasis	  regulation	  in	  the	  cell.	  HIF-­‐1α	  directly	  regulates	  the	  expression	  of	  over	  40	   important	   target	   genes	   such	   as	   vascular	   endothelial	   growth	   factor	   (VEGF),	  erythropoietin,	   glycolytic	   enzymes,	   and	   glucose	   transporters	   (13).	   The	   HIF-­‐1α	  concentration	   is	   regulated	   through	   ubiquitin-­‐mediated	   proteolysis,	   governed	   by	  the	  activity	  of	  the	  von	  Hippel–Lindau	  (VHL)	  tumor	  suppressor	  protein	  (pVHL)	  (55).	  VHL	   is	   the	   key	   player	   in	   VHL	   syndrome,	   a	   dominantly	   inherited	   familial	   cancer	  syndrome	   with	   variable	   expression	   and	   an	   age-­‐dependent	   penetrance.	   It	   is	  characterized	   by	   a	   predisposition	   to	   develop	   retinal	   and	   central	   nervous	   system	  hemangioblastomas,	   pheochromocytomas,	   clear	   cell	   renal	   carcinomas,	   islet	   cell	  tumors	   of	   the	   pancreas,	   and	   endolynphatic	   sac	   tumors,	   as	   well	   as	   cysts	   and	  cystadenomas	  in	  the	  kidney,	  pancreas,	  epididymis,	  and	  broad	  ligament	  (3,12).	  The	  predisposition	  to	  develop	  this	  variety	  of	   tumors	   is	   linked	  to	  germline	   inactivation	  of	   VHL.	   Development	   of	   the	   pathology	   in	   VHL	   disease	   occurs	   subsequently	   to	  somatic	   inactivation	   of	   the	   remaining	   wildtype	   allele	   in	   a	   susceptible	   cell	   (5).	  Importantly,	  sporadic	   forms	  of	  the	  same	  tumor	  types	  that	  are	  common	  in	  familial	  VHL	   disease	   display	   bi-­‐allelic	   somatic	   VHL	   inactivation	   through	   a	   variety	   of	  mechanisms,	  including	  mutations	  and	  hypermethylation.	  For	  example,	  inactivation	  of	   VHL	   has	   been	   demonstrated	   in	   70–80%	   of	   all	   sporadic	   clear	   cell	   renal	   cell	  carcinomas	   (57).	  pVHL	   is	  a	  multifunctional	  adapter	   that	   interacts	  with	  numerous	  proteins	   such	   as	   ElonginB/C-­‐	   Cullin2,	   to	   form	   the	   well	   characterized	   VBC	  degradation	   complex	   (58,59),	   and	   cytoplasmic	  microtubules	   during	  mitosis	   (60).	  Previous	   computational	   work	   on	   VHL	   has	  mainly	   concentrated	   on	   analyzing	   the	  many	   known	   pVHL	   interactions	   (61)	   and	   explaining	   possible	   effects	   of	   known	  mutations	  either	  empirically	  (62,63)	  or	  with	  molecular	  dynamics	  simulations	  (64–66).	   VBC	   mediated	   degradation	   of	   HIF-­‐1α	   under	   normal	   oxygen	   conditions	   is	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promoted	  by	  oxygen-­‐dependent	  hydroxylation	  of	  P564	  and	  P402	  residues	  operated	  by	   members	   of	   the	   HIF-­‐prolyl	   hydroxylase	   family	   (PHDs)	   (67,68).	   A	   crystal	  structure	   of	   the	   VBC/HIF-­‐1α	   complex	   (1.8	   Å)	   including	   the	   HIF-­‐1α	   recognition	  mechanism	   operated	   by	   pVHL	   was	   solved	   in	   2002	   (69).	   The	   protein–protein	  interaction	   is	  mediated	   by	   a	   highly	   conserved	  hydrogen	   bonds	   network	   between	  pVHL	   residues	   S111,	   H115,	   W117	   and	   the	   hydroxylated	   HIF-­‐1α	   P564.	   Under	  pathological	  conditions,	  such	  as	  tumor	  growth,	  lack	  of	  oxygen	  inhibits	  normal	  PHD	  activity	  and	  results	  in	  reduced	  HIF-­‐1α	  degradation	  (70).	  	  Loss	  of	  HIF-­‐1α	  degradation	  then	  promotes	  transcriptional	  activation	  of	  numerous	  genes,	   resulting	   in	   the	   commonly	   observed	   hypervascularized	   tumors	   and	   cysts	  observed	   in	  VHL	  patients	   (71).	  The	  post	   translational	  modification	   introduced	  by	  PHD	   assumes	   a	   crucial	   role	   in	   HIF-­‐1α	   balance	   and	   regulation.	   The	   HIF-­‐prolyl	  hydroxylases	   are	   a	   heterogeneous	   enzyme	   family	   composed	   of	   three	   different	  
Figure	   	  3:	  Overview	  of	  the	  pVHL/HIF-­‐1α	  complex.	  Cartoon	  representation	  of	   the	  crystallographic	  structure	  of	  
pVHL	   in	  complex	  with	  HIF-­‐1α	  (PDB	  identifier	  1LM8).	  The	  pVHL	  α-­‐domain	  is	  shown	  in	  orange	  color,	  while	  the	  
pVHL	  β-­‐domain	   is	   in	   green	  and	  HIF-­‐1α	  peptide	   in	   yellow.	  Hydrogen	  bonds	   are	   shown	  as	   thin	   blue	   lines.	   The	  
HYP564	  and	  P567	  side	  chains	  are	  shown	  in	  sticks	  and	  labeled.	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proteins	   termed	   PHD-­‐1	   to	   -­‐3.	   PHD-­‐3,	   in	   particular,	   appears	   to	   be	   a	   functionally	  specialized	  paralog	  of	  the	  first	  two	  enzymes.	  Smaller,	  and	  with	  a	  markedly	  different	  cellular	   localization,	   it	  was	  recently	  demonstrated	  to	  also	  have	  different	  substrate	  specificity,	   at	   least	   in	   vitro	   (72).	   While	   PHD-­‐1	   and	   -­‐2	   require	   a	   specific	   target	  sequence,	  known	  as	  LxxLAP	  motif	  (67),	  PHD-­‐3	  seems	  to	  be	   less	  sequence	  specific	  and	   able	   to	   carry	   out	   its	   hydroxylation	   activity	   with	   the	   only	   requirement	   of	   a	  proline	  residue	  in	  the	  linear	  motif.	  In	  2007,	  Fedulova	  and	  co-­‐workers	  demonstrated	  that	  PHD-­‐3	  hydroxylates	  P567	  in	  HIF-­‐1α	  (6),	  which	  is	  not	  LxxLAP	  motif	  compliant.	  In	   another	   work,	   the	   same	   residue	   was	   also	   reported	   to	   increase	   the	   binding	  affinity	   of	   PHD-­‐3(73)).	   Both	   observations	   suggest	   the	   possible	   existence	   of	   an	  alternative	   HIF-­‐1α	   regulation	   pathway	   mediated	   by	   PHD-­‐3.	   Here,	   we	   used	  molecular	   dynamics	   to	   investigate	   the	   structural	   effect	   on	   the	   pVHL/HIF-­‐1α	  binding	  interface	  when	  P567	  is	  hydroxylated.	  Sequence	  analysis	  confirms	  P567	  to	  be	   broadly	   conserved	   during	   evolution,	   further	   strengthening	   the	   idea	   of	   an	  evolutionarily	  conserved	  functional	  mechanism.	  
2.4	  Methods	  
2.4.1	  Molecular	  dynamics	  simulations	  	  The	  crystal	  structure	  of	  pVHL	  solved	  at	  1.8	  Å	  resolution	  (69)(PDB	  identifier	  1LM8)	  was	  used	  as	  a	  starting	  model,	  considering	  chains	  V	  (pVHL)	  and	  H	  (HIF-­‐1α	  peptide).	  Chains	  B	  and	  C,	  corresponding	  to	  Elongin	  B	  and	  C	  respectively,	  were	  excluded	  from	  the	  simulations	  as	  they	  are	  distant	  from	  the	  pVHL/HIF-­‐1α	  interaction	  site	  with	  40	  and	  55	  Å,	  respectively	  and	  should	  not	  have	  a	  direct	  effect	  on	  the	  binding	  interface	  interactions	  of	  interest	  for	  the	  present	  work.	  The	  pVHL	  crystal	  structure	  also	  lacks	  6	   N-­‐terminal	   and	   4	   C-­‐terminal	   residues,	   which	   are	   also	   not	   involved	   in	   HIF-­‐1α	  interaction.	  The	  protonation	  state	  of	  the	  protein	  was	  adjusted	  to	  mimic	  a	  pH	  value	  of	   7.0.	   All	   lysine	   residues	   were	   positively	   charged	   and	   histidine	   residues	   were	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modeled	  as	  neutral	  by	  protonating	  the	  Nε2	  atom.	  In	  particular,	  H115	  was	  modeled	  as	  neutral	  by	  protonating	   the	  Nd1	  atom	  as	  reported	   in	   the	  crystal	   structure	  (69).	  Aspartate	   and	   glutamate	   residues	   were	   considered	   fully	   deprotonated.	   All	  simulations	  were	  carried	  out	  with	  Gromacs	  (46),	  using	  the	  CHARMM	  27	  (38)	  force	  field.	   Hydrogen	   atoms	   were	   added	   to	   the	   system	   by	   means	   of	   the	   Gromacs	  pdb2gmx	  routine.	  Each	  run	  was	  constituted	  by	  a	  minimization	  step,	  100	  ps	  of	  NVT	  (constant	   number	   of	   molecules,	   volume	   and	   temperature)	   simulation,	   100	   ps	   of	  NPT	  (constant	  number	  of	  molecules,	  pressure	  and	  temperature)	  simulation	  and	  50	  ns	   of	   classical	   molecular	   dynamics	   (MD)	   simulation.	   The	   minimization	   used	   a	  steepest	   descent	   algorithm.	   NVT	   simulations	   were	   performed	   with	   no	   pressure	  coupling.	   Temperature	   was	   coupled	   with	   a	   modified	   Berendsen	   thermostat,	   to	  obtain	   a	  Maxwell	   distribution	   of	   energies.	   Temperature	  was	   kept	   at	   300	   K.	   NPT	  simulations	  were	  performed	  with	  a	  Parinello-­‐Rahman	  barostat,	  at	  a	  temperature	  of	  300	  K,	  and	  the	  pressure	  was	  kept	  at	  1	  atm.	  The	  solvent	  box	  was	  generated	  covering	  a	  distance	  of	  10	  Å	  from	  the	  farthest	  point	  of	  the	  protein	  boundaries	  on	  each	  of	  the	  three	  dimensions.	  The	  generated	  box	  was	  constituted	  by	  ~	  1.8	  x	  104	  TIP3p	  water	  molecules,	   and	   sized	   82x82x82	   Å3.	   As	   HYP	   is	   not	   a	   standard	   amino	   acid,	   its	  parameters	  are	  not	  included	  in	  standard	  molecular	  modeling	  force	  fields.	  A	  proper	  set	  of	  values,	  compatible	  with	  the	  CHARMM	  27	  force	  field	  was	  generated	  and	  used	  for	   the	   simulation	   as	   follows.	   The	   CHARMM	   force	   field	   includes	   four	   different	  contributions,	   namely	   bond	   stretching,	   angle	   bending,	   bond	   rotation	   and	   non-­‐bonded	   interactions.	   For	   the	   first	   three	   we	   used	   CHARMM	   standard	   values.	   To	  obtain	   partial	   atomic	   charges,	   HYP	   was	   examined	   with	   the	   MOPAC	   AM1	   (URL:	  http://OpenMOPAC.net/)	   ab	   initio	   method.	   The	   charges	   were	   almost	   all	  comparable,	  with	  small	  differences	   in	   the	  CD	  atom	  (see	  Supplementary	  material),	  which	  according	  to	  our	  calculations	  appears	  to	  be	  slightly	  positively	  charged,	  as	  it	  is	  bound	  to	  a	  peptide	  nitrogen	  atom,	  in	  agreement	  with	  previous	  AMBER	  calculations	  (74).	  The	  charges	  were	  implemented	  in	  CHARMM27	  force	  field,	  as	  previously	  done	  for	  collagen	  peptides	  (27,28).	  The	  resulting	  values	  are	  shown	  in	  Supplementary	  Fig.	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1.	  HYP567	  was	  generated	  keeping	  the	  same	  stereoisomer	  as	  HYP564,	  and	  both	  4-­‐hydroxyl	  moieties	  were	   placed	   in	   the	   (R)	   conformation.	   The	   total	   system	   charge	  was	  neutralized	  by	  one	   chloride	   ion.	  Default	  CHARMM	  parameters	  were	  used	   for	  ions	  in	  bulk	  solution.	  All	  systems	  were	  caged	  into	  periodic	  boundary	  condition	  cells	  and	  Particle	  Mesh	  Ewald	  (PME)	  grids.	  All	  MD	  runs	  are	  50	  ns	  long	  and	  performed	  on	  a	  x86	  Linux	  cluster.	  The	  average	  occupancy	  was	  32	  cores	  per	  run.	  To	  confirm	  the	  simulation	   results	   shown,	   two	   different	   MD	   runs	   were	   used	   for	   each	   analyzed	  system.	  The	  stereochemical	  quality	  of	   the	  system	  at	   frame	  0	  was	  confirmed	  using	  PROCHECK(77)	  and	  TAP	  (78).	  
2.4.2	  Electrostatic	  analysis	  	  Electrostatic	   interaction	  energies	  were	  derived	  using	  APBS	  (79),	  which	  calculates	  them	   by	   splitting	   the	   complex	   into	   two	   separate	   interactors.	   The	   transfer	   free	  energies	   are	   determined	   from	   a	   homogeneous	   dielectric	   environment	   to	   an	  inhomogeneous	   dielectric	   environment	  with	   different	   bulk	   and	   solvent	   dielectric	  constants.	   The	   difference	   between	   the	   energetic	   state	   of	   the	   divided	   interactors	  with	   inhomogeneous	  dielectrics	  and	   the	  complex	  with	   inhomogeneous	  dielectrics	  represents	  the	  binding	  energy	  estimate.	  The	  APBS	  calculations	  were	  carried	  out	  on	  the	  last	  frame	  of	  each	  run.	  
2.4.3	  Sequence	  analysis	  	  A	   multiple	   sequence	   alignment	   of	   the	   HIF-­‐1α	   sequence	   surrounding	   the	  hydroxylation	   site	   was	   extracted	   from	   Pfam(80))	   family	   PF11413	   to	   map	   the	  evolutionary	  conservation	  of	  residue	  P567.	  All	  Metazoan	  sequences,	  covering	  327	  sequences	   and	   100	   species	   were	   collected	   (accessed	   on	   25th	   June	   2013).	   A	  sequence	   logo	   was	   built	   with	   (81)	   from	   this	   data	   and	   overlaid	   with	   the	  experimental	   HIF-­‐1α	   peptide	   structure	   from	   PDB	   identifier	   1LM8,	   chain	   H	   (69).	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Intrinsic	  disorder	  for	  the	  HIF-­‐1α	  sequence	  was	  predicted	  with	  CSpritz	  (82).	  
2.5	  Results	  
2.5.1	  Molecular	  dynamics	  simulations	  	  The	   pVHL	   protein	   is	   composed	   of	   two	   main	   domains,	   termed	   a-­‐	   and	   β-­‐domain,	  respectively.	  The	  α-­‐domain	  is	  known	  to	  be	  partially	  disordered	  when	  not	  involved	  in	   interactions	  with	   other	   proteins,	  while	   the	   β-­‐domain	   is	   definitely	  more	   stable	  due	  to	  the	  presence	  of	  long	  β-­‐strands	  (see	  Fig.	  3).	  To	  investigate	  the	  effect	  induced	  by	   HIF-­‐1α	   P567	   hydroxylation,	   a	   50	   ns	   MD	   simulation	   was	   performed	   on	   the	  pVHL/HIF-­‐1α	   complex.	   Four	   different	   conditions	   were	   postulated	   and	   analyzed:	  hydroxylation	  of	  P564	  (HYP564),	  hydroxylation	  of	  P567	  (HYP567),	  hydroxylation	  of	  both	  P564	  and	  P567	  and	   the	  pVHL/HIF-­‐1α	  complex	  without	  post-­‐translational	  modifications.	  The	  unmodified	  complex	  was	  also	  used	  as	  baseline	  to	  configure	  the	  simulation	   environment.	   The	   variation	   of	   the	   weighted	   root-­‐mean-­‐square	  deviations	   (RMSD)	   was	   monitored	   to	   investigate	   the	   stability	   of	   pVHL/HIF-­‐1α	  interaction.	  RMSD	  plots	  obtained	  for	  the	  four	  analyzed	  systems	  are	  shown	  in	  Fig.	  4.	  The	  steady	  RMSD	  observed	  for	  the	  backbone	  atoms	  indicates	  that	  the	  four	  systems	  remain	  stable	  for	  the	  entire	  simulation	  time,	  with	  the	  main	  variations	  limited	  to	  the	  pVHL	   a-­‐domain.	   This	   result	   is	   consistent	   with	   the	   literature	   (65)	   and	   could	   be	  considered	   a	   reliability	   check	   of	   the	   MD	   simulation	   parameters	   used.	   The	  pVHL/HIF-­‐1α	  system	  with	  no	  hydroxyproline	  residues	  shows	  a	  modest	  but	   linear	  RMSD	   increase	   during	   time,	   suggesting	   possible	   major	   variations	   over	   longer	  simulation	   times.	   Analysis	   of	   the	   last	   MD	   frame	   reveals	   the	   complex	   to	   be	  compatible	  with	   the	   previously	   observed	   crystal	   structure,	   revealing	   small	   pVHL	  movements	   limited	   to	   the	   a-­‐domain.	   Binding	   between	  HIF	   and	   pVHL	   is	   correctly	  simulated	  and	  consistent	  with	  a	  pseudo	  β-­‐sheet	  connection	  of	  the	  HIF	  linear	  motif	  (residues	   Y565,	   I566,	   F572,	   Q573,	   L574)	   and	   the	   fourth	   pVHL	   β-­‐strand	   (H110,	  G106,	  T105,	  G104)	  as	  previously	  described	  (69).	  The	  internal	  HIF-­‐1α	  motif	  region	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from	  P566	  to	  D571	  shows	  a	  stable	  coil-­‐shaped	  organization	  with	  hydrogen	  bonds	  remaining	  stable	  during	  the	  entire	  simulation.	  	  
	  
Figure	   	   4:	  Weighted	   RMSD	   fluctuations	   of	   the	   pVHL/HIF-­‐1α	   complex	   backbone	   over	   time.	   The	   four	   panels	  
show	   the	   results	   without	   hydroxyproline	   (VHL-­‐HIF	   No	   HYP),	   with	   HYP564	   (VHL-­‐HYP	   564),	   with	   HYP567	  
(VHL-­‐HYP	   567)	   and	  with	   double	   hydroxylation	   at	  HYP564	   and	  HYP567	   respectively	   (VHL-­‐HIF	   2	  Hyp).	   The	  
RMSD	  variation	  was	  calculated	  from	  their	  initial	  position	  during	  50	  ns	  of	  MD	  simulation.	  
	  Similar	   results	   for	   this	   region	  were	  obtained	   for	  all	   tested	  systems.	  pVHL/HIF-­‐1α	  with	   HYP564	   shows	   smaller	   fluctuations	   in	   the	   β-­‐domain,	   probably	   due	   to	   the	  stabilizing	   effect,	   induced	   by	   interactions	   between	   pVHL	   S111,	   H115,	  W117	   and	  HYP564	   (see	   Fig.	   5).	   Bigger	   but	   not	   relevant	   variations	   (RMSD	   <0.5	   Å)	   were	  observed	   for	   the	  a-­‐domain,	  probably	   related	   to	   the	  absence	  of	   a	   stabilizing	  effect	  usually	  induced	  by	  the	  ElonginB/C-­‐Cullin2	  proteins	  which	  were	  not	  included	  in	  our	  simulations.	  The	  RMSD	  plot	  clearly	  shows	  how	  the	  overall	  system	  initially	  remains	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stable	  with	  little	  fluctuations.	  After	  40	  ns	  of	  simulation	  the	  RMSD	  value	  appears	  to	  follow	  a	  growing	  trend	  (Fig.	  4).	  pVHL/HIF-­‐1α	  with	  HYP567	  shows	  less	  fluctuations,	  with	   an	   estimated	   average	   RMSD	   value	   around	   0.2	   Å.	   Here,	   we	   tested	   if	   P567	  hydroxylation	   could	   play	   a	   role	   in	   pVHL/HIF-­‐1α	   complex	   formation.	   HYP	   in	  position	   567	   is	   able	   to	   promote	   a	   new	  hydrogen	   bond	  network	   localized	   around	  HYP567,	   shown	   in	  Fig.	   3,	   involving	   the	  pVHL	  H110,	  Q73,	  R108	  and	  HIF-­‐1α	  D569	  residues.	  This	  appears	  to	  confirm	  the	  observation	  that	  PHD-­‐3	  is	  able	  to	  hydroxylate	  a	   proline	   residue	   not	   strictly	   compliant	   with	   the	   LxxLAP	   motif.	   In	   the	   double	  hydroxylated	  pVHL/	  HIF-­‐1α	  system,	  the	  RMSD	  plot	  shows	  an	  intermediate	  pattern.	  For	  the	  first	  12	  ns,	  the	  system	  seems	  to	  replicate	  the	  previously	  observed	  behavior	  of	   the	   non-­‐HYP564,	   while	   it	   and	   gets	   closer	   to	   the	   HYP567	   behavior	   for	   the	  remaining	  38	  ns	  of	  simulation.	  A	  significant	  spike	  is	  visible	  at	  11	  ns	  (Fig.	  4)	  and	  MD	  frame	   analysis	   reveals	   a	   reorganization	   event	   of	   the	   hydrogen	   bond	   network	  around	   HYP564	   and	   HYP567.	   Spikes	   of	   similar	   magnitudes	   were	   also	   noted	   in	  RMSD	  plots	  for	  other	  simulations,	  but	  in	  these	  cases	  were	  related	  to	  rearrangement	  of	   single	   side	   chains	   involved	   in	   the	   VHL–HIF	   interaction.	   In	   the	   double	  hydroxylated	  system	  presence	  of	  the	  second	  hydroxyproline	  seems	  to	  promote	  an	  increased	   distance	   between	  HYP564	   and	   pVHL	   S111	   from	  2.86	   to	   4.34	  Å,	  with	   a	  consequent	   partial	   interruption	   of	   the	   hydrogen	   bond	   network.	   Although	   a	  reorientation	   event	   of	   HYP564	   and	   H115	   with	   respect	   to	   S111	   is	   visible,	   the	  interaction	   between	   these	   residues	   remains	   stable	   during	   the	   simulation.	   The	  rearrangement	  of	  connections	  seems	  to	  be	  due	  to	  the	  rigidity	  imposed	  by	  the	  new	  hydrogen	   bond	   network	   localized	   around	   HYP567	   and	   shown	   in	   Fig	   5.	   Our	  simulation	  results	  suggest	  pVHL	  residues	  H110,	  Q73,	  R108	  and	  HIF-­‐1α	  D569	  to	  be	  important	   to	   establish	   the	   hydrogen	   bond	   network	   around	   HYP567.	   Q73	   in	  particular	   seems	   to	  play	  a	  key	   role	   in	  establishing	   this	  network,	   although	   further	  experimental	  validation	  is	  necessary	  to	  confirm	  its	  role.	  Analysis	  of	  the	  pVHL	  –	  HIF-­‐1α	   HYP567	   complex	   trajectory	   suggests	   that	   the	   P567	   modification	   alone	   is	  sufficient	  to	  promote	  the	  organization	  of	  a	  well	  structured	  hydrogen	  bond	  network	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around	  this	  residue.	  Connections	  with	  the	  pVHL	  H110,	  Q73,	  R108	  and	  the	  HIF-­‐1α	  D569	   residues	   are	   apparently	   formed	   due	   to	   an	   increased	   distance	   between	   the	  coil-­‐shaped	   region	   and	   residues	   on	   the	   fourth	   pVHL	   β-­‐strand	   (data	   not	   shown).	  Based	   on	   MD	   simulation	   results,	   residue	   P567	   seems	   important	   in	   the	   complex	  formation.	  To	   investigate	   the	   role	  of	   single	   residues	   in	  VHL–HIF-­‐1α	   interaction,	   a	  root-­‐mean-­‐square	  fluctuation	  (RMSF)	  analysis	  was	  performed,	  see	  Supplementary	  material.	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2.5.2	  Control	  MD	  simulations	  	  In	  order	  to	  check	  the	  pVHL/HIF-­‐1α	  complex	  stability	   two	  control	  MD	  simulations	  were	   performed.	   The	   first	   one,	   derived	   from	   sequence	   analysis,	   containing	   the	  
Figure	  	  5:	  Hydrogen	  bond	  network	  around	  the	  hydroxylated	  HIF-­‐1α	  residues.	  A	  close-­‐up	  of	  the	  pVHL/HIF-­‐1α	  
complex	  is	  shown	  under	  different	  conditions	  in	  analogy	  to	  Fig.	  1.	  Side	  chains	  of	  involved	  in	  the	  hydrogen	  bond	  
network	   of	   the	   two	  hydroxylated	   prolines	   are	   shown	   as	   sticks,	   with	   thin	   blue	   lines	   representing	   hydrogen	  
bonds.	   The	   three	   panels	   are	   organized	   as	   follows:	   (A)	   Crystal	   structure	  with	   HYP564.	   (B)	   Hydrogen	   bond	  
network	  reorganization	  around	  residue	  HYP564	  promoted	  by	  hydroxylation	  of	  PRO567.	  (C)	  The	  putative	  new	  
hydrogen	  bond	  network	  around	  HYP567.	  Notice	   how	  hydroxylation	   of	   P567	   creates	   novel	   hydrogen	  bonds	  
with	  H110	  and	  Q73,	  while	  tilting	  the	  positions	  of	  S111	  and	  W117.	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P567S	  mutant,	   the	   second	   one	   consisting	   in	   P564L	   and	   P567L	  mutants.	   The	  MD	  simulations	  suggest	  no	  destabilization	  of	  the	  pVHL/HIF-­‐1α	  complex	  with	  the	  P567S	  substitution,	  consistent	  with	  its	  presence	  in	  a	  subset	  of	  HIF	  sequences.	  The	  P564L	  and	  P567L	  double	  mutant	  instead	  presented	  a	  significant	  destabilization	  leading	  to	  gradual	   dissociation	   of	   the	   HIF-­‐1α	   peptide	   from	   pVHL.	   A	  more	   detailed	   analysis,	  including	  RMSF,	  can	  be	  found	  in	  Supplementary	  material.	  
2.5.3	  HIF1-­‐α	  motif	  sequence	  analysis	  	  
To	  reinforce	  this	  observation,	  we	  made	  a	  conservation	  analysis	  of	  the	  HIF-­‐1α	  linear	  motif	   residues	   among	   homologous	   proteins	   by	   selecting	   all	   Metazoan	   HIF	  sequences	   in	   Pfam	   (see	   Fig.	   6).	   The	   sequence	   logo	   shows	   how	   the	  HIF-­‐1α	   linear	  motif	  is	  located	  in	  an	  ordered	  segment	  with	  strong	  sequence	  conservation,	  flanked	  by	   charged	   residues	   on	   both	   sides,	   inside	   an	   otherwise	   intrinsically	   disordered	  region.	   Such	   an	   arrangement	   is	   generally	   indicative	   of	   a	   functional	   linear	   motif	  
Figure	  	  6:	  Overview	  of	  the	  HIF-­‐1α	  peptide	  features.	  The	  HIF-­‐1α	  sequence	  logo	  surrounding	  the	  hydroxylation	  
site	  is	  shown	  with	  the	  canonical	  hydroxylation	  motif	  above	  and	  the	  human	  HIF-­‐1α	  sequence,	  features	  from	  
the	   crystallographic	   HIF-­‐1α	   structure	   (PDB	   identifier	  1lm8)	   and	  predicted	   disorder	   below.	   The	   secondary	  
structure	   is	  shown	  as	  a	  green	  line	  for	  coil	  and	  yellow	  arrow	  for	  β-­‐strand.	  Predicted	  disorder	   is	   shown	  as	  a	  
red	   line	   and	   predicted	   structure	   in	   light	   blue.	   The	   bottom	   part	   shows	   a	   schematic	   representation	   of	   the	  
simulated	   peptides,	  with	   red	  markers	  depicting	   the	   presence	  of	   hydroxylated	  prolines	   of	   the	   two	  modeled	  




(83).	   In	   particular,	   P567	   to	   be	   conserved	   in	   76%	   of	   sequences	   included	   in	   the	  alignment.	   The	   only	   substitution	   is	   serine	   (24%	   of	   sequences),	   a	   residue	  hypothetically	  compatible	  with	  the	  hydrogen	  bond	  network	  observed	  around	  P567	  (see	  Fig.	  5).	  To	  better	  understand	  the	  role	  of	  a	  serine	  567	  substitution,	  we	  analyzed	  the	  sequences	  presenting	  the	  substitution.	  The	  mutation	  seems	  to	  be	  present	  only	  in	  HIF-­‐3α	  orthologs	  and	  a	  less	  characterized	  subgroup	  including	  sweet	  water	  fish	  of	  the	   Cyprini-­‐formes	   order.	  HIF-­‐3α	  has	   a	   different	   expression	  pattern	   from	  HIF-­‐1α	  and	   -­‐2α	   (84).	   Sweet	   water	   ecosystems	   like	   shallow	   lakes	   or	   slow	   rivers	   during	  summer	   are	   subject	   to	   severe	   oxygen	   reduction	   connected	   with	   algal	   bloom	  phenomena	   (85).	   The	   existence	   of	   an	   adaptive	   hypoxia	   tolerance	   related	   to	  environmental	   conditions	   was	   recently	   demonstrated	   for	   a	   marine	   species,	   the	  common	   sole	   (Solea	   solea)	   (86).	   In	   other	  words,	   functional	   specialization	   among	  HIF	   paralogs	   and	   seasonal	   fluctuations	   of	   oxygen	   concentration	   may	   have	  influenced	   the	   evolution	   of	   an	   alternative	   regulation	   of	   the	   hypoxia	   response	  pathway	  including	  the	  S567	  mutation.	  
2.5.4	  In	  silico	  electrostatic	  binding	  energy	  calculation	  	  In	   order	   to	   confirm	  our	   results	  with	   experimental	   data,	   putative	   electrostatic	  DG	  values	  were	  calculated	  with	  APBS	  (79)	  (see	  Fig.	  6),	  which	  evaluates	  energetic	  states	  calculating	   the	   difference	   between	   the	   solvated	   unbound	   interactors	   and	   the	  solvated	   complex.	   The	   values	   obtained	  were	   compared	  with	   previously	   reported	  experimental	  values,	  where	  the	  complex	  containing	  HYP564	  was	  reported	  to	  have	  DG	  =	  -­‐9.1	  ±	  0.05	  kcal/mol	  (-­‐38.07	  kJ/mol),	  while	  no	  interactions	  could	  be	  detected	  by	  the	  authors	  on	  the	  non-­‐hydroxylated	  HYP564	  complex	  (69).	  According	  to	  APBS,	  the	  electrostatic	  DG	  contribution	  of	  HYP564	  to	  the	  complex	  is	  -­‐371	  kJ/	  mol,	  which	  is	   consistent	  with	   the	   reported	  DG	   trend.	  Repulsive	   forces	   seem	   to	   appear	   in	   the	  tested	  non-­‐hydroxylated	  complex,	  with	  a	  positive	  electrostatic	  contribution	  of	  14.2	  kJ/mol,	   consistent	   with	   (69).	   Based	   upon	   these	   consistent	   results,	   electrostatic	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contributions	  were	  calculated	  with	  APBS	  for	  all	  complexes.	  The	  resulting	  putative	  electrostatic	  contribution	  of	  the	  HYP564/HYP567	  complex	  was	  -­‐457.5	  kJ/mol.	  The	  HYP567	  complex	  showed	  a	  very	  similar	  putative	  value	  of	  -­‐457.3	  kJ/mol.	  Given	  the	  in	   silico	   nature	   of	   the	   results,	   we	   cannot	   exclude	   other	   interpretations	   or	  conclusions	  except	  that	  a	  set	  of	  residues	  present	  on	  pVHL	  is	  compatible	  with	  a	  post	  translational	  modification	  of	  both	  P564	  and	  P567	  residues.	  
2.6	  Discussion	  	  In	  this	  work	  we	  presented	  results	  obtained	  from	  MD	  simulations	  of	  the	  pVHL/HIF-­‐1α	   complex.	   Four	   different	   hydroxylation	   patterns	   (and	   two	   controls)	   were	  simulated	  for	  the	  proline	  residues	  present	  on	  a	  small	  linear	  motif	  of	  HIF-­‐1α	  known	  to	  interact	  with	  pVHL.	  The	  simulation	  started	  from	  an	  observation	  of	  Fedulova	  et	  al.	  (6)	  that	  PHD-­‐3,	  a	  member	  of	  human	  PHD	  family,	  hydroxylates	  the	  P567	  residue	  not	  included	   in	   the	  canonical	  LxxLAP	  motif	  usually	   required	  by	  PHD	  enzymes.	  PHD-­‐3	  differs	   from	   other	   PHD	   family	   members	   by	   size,	   cellular	   localization	   and	   target	  specificity	  (71).	  Here,	  we	  tested	  the	  structural	  compatibility	  of	  P567	  hydroxylation	  through	  MD	  simulations	  of	  the	  effect	  of	  this	  non-­‐conventional	  hydroxylation	  on	  the	  interaction	   interface	   between	   pVHL	   and	   the	   HIF-­‐1α	   linear	   motif.	   Our	   results	  suggest	  that	  a	  previously	  not	  described	  reorganization	  of	  hydrogen	  bond	  network	  between	   pVHL	   and	   HIF-­‐1α	   appears	   around	   the	   HIF-­‐1α	   P567	   linear	   motif	   when	  hydroxylated.	  Recently,	  Jaakkola	  and	  coworkers	  (87)	  demonstrated	  involvement	  of	  PHD-­‐3	   in	   apoptotic	   events	   under	   normoxia,	   apparently	   related	   to	   an	   over-­‐saturation	  of	  the	  proteosomal	  degradation	  system	  connected	  with	  massive	  protein	  aggregation.	   They	   also	   demonstrated	   a	  massive	   transcription	   induction	   of	   PHD-­‐3	  mRNA	   promoted	   by	   HIF-­‐1α	   (73).	   Again,	   their	   work	   demonstrates	   how	   PHD-­‐3	  activity	   is	   maximal	   when	   oxygen	   concentration	   is	   restored	   after	   strong	   hypoxia	  events,	  probably	  co-­‐occurring	  with	  PHD-­‐1	  and	  -­‐2	  reactivation.	  Our	  results	  suggest	  that	   the	   reorganization	   of	   the	   hydrogen	   bond	   network	   also	   appears	   when	   both	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HYP564	  and	  HYP567	  are	  present.	  This	  scenario	  is	  consistent	  with	  two	  distinct	  post	  translational	   modifications	   due	   to	   the	   subsequent	   activity	   of	   two	   different	   PHD	  enzymes.	   On	   the	   other	   hand,	   due	   to	   the	   massive	   expression	   of	   PHD-­‐3	   during	  hypoxia,	   it	   is	  also	  possible	   to	   imagine	   that	  double	  hydroxylation	   is	   the	  result	  of	  a	  higher	  intracellular	  concentration	  of	  PHD-­‐3.	  The	  latter	  is	  also	  known	  to	  be	  actively	  expressed,	   under	   normal	   conditions,	   only	   in	   heart	   and	   brain	   tissues	   (72,87,88).	  Considering	  our	  results	  in	  context	  of	  this	  evidence,	  it	  is	  easy	  to	  speculate	  that	  they	  could	  indicate	  an	  alternative	  regulation	  pathway	  trigged	  by	  the	  PHD-­‐3	  enzyme.	  In	  other	   words,	   we	   can	   imagine	   that	   hydroxylation	   of	   P567	   could	   act	   as	   a	  reinforcement	  of	  the	  ubiquitin–proteasome	  degradation	  pathway	  evolving	  in	  highly	  specialized	  tissues,	  which	  are	  very	  sensible	  to	  oxygen	  variation.	  While	  this	  evidence	  is	   suggestive,	   we	   cannot	   assume	   that	   the	   obtained	   computational	   results	   are	  exclusively	   connected	   with	   PHD-­‐3	   activity	   and	   more	   complex	   scenarios	   where	  different	  PHDs	  act	   in	  concert	  cannot	  be	  excluded.	  Furthermore,	  data	  presented	   in	  this	   work	   suffers	   from	   limits	   and	   approximations	   inherent	   in	   computational	  techniques.	   Despite	   the	   apparently	   good	   results	   obtained	   with	   50	   ns	   MD	  simulations,	   we	   cannot	   exclude	   complex	   dissociation	   on	   longer	   timescales.	  Performing	  micro	  or	  millisecond	  simulations	  may	  provide	  different	  outcomes,	  but	  is	   still	   computationally	   too	   expensive	   to	   be	   feasible.	   Finally,	   understanding	   the	  biological	   role	   and	   relevance	   of	   the	   results	   presented	   on	   the	   etiopathogenesis	   of	  VHL	  disease	  will	  require	  experimental	  confirmation,	  as	  it	  is	  beyond	  the	  possibility	  of	  the	  in	  silico	  techniques	  used.	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3.	  Design	  and	  analysis	  of	  a	  Petri	  net	  	  model	  of	  the	  
Von	  Hippel-­‐Lindau	  (VHL)	  tumor	  suppressor	  
interaction	  network.	  	  	  This	  chapter	  has	  been	  published	  in	  (16)	  Minervini	  G,	  Panizzoni	  E,	  Giollo	  M,	  Masiero	  A,	   Ferrari	   C,	   Tosatto	   SCE.	   Design	   and	   Analysis	   of	   a	   Petri	   Net	   Model	   of	   the	   Von	  Hippel-­‐Lindau	   (VHL)	   Tumor	   Suppressor	   Interaction	   Network.	   PloS	   One.	  2014;9(6):e96986.	  
3.1	  Summary	  	  	  The	   best-­‐characterized	   function	   of	   pVHL	   is	   the	   ubiquitination	   dependent	  degradation	   of	   Hypoxia	   Inducible	   Factor	   (HIF)	   via	   the	   proteasome.	   It	   is	   also	  involved	   in	   several	   cellular	   pathways	   acting	   as	   a	   molecular	   hub	   and	   interacting	  with	  more	  than	  200	  different	  proteins.	  Molecular	  details	  of	  pVHL	  plasticity	  remain	  in	   large	   part	   unknown.	   Here,	   we	   presented	   a	   manually	   curated	   Petri	   Net	   (PN)	  model	  of	  the	  main	  pVHL	  functional	  pathways.	  The	  model	  was	  built	  using	  functional	  information	  derived	  from	  the	  literature.	  It	  includes	  all	  major	  pVHL	  functions	  and	  is	  able	  to	  credibly	  reproduce	  VHL	  syndrome	  at	  the	  molecular	  level.	  The	  reliability	  of	  the	   PN	   model	   also	   allowed	   in	   silico	   knockout	   experiments.	   The	   network	   was	  designed	   in	   the	   Snoopy	   PN	   framework.	   We	   chose	   Snoopy	   to	   facilitate	   future	  extensions	   of	   the	   VHL	   pathway	   presented	   here.	   Both	   Charlie	   and	   PInA	   analyzers	  were	  used	  for	  PN	  analysis	  and	  validation.	  Further,	  in	  silico	  knock	  out	  experiments	  were	  used	  to	  test	  the	  biological	  reliability	  of	  the	  model.	  Structural	  model	  validation	  was	  made	  by	  analysis	  of	  the	  T-­‐invariants	  to	  demonstrate	  whether	  the	  system	  was	  covered	   by	  T-­‐invariants	   and	   to	   confirm	   the	   biological	  meaning	   of	   each	   invariant.	  The	   computed	   invariants	   were	   grouped	   in	   Maximal	   Common	   Transition	   Sets	  (MCTS)	  and	  Clusters,	  the	  former	  based	  on	  occurrence	  of	  specific	  sets	  of	  transition	  inside	   the	   various	   T-­‐invariants,	   and	   the	   latter	   based	   on	   similarities	   between	   T-­‐
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invariants.	   The	   validation	   was	   made	   by	   selectively	   deleting	   tokens	   inside	   the	  model,	  imitating	  possible	  biological	  disruptions	  such	  as	  disease-­‐causing	  mutations.	  We	  started	  from	  the	  transcription	  activity	  of	  HIF	  due	  to	   its	  regulation	  is	   the	  most	  studied	   pVHL	   function.	   Our	   model,	   as	   expected	   from	   literature	   data,	   shows	   that	  HIF-­‐1α	  enters	  the	  nucleus	  when	  not	  degraded	  by	  pVHL.	  It	  subsequently	  binds	  HIF-­‐1β	  to	  form	  the	  HIF	  heterocomplex,	  which	  interacts	  with	  DNA.	  The	  model	  simulates	  the	  increased	  affinity	  of	  HIF	  towards	  DNA.	   	  The	  network	  itself	  was	  the	  first	  result	  we	   obtained,	   and	   we	  made	   it	   publicly	   available	   for	   further	   implementation.	   The	  network	  proved	  to	  be	  alive,	  covered	  in	  T-­‐invariants	  and	  usable	  for	  the	  analysis.	  The	  in	  silico	  knock	  out	  experiments	  provided	  the	  following	  results:	  (i)	   pVHL	   knock	   out.	   Degradation	   of	   HIF-­‐1α	   is	   not	   completely	   depleted	   due	   to	  presence	  of	  both	  p53-­‐	  and	  GSK3β-­‐dependent	  alternative	  degradation	  pathways.	  All	  other	   processes	   usually	   inhibited	   by	   pVHL	   take	   place	   in	   an	   uncontrolled	   way,	  including	   creation	   of	   VEGF	   via	   Sp1	   transcription	   activity	   and	   increased	   matrix	  regulation	  due	  to	  lack	  of	  fibronectin	  crosslinking.	  Hur	  resulted	  constantly	  activated	  and	   nur77	   can	   stimulate	   synthesis	   of	   Proopiomelanocortin,	   precursor	   for	   the	  Adrenocorticotropic	   hormone.	   Card9	   increases	   release	   of	   tumor	   necrosis	   factor,	  and	  NF-­‐kB	  when	   not	   inhibited	   by	   pVHL.	   Instead,	   Jade1	   is	   unable	   to	   survive	   long	  enough	  to	  inhibit	  β−catenin,	  generating	  a	  proliferation	  signal	  with	  Wnt.	  Lactic	  acid	  is	   also	   not	   produced	   due	   to	   LDH	   enzyme	   production	   being	   HIF-­‐1α	   transcription	  activity	  dependent.	  	  (ii)	   HIF-­‐1α	   knock	   out.	   VEGF	   is	   still	   created	   thanks	   to	   Sp1,	   thus	   oxygen	   is	   still	  generated	  even	  if	   in	   lower	  proportion.	   If	  HIF-­‐1α	  and	  Sp1	  are	  both	  knocked	  out	  at	  the	  same	  time,	  oxygen	  is	  quickly	  consumed	  and	  the	  metabolism	  is	  soon	  unable	  to	  proceed.	  Lactic	  acid	  is	  not	  produced	  due	  to	  LDH	  enzyme	  production	  being	  HIF-­‐1α	  transcription	   activity	   dependent.	   Glycolysis	   and	   glycogen	   are	   produced	   normally	  and	   the	  metabolism	   is	  not	   inhibited	  by	  PyrDH	  negative	   regulation	  and	   lactic	   acid	  formation.	   Since	   pVHL	   is	   present,	   other	   tumor	   suppressor	   activities	   are	   enabled,	  except	   for	   proteasomal	   degradation	   of	   HIF-­‐1α	   due	   to	   the	   substrate	   being	   non-­‐
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existent.	   My	   role	   in	   this	   work	   passed	   from	   the	   validation	   of	   protein-­‐protein	  interactions	  to	  the	  interpretation	  of	  the	  output	  provided	  by	  the	  analysis.	  	  	  
3.2	  Abstract	  	  	  Von	  Hippel-­‐Lindau	  (VHL)	  syndrome	   is	  a	  hereditary	  condition	  predisposing	   to	   the	  development	   of	   different	   cancer	   forms,	   related	   to	   germline	   inactivation	   of	   the	  homonymous	  tumor	  suppressor	  pVHL.	  The	  best	  characterized	  function	  of	  pVHL	  is	  the	  ubiquitination	  dependent	  degradation	  of	  Hypoxia	  Inducible	  Factor	  (HIF)	  via	  the	  proteasome.	   It	   is	  also	   involved	   in	   several	   cellular	  pathways	  acting	  as	  a	  molecular	  hub	   and	   interacting	   with	   more	   than	   200	   different	   proteins.	   Molecular	   details	   of	  pVHL	  plasticity	  remain	  in	  large	  part	  unknown.	  Here,	  we	  present	  a	  novel	  manually	  curated	   Petri	  Net	   (PN)	  model	   of	   the	  main	   pVHL	   functional	   pathways.	   The	  model	  was	   built	   using	   functional	   information	   derived	   from	   the	   literature.	   It	   includes	   all	  major	   pVHL	   functions	   and	   is	   able	   to	   credibly	   reproduce	   VHL	   syndrome	   at	   the	  molecular	   level.	   The	   reliability	   of	   the	   PN	   model	   also	   allowed	   in	   silico	   knockout	  experiments,	  driven	  by	  previous	  model	  analysis.	  Interestingly,	  PN	  analysis	  suggests	  that	   the	   variability	   of	   different	   VHL	   manifestations	   is	   correlated	   with	   the	  concomitant	  inactivation	  of	  different	  metabolic	  pathways.	  	  
3.3	  Introduction	  	  	  Pathological	  deregulation	  of	  cellular	  pathways	  often	  results	  in	  a	  family	  of	  complex	  and	   correlated	   diseases	   commonly	   termed	   cancer	  (2).	   Cancer	   is	   a	  multi	   factorial	  disease	   where	   different	   causes	   contribute	   to	   its	   development.	   Several	  computational	  methods	   have	   been	   developed	   to	   explore	   the	   functional	   pathways	  involved	   in	   tumorigenesis.	   Some	   of	   them	   focus	   on	   differential	   gene	   expression	  between	   healthy	   and	   pathologic	   tissues	   (89,90),	   on	   protein-­‐protein	   interaction	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network	   analysis(61,62))	   or	   on	   molecular	   dynamics	   simulations(54).	   Other	  methods	  approach	   the	  disease	   through	  discretization	  of	  pathological	   components	  that	   result	   in	   tumo(91).	   All	   of	   these	   approaches	   are	   very	   powerful	   when	   the	  variables	  related	  to	  the	  disease,	  although	  complex,	  are	  well	  known	  and	  studied.	  A	  multi-­‐factorial	   disease	   can	   be	   approached	   by	   means	   of	   mathematical	   theory,	  building	  a	  theoretical	  model	  where	  cell	  components	  are	  connected	  with	  each	  other.	  In	  biology,	  several	  problems	  were	  dealt	  with	  network	  theory	  (47,48).	  A	  network	  is	  a	   group	   of	   objects	   strongly	   inter-­‐connected	   with	   each	   other	   (e.g.	   proteins	   and	  enzymes	   of	   a	   pathway	   or	   animals	   belonging	   to	   interacting	   populations).	   Their	  construction	  and	  subsequent	  simulation	   is	  made	  via	  mathematical	  analysis	  of	   the	  connections	   between	   nodes	   found	   in	   the	   system	   and	   their	   time-­‐dependent	  behaviour(48)).	   A	   biological	   network	   is	   generally	   composed	   of	   proteins,	   nucleic	  acids	   and	   cofactors	   connected	   by	   biological	   reactions	   such	   as	   protein	   complex	  formation	  or	  enzyme	  activity	  regulation	  (48).	  Von	  Hippel-­‐Lindau	  syndrome	  (VHL)	  (94)	  is	  a	  good	  study	  case	   to	   test	   the	  network	   theory	  applied	   to	  cancer	  due	   to	   the	  similar	   medical	   history	   and	   pathological	   phenotype	   that	   patients	   share.	   While	  hereditary	   cancers	   represent	   only	   a	   small	   part	   of	   all	   human	   tumors,	   their	  investigation	   represents	  a	   challenge	   to	  understand	   the	  pathway	   leading	   to	   tumor	  formation.	  In	  2010,	  Heiner	  et	  al.	  first	  approached	  VHL	  using	  the	  so-­‐called	  Petri	  Net	  (PN)	   simulation	   networks	   (95).	   Their	   work,	   inspired	   by	   a	   previous	   theoretical	  model	   of	   cellular	   oxygen-­‐related	   pathways	  ((96,97),	   was	   a	   preliminary	  investigation	  of	  the	  core	  oxygen	  sensing	  system	  and	  its	  connection	  with	  VHL	  onset.	  Heiner	  and	  coworkers	  proposed	  three	  different	  functional	  modules	  responsible	  for	  hypoxia	   network	   control	   and	   for	   HIF-­‐1α	   degradation	   (51).	   In	   other	   words,	   they	  theorized	  that	  hereditary	  forms	  of	  cancer,	  such	  as	  different	  manifestations	  of	  VHL,	  are	  the	  result	  of	  different	  and	  concomitantly	  compromised	  metabolic	  pathways.	  
3.3.1	  Von	  Hippel-­‐Lindau	  Disease	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Von	  Hippel-­‐Lindau	  protein	   (pVHL)	   is	   the	  product	   of	   the	   von	  Hippel-­‐Lindau	   gene,	  located	   in	   the	   short	   arm	   of	   3rd	   chromosome,	   and	   constantly	   transcribed	   in	   both	  fetal	  and	  adult	  tissues	  (4).	  Mutations	  of	  pVHL	  are	  related	  to	  a	  pathological	  outcome	  termed	   VHL	   syndrome,	   an	   inherited	   form	   of	   cancer	   (3).	   VHL	   syndrome	   is	  characterized	  by	  cysts	  and	  tumors	  growing	  in	  specific	  parts	  of	  the	  organism	  (3,12).	  It	  is	  considered	  a	  severe	  autosomal	  dominant	  genetic	  condition	  with	  inheritance	  of	  one	  person	  in	  over	  35,000	  (15).	  The	  tumor	  injuries,	  which	  can	  be	  either	  benign	  or	  malign,	   are	   usually	   located	   in	   the	   retina,	   adrenal	   glands,	   epididymis,	   central	  nervous	   system,	  kidneys	  and	  pancreas(56).	  As	   a	   genetic	  disorder,	  VHL	   syndrome	  follows	  Knudson’s	  two	  hit	  principle.	  A	  copy	  of	  the	  gene	  is	  mutated	  in	  the	  germ	  line,	  but	   the	   other	   gene	   copy	   still	   produces	   a	   functional	   protein.	   Complete	   protein	  inactivation	   appears	   during	   life	   due	   to	   somatic	   inactivation	   of	   the	   remaining	  functional	   copy	  (17).	   On	   the	   contrary,	   mutations	   occurring	   during	   early	   fetal	  formation	  result	  in	  unsuccessful	  development(18).	  The	  pVHL	  gene	  has	  11,213	  base	  pairs	   including	   three	   exons	  (15)	   and	   the	   final	   transcript	   is	   a	   protein	   commonly	  present	   in	   two	   isoforms:	   pVHL30	   and	   pVHL19,	   of	   213	   and	   160	   residues	  respectively.	   Neither	   isoform	   contains	   a	   known	   enzymatic	   domain,	   but	   rather	  appears	   to	  serve	  as	  a	  multipurpose	  adapter	  protein	  engaging	   in	  multiple	  protein-­‐protein	  interactions	  (5).	  pVHL	  structure	  is	  organized	  in	  an	  α-­‐	  and	  β-­‐domain	  and	  its	  stability	  was	  demonstrated	  to	  be	  ensured	  by	  direct	  interaction	  with	  other	  proteins	  such	  as	  Elongins	  B	  and	  C(98).	  Both	  Elongin	  B	  and	  C	  are	  also	  required	  for	  the	  best	  characterized	   function	   of	   pVHL,	   the	   ubiquitination	   dependent	   degradation	   of	  Hypoxia	   Inducible	   Factor	   (HIF)	   via	   the	   proteasome	  (13).	   However,	   pVHL	   is	  considered	  a	  multipurpose	  protein	  due	  to	  its	  high	  number	  of	  known	  interactors.	  At	  the	   time	   of	   writing,	   the	   IntAct	   database(99))	   presents	   more	   than	   200	   different	  interaction	  partners,	  with	   some	  of	   them	  competing	   for	   the	   same	  Elongin	  binding	  site.	   Indeed,	  pVHL	  was	   found	   in	  different	  cellular	  compartments	  and	  seems	   to	  be	  involved	   in	  many	  different	  cellular	  processes	  such	  as	  apoptosis,	  cell	  proliferation,	  survival	   and	   motility	  (100).	   Considering	   the	   huge	   number	   of	   interactors	   and	  
	  38	  
multiple	   cellular	   localizations,	   many	   different	   functions	   have	   been	   described	   or	  hypothesized,	   such	  as	   regulation	  of	   cytoplasmic	  microtubules	  during	  mitosis	  (60)	  and	   endothelial	   extracellular	   matrix	   deposition	   (101).	   On	   the	   other	   hand,	  considering	  the	  huge	  number	  of	  players	  involved	  in	  VHL	  syndrome	  and	  the	  lack	  of	  reliable	  kinetic	  data,	  a	  PN	  based	  approach	  may	  be	  a	  preferable	  option	  for	  an	  entire	  VHL	  pathway	  simulation.	  
3.3.2	  Petri	  Net	  for	  Interaction	  Pathways	  	  Since	  their	  invention,	  by	  Carl	  Adam	  Petri	  in	  the	  early	  sixties,	  PNs	  were	  mostly	  used	  to	   describe	   technical	   systems,	   but	   later	   the	   utility	   in	   describing	   biological	   and	  biochemical	   functions	   has	   also	   been	   demonstrated	  (53).	   PNs	   were	   successfully	  used	  in	  many	  studies	  to	  describe	  biological	  networks	  ((49)	  such	  as	  the	  regulation	  and	  etiopathology	   in	  human	  Duchenne	  Muscular	  Dystrophy	  (51)	   and	   the	  hypoxia	  response	   network	  (95).	   PNs	   are	   qualitative	   mathematical	   models	   that	   can	  graphically	   represent	   many	   object	   types,	   not	   only	   metabolites	   but	   also	   different	  protein	  states	  and	  are	  useful	  to	  simulate	  networks	  where	  not	  only	  metabolites	  are	  involved.	  Indeed,	  PNs	  can	  be	  a	  powerful	  tool	  to	  study	  all	  concurrent	  interactions	  in	  a	  specific	  pathway,	  even	  if	  the	  proteins	  or	  kinetics	  are	  not	  well-­‐known.	  Due	  to	  the	  large	  number	  of	  different	  pVHL	  functions	  involved	  in	  VHL	  disease	  progression,	  we	  decided	   to	   extend	   the	   PN	   based	   analysis	   of	  (95)	   increasing	   the	   number	   of	  considered	   protein-­‐protein	   interactions.	  We	   generated	   a	   novel	  manually	   curated	  PN	  model	   of	   the	   entire	  VHL	   regulation	   system	  collecting	  data	   from	   the	   literature	  and	  including	  the	  signaling	  pathways	  and	  glucidic	  metabolism.	  In	  order	  to	  build	  a	  realistic	   network,	   literature	   from	   both	   biochemical	   experiments	   and	  in	  
silicopredictions	   were	   used	   as	   source.	   It	   was	   decided	   to	   build	   a	   PN	   with	   only	  confirmed	  pVHL	  interactions	  whose	  function	  was	  also	  known.	  The	  resulting	  PN	  was	  validated	  using	  an	  analysis	  of	  specific	  properties	  as	  suggested	  by	  previous	  studies	  using	  the	  same	  method	  ((53).	  After	  validating	  the	  PN	  structure,	  in	  silico	  knock	  outs	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of	  specific	  proteins	  were	  done	  in	  order	  to	  observe	  the	  different	  network	  behaviors	  and	  the	  resulting	  biological	  effect.	  	  
3.4	  Methods	  	  The	   network	   was	   designed	   in	   the	   Snoopy	   PN	   framework	   (version	   2,	   revision	  1.13)	  (102),	   respecting	   the	  mathematical	   PN	   formalism	   as	   described	   in	   (95,103).	  PN	  were	  demonstrated	  to	  be	  useful	  in	  describing	  discrete	  and	  concurrent	  processes	  in	   a	   simple	   graphical	   representation	   (49)	  and	   have	   been	   used	   to	   describe	  biomedical	   processes	   due	   to	   their	   capacity	   of	   representing	   sequential	   steps	   in	   a	  process.	  PN	  modeling	  methods	  are	  actively	  used	  to	  describe,	  simulate,	  analyze,	  and	  predict	  the	  behavior	  of	  biological	  systems.	  The	  Snoopy	  PN	  framework	  provides	  an	  extensible	   multi-­‐platform	   framework	   to	   design,	   animate,	   and	   simulate	   Petri	  nets	  (102).	   We	   chose	   Snoopy	   to	   facilitate	   future	   extensions	   of	   the	   VHL	   pathway	  presented	  here.	  Among	  different	  available	  PN	  types	  a	  standard	  PN	  was	  chosen	  to	  limit	   the	  number	  of	  variables.	  Both	  Charlie	  and	  PInA	  analyzers	  were	  used	   for	  PN	  analysis	  and	  validation	  (104).	  Further,	  in	  silico	  knock	  out	  experiments	  were	  used	  to	  test	  the	  biological	  reliability	  of	  the	  model.	  Structural	  model	  validation	  was	  made	  by	  analysis	  of	  the	  T-­‐invariants	  to	  demonstrate	  whether	  the	  system	  was	  covered	  by	  T-­‐invariants	   and	   to	   confirm	   the	  biological	  meaning	  of	   each	   invariant.	  The	  use	  of	  T-­‐	  and	  P-­‐invariants	  is	  given	  by	  their	  own	  properties:	  they	  are	  a	  set	  (of	  transitions	  or	  places,	   respectively)	   that	   allows	   the	   reproduction	   of	   the	   same	   state	  after	  n	  transformations.	  A	  P-­‐invariant	  represents	  a	  set	  of	  places	  where	  the	  number	  of	   tokens	   is	   constant	   and	   independent	   on	   the	   firing	   rate.	   A	   T-­‐invariant	   instead	  represents	  a	  set	  of	   transitions	   that	  cyclically	  comes	  back	  to	  show	  the	  same	   initial	  set.	   Biologically	   a	   P	   invariant	   can	   represent	   the	   process	   of	   regulating	   a	   protein,	  whereas	   T	   invariants	   can	   represent	   cyclical	   biochemical	   transformations	   such	   as	  metabolic	  reactions.	  To	  this	  end,	  the	  computed	  invariants	  were	  grouped	  in	  Maximal	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Common	  Transition	  Sets	  (MCTS)	  and	  Clusters,	   the	   former	  based	  on	  occurrence	  of	  specific	   sets	   of	   transition	   inside	   the	  various	  T-­‐invariants,	   and	   the	   latter	  based	  on	  similarities	   between	   T-­‐invariants.	   Different	   numbers	   of	   clusters	   will	   be	   defined	  depending	   on	   the	   resulting	   square	   matrix.	   Where	   MCTS	   create	   disjunctive	   nets,	  Clusters	  merge	   together	   similar	   T-­‐invariants.	   Behavioral	   validation	  was	  made	   by	  selectively	   deleting	   tokens	   inside	   the	   model,	   imitating	   possible	   biological	  disruptions	   such	   as	   disease-­‐causing	   mutations.	   The	   resulting	   network	   behavior	  was	   compared	   to	  what	   is	   reported	   in	   the	   literature.	   Total	   runtime	   for	   invariants	  computation	  were	   less	   than	  ten	  seconds	  on	  a	  mainstream	  Linux	  x86	  workstation.	  Literature	  sources	  used	  to	  build	  the	  model	  are	  reported	  in	  Table	  S1	  (see	  Appendix).	  The	  Snoopy	  framework	  for	  PN	  construction,	  Charlie	  and	  PInA	  tools	  for	  analysis	  are	  available	   at	   the	   website	   (URL:	  http://www-­‐dssz.informatik.tu-­‐cottbus.de/DSSZ/Software).	   Finally,	   the	  model	  was	   used	   to	   simulate	   the	   network	   behavior	  through	   visual	   inspection	   of	   both	   token	  movement	   and	   accumulation	   in	   specific	  parts	   of	   the	   network.	   For	   a	   visual	   explanation	   of	   token	  movement	   in	   a	   PN	   refer	  to	  Video	  S1	  (available	  only	  for	  the	  online	  version).	  
Model	  Availability	  
The	  resulting	  VHL	  disease	  PN	  model	  is	  available	  in	  File	  S1	  (see	  Appendix).	  
3.5	  Results	  	  
3.5.1	  Notations	  and	  Assumptions	  	  The	   PN	   built	   here	   focuses	   on	   pVHL	   interactions	   that	   were	   already	   proven	   by	  biochemical	   experiments	   and	   reported	   in	   the	   literature.	   We	   chose	   to	   model	   a	  realistic	   VHL	   disease	   pathways	   based	   on	   confirmed	   literature	   data,	   including	   all	  known	   VHL	   functions,	   VHL	   related	   signal	   pathway	   and	   glucidic	   metabolism.	   All	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bibliographic	   sources	   used	   to	   design	   the	   model	   are	   presented	   in	  Table	   S1	   (see	  Appendix).	  The	  final	  PN	  is	  composed	  of	  323	  places	  and	  238	  transitions,	  connected	  by	  801	  arcs.	  Tables	   S1	  and	  S2	   (see	  Appendix)	  show	  all	   places	   and	   transitions	   and	  the	   related	   biological	   correspondence.	   Places	   are	   mainly	   proteins	   and	   enzymes,	  while	   some	   represent	   DNA	   or	   small	   molecular	   substrates	   such	   as	   glucose	   and	  cofactors	   (e.g.	   ATP).	   Notation	   for	   both	   pre-­‐	   and	   post-­‐places	   and	   their	   biological	  meaning	  are	  explained	  in	  Table	  S1	  (see	  Appendix).	  In	  a	  few	  cases,	  places	  are	  used	  to	  represent	  a	  whole	  group	  of	  changes	  generated	  by	  DNA	  transcription,	  (e.g.	  p_32	  and	  p_33	  or	  Et_eff1	  and	  Et_eff2).	  Transitions	  instead	  symbolize	  complex	  formation	  between	  two	  proteins	  or	  post-­‐translational	  modifications.	  Output	  transitions	  stand	  for	   degradation	   or	  movement	   to	   other	   parts	   of	   the	   cell	   or	   organism	   to	   complete	  their	   functions	   (e.g.	   degrad_1	   and	   degrad_2)	  whereas	   input	   transitions	   show	   the	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generation	  of	  a	  substrate	  or	  protein.	  In	  order	  to	  simplify	  the	  design	  of	  such	  a	  large	  network,	  we	  decided	  to	  use	  macro	  nodes	  to	  group	  reactions	  representing	  complex	  molecular	  pathways	  such	  as	  signaling	  pathways	  or	  secondary	  signal	  cascades.	  The	  whole	   process	   is	   merged	   into	   a	   single	   node	   with	   a	   given	   name	   to	   allow	   visual	  inspection	  only	  in	  case	  of	  need.	  From	  the	  top	  level	  all	  transitions	  can	  still	  be	  found	  in	  a	  hierarchical	  lower	  layout	  level.	  Logic	  nodes	  were	  used	  for	  places	  participating	  in	  many	  reactions	  throughout	  the	  network	  such	  as	  ATP	  and	  ADP	  (7	  logical	  copies	  each)	  or	  NAD	  and	  NADH	  (4	   logical	  copies	  each).	  A	  total	  nesting	  depth	  of	   two	  was	  chosen	  to	  model	  macro	  nodes.	  Special	  arcs	  were	  not	  used	  while	  we	  chose	  to	  model	  the	  permanent	  presence	  of	  some	  objects	  using	  double	  arcs	  (e.g.	   for	  elob,	  eloc	  and	  places	   standing	   for	   enzymatic	   activity).	   In	   case	   of	   proteins,	   which	   are	   actively	  degraded,	   it	   was	   preferred	   to	   create	   an	   input	   transition	   simulating	   constant	  
	   43	  	  
production	   (or	   synthesis)	   and	   an	   output	   for	   consumption.	   This	   is	   the	   case	   for	  pkcz2,	   Jade1,	   pVHL	   and	   HIF-­‐1α.	   As	   can	   be	   seen	   from	  figures	   7	  to	  10,	   which	  
represent	  the	  entire	  model,	  two	  major	  nodes	  can	  be	  immediately	  identified:	  pVHL	  and	  vcb,	  the	  complex	  made	  by	  pVHL	  and	  the	  two	  elongins.	  Another	  relevant	  part	  is	  the	   glucidic	   metabolism,	   modeled	   due	   to	   its	   hypoxia-­‐induced	   regulation.	   It	   is	  represented	  in	  detail	  in	  Figure	  8.	  
	  
Figure	  	  7:	  Lower	  hierarchical	  PN	  levels.	  
Pathways	  from	  the	  top	  level	  are	  grouped	  in	  macro-­‐nodes	  (functional	  subordinated	  layer),	  in	  particular	  glucidic	  




















Figure	  	  8:	  Lower	  hierarchical	  PN	  levels.	  
Pathways	  from	  the	  top	  level	  are	  grouped	  in	  macro-­‐nodes	  (functional	  subordinated	  layer),	  in	  particular	  glucidic	  
metabolism	  and	  various	  VHL	  functions.	  	  












Figure	  	  9: Lower	  hierarchical	  PN	  levels,	  in	  particular	  HIF-­‐1α	  regulation	  and	  HIF-­‐1α-­‐dependent	  
pro-­‐angiogenic	  signaling.	  
VEGF	  and	  EPO	  pathways	  are	  at	  a	  lower	  hierarchical	  level	  than	  the	  pro_angio	  macro-­‐node.	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3.5.2	  HIF-­‐1α	  Transcription	  Activity	  	  The	   HIF-­‐1α	   transcription	   factor	   stimulates	   proliferation	   of	   endothelial	   cells	   to	  create	  new	  blood	  vessels	  during	  localized	  or	  broad	  hypoxia.	  In	  human,	  it	  is	  present	  as	   three	   different	   paralogs:	   HIF-­‐1α,	   HIF-­‐2α	   and	   HIF-­‐3α.	   The	   sequence	   is	   quite	  conserved	  between	  the	  former	  two,	  whereas	  the	  latter	  is	  slightly	  shorter	  and	  seems	  to	  have	  completely	  different	   functions	  compared	   to	   the	  other	   two(103,104).	  Both	  HIF-­‐1α	  and	  -­‐2α	  stimulate	  DNA	  transcription	  but	  the	  exact	  products	  of	  this	  activity	  are	   still	   poorly	   understood.	   In	   our	   model,	   only	   HIF-­‐1α	  in	   vivo	  activity	   was	  considered.	   It	   cannot	   be	   excluded	   that	   other	   biological	   effects	   depend	   on	   the	  second	  paralog.	  Indeed,	  both	  have	  a	  pro-­‐angiogenetic	  function	  and	  are	  degraded	  by	  pVHL	  via	  proline-­‐directed	  hydroxylation.	  HIF	  is	  a	  heterodimer	  of	  HIF-­‐1α	  and	  HIF-­‐1β,	   the	   latter	  being	  also	   termed	  Aryl	  hydrocarbon	  Receptor	  Nuclear	  Translocator	  (ARNT).	  We	  started	   from	   the	   transcription	  activity	  of	  HIF	  due	   to	   its	   regulation	   is	  the	   most	   studied	   pVHL	   function.	   Our	   model,	   as	   expected	   from	   literature	   data,	  shows	  that	  HIF-­‐1α	  enters	  the	  nucleus	  when	  not	  degraded	  by	  pVHL.	  It	  subsequently	  binds	  HIF-­‐1β	  to	  form	  the	  HIF	  heterocomplex	  which	  interacts	  with	  DNA.	  Our	  model	  correctly	   simulates	   the	   increased	   affinity	   of	   HIF	   towards	   DNA.	   Transcription	   is	  enhanced	  by	  some	  co-­‐factors	  binding	  both	  subunits	  of	  HIF	  and	  other	  proteins	  such	  as	   p300,	   Creb	   and	   cjun.	   This	   takes	   place	   in	   a	   specific	   DNA	   promoter	   sequence	  termed	  Hypoxia	  Response	  Element	  (HRE).	  Furthermore,	  during	  transcription	  some	  pro-­‐angiogenic	   factors	  are	  produced:	  Vascular	  Endothelial	  Growth	  Factor	   (VEGF),	  Endothelin	   (ET)	   and	   Erythropoietin	   (EPO).	   All	   described	   pathways	   are	   in	  agreement	  with	  previous	  observations	  reported	  in	  (105).	  
3.5.3	  Metabolic	  Processes	  	  HIF-­‐1α	   transcription	   activity	   includes	   some	   proteins	   which	   are	   dependent	   on	  oxygen	  but	   involved	   in	  other	  pathways	   (e.g.	  oxidative	  metabolism)	  or	   completely	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independent	   (e.g.	   metallo-­‐proteinase	   MT1MMP).	   Further,	   HIF-­‐1α	   stimulates	  production	  of	   proteins	   involved	   in	   the	   glucidic	   pathway.	  The	   final	   product	   of	   the	  metabolism	   is	   adenosine	   triphosphate	   (ATP),	   a	   molecular	   form	   of	   energy,	  composed	   by	   adenosine,	   an	   adenine	   ring	   connected	   to	   a	   ribose	   sugar,	   and	   three	  phosphate	   moieties.	   When	   a	   phosphate	   moiety	   is	   hydrolyzed	   it	   releases	   energy,	  used	   by	   cells	   for	   enzymatic	   reactions.	   The	   glucidic	   metabolism	   is	   composed	   of	  glycolysis,	   Krebs	   cycle,	   glycogen	   formation	   and	   respiratory	   chain	   with	   ATP	  synthesis.	  Glucose	   is	  absorbed	   in	  cells	  by	  enzymatic	  glucose	   transporters	   (GLUT),	  which	  carry	  the	  molecule	  to	  the	  location	  inside	  the	  cell	  where	  the	  metabolism	  takes	  place	  ((106).	  There	  are	  many	   isoforms	  of	   these	   transporters:	  GLUT1	   is	  present	   in	  all	   cells	   and	   in	   particular	   in	   erythrocytic	   membranes,	   neurons	   and	   glia	  (107).	  GLUT2,	   located	   in	   both	   liver	   and	   pancreatic	   beta	   cells,	   is	   characterized	   by	   low	  affinity	   for	   glucose,	   hence	   it	   requires	   a	   higher	   glucose	   concentration	   to	   be	  activated(108).	  Right	  after	  eating,	  glucose	  concentration	  increases,	  thereby	  quickly	  activating	  them.	  GLUT2	  stimulates	  production	  of	  insulin,	  a	  hormone	  regulating	  the	  plasmatic	  glucose	  concentration.	  Glucose	  plasmatic	  concentration	  can	  also	  increase	  due	  to	  an	  opposite	  pathway,	  originating	  from	  liver	  glycogen	  being	  decomposed	  into	  glucose	   and	   reaching	   systemic	   circulation.	   GLUT3	   is	   mostly	   present	   in	   neurons,	  whereas	  GLUT4	  is	  the	  insulin	  activated	  transporter	  located	  in	  myocytes,	  adipocytes	  and	  cardiomyocytes	  (106,109).	  In	  our	  model,	  we	  chose	  to	  exclude	  GLUT3	  due	  to	  its	  specific	   role	   in	  neuronal	   cells.	  Glycolysis	   occurs	   in	   the	   cytoplasm	  and	  during	   this	  process	   each	   glucose	   molecule	   is	   phosphorylated,	   consuming	   two	   molecules	   of	  ATP,	   then	  divided	   into	   two	  smaller	  molecules.	  Further	  modifications	  of	   these	   two	  molecules	   result	   in	   new	   ATP	   production.	   The	   molecule	   obtained	   at	   the	   end	   of	  glycolysis	   is	   pyruvate,	   which	   can	   be	   again	   modified	   through	   three	   different	  pathways.	   It	  can	  be	  decarboxylated	  and	  linked	  to	  Co-­‐enzyme	  A	  to	  form	  acetyl-­‐Co-­‐enzyme	   A.	   It	   can	   then	   be	   carboxylated	   to	   obtain	   oxalacetate,	   or	   transformed	  through	  lactate	  dehydrogenase	  into	  lactic	  acid.	  Pyruvate	  can	  also	  be	  generated	  by	  other	   metabolic	   pathways,	   like	   protein	   or	   fatty	   acid	   disruption	   and	   amino-­‐acid	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modifications.	  Acetyl-­‐CoA	  and	  oxalacetate	  are	  the	  molecules	  used	  in	  the	  following	  glucidic	   metabolism	   process,	   the	   Krebs	   cycle,	   taking	   place	   in	   the	   mitochondrial	  matrix.	  The	  Krebs	   cycle	   starts	  with	   acetyl-­‐CoA	  and	  oxalacetate	  merging	   to	   create	  citric	   acid,	  which	   continues	   undergoing	  modifications	   until	   oxalacetate	   is	   formed	  again.	   During	   the	   process	   some	   co-­‐enzymes	   are	   modified.	   Decarboxylation	   of	  pyruvate	   to	   form	   acetyl-­‐CoA	   already	   transforms	   a	   NAD+	   (Nicotinamide	   Adenine	  Dinucleotide)	   in	   NADH	   (reduced	   form),	   afterwards	   obtaining	   one	   more	   of	   ATP,	  GTP,	   FADH2	  (Flavin	   Adenine	   Dinucleotide)	   and	   three	   more	   NADH	   per	   pyruvate	  molecule	  entering	  the	  Krebs	  cycle.	  The	  redox	  co-­‐enzymes	  are	  considered	  electron	  transporters.	  During	  metabolic	  reactions	  they	  reduce	  themselves	  and	  get	  electrons	  (and	  protons)	   to	  oxidize	   the	   substrate	  of	   the	   enzymatic	   reaction.	  Electrons	   taken	  during	  the	  glucose	  metabolism	  are	  then	  used	  in	  the	  respiratory	  chain	  taking	  place	  in	   the	   internal	   mitochondrial	   membrane.	   The	   respiratory	   chain	   consists	   in	  transporting	   electrons	   through	   enzymes	   called	   cytochromes	   and	   others	   co-­‐enzymes,	   characterized	   by	   the	   capability	   to	   receive	   and	   donate	   electrons.	   NADH	  (FADH2)	  is	  oxidized	  again	  by	  cytochromes	  going	  back	  to	  the	  form	  of	  NAD	  (or	  FAD).	  Electrons	   gained	   through	  oxidation	   are	  used	   to	   reduce	  half	   a	  molecule	  of	   oxygen	  into	  water,	  releasing	  more	  energy.	  The	  FADH2	  and	  NADH	  redox	  chain	  establishes	  a	  chemical	   potential	   causing	   the	   push	   of	   protons	   outside	   the	   internal	   membrane	  towards	  the	   inter-­‐membrane	  space,	  which	  stays	  between	  the	  mitochondrial	   inner	  and	  outer	  membrane.	   This	   also	   causes	   a	   higher	   concentration	  of	   protons	   outside	  the	   inner	   membrane.	   The	   resulting	   gradient	   causes	   the	   tendency	   of	   protons	   to	  enter	   the	   cell.	   The	   final	   step	   is	   ATP-­‐synthetase,	   formed	   by	   a	   channel	   that	   allows	  protons	   to	   enter,	   pushed	   by	   the	   gradient,	   allowing	   the	   enzyme	   to	   change	  conformation	  and	  make	   its	  reaction.	  This	  kinetic	  energy	   is	  converted	   into	  ATP.	   In	  our	  model,	  the	  glycolytic	  and	  Krebs	  cycles	  were	  described	  in	  detail,	  represented	  at	  the	   hierarchical	   second	   level	   by	   the	   coarse	   transition	   Glycolysis.	   The	   respiratory	  chain	  was	  instead	  merged	  into	  a	  single	  node	  (t_97).	  We	  chose	  to	  represent	  creation	  and	  consumption	  of	  ATP	   in	  order	   to	  show	  the	  effects	  of	   lower	  and	  higher	  oxygen	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concentration	   on	   the	   network.	   On	   the	   other	   hand,	   oxygen	   consumption	   for	   ATP	  synthesis	   during	   the	   respiratory	   chain	   creates	   a	   flow	   of	   oxygen	   in	   the	   model.	  Oxygen	   is	   not	   the	   only	   connection	   between	   glucidic	   metabolism	   and	   hypoxia.	  Indeed,	   HIF-­‐1α	   transcription	   activity	   enhances	   the	   transcription	   of	   many	   GLUT	  isoforms	   (such	   as	   1,	   3	   and	   9)	   and	   the	   pyruvate	   dehydrogenase	   kinase,	   which	  determines	   the	   pyruvate	   dehydrogenase	   (PyrDH)	   inactivation	   and	   consequent	  Acetyl-­‐CoA	   formation	   from	   pyruvate.	   Finally,	   Lactate	   dehydrogenase	   is	   also	  produced,	   to	   ensure	   an	   alternative	   compound,	   creating	   energy	   needed	   for	   cell	  survival	  (106,110).	  
3.5.4	  pVHL-­‐dependent	  Processes	  	  Some	   interactors	   can	  bind	  pVHL	   in	   regions	   interacting	  with	  Elongin	  C.	  These	   are	  HuR,	   Nur77,	   p53	   and	   Jade1.	   Nur77	   has	   a	   complex	   function	   and	   its	   role	   in	   pVHL	  tumor	  suppressor	  activity	  is	  still	  not	  entirely	  clear.	  Nur77	  can	  bind	  pVHL,	  inhibiting	  Elongin	   binding	  while	   allowing	  HIF-­‐1α	  binding.	   Its	   transcription	   is	   stimulated	  by	  HIF-­‐1α	   itself,	   and	   pVHL-­‐HIF-­‐1α-­‐Nur77	   complex	   formation	   stabilizes	   the	  transcription	   activity	   of	   HIF-­‐1α	   by	   inhibiting	   the	   pVHL-­‐dependent	  degradatio((111)).	   Another	   Nur77	   function	   is	   the	   stimulation	   of	  proopiomelanocortin	   (POMC)	   transcription,	   which	   is	   a	   precursor	   for	  adrenocorticotropic	   hormone	   (ACTH)	   formation.	   This	   hormone	  has	   an	   important	  stress	   response	   function,	   stimulating	   cortisol	   production	   and	   other	  neurotransmitters	   from	   the	   adrenal	   glands,	   to	   enhance	   the	   organism	   reaction	   to	  danger	   and	   stress	  stimuli	  e.g.	   increase	   of	   gluconeogenesis	   and	   muscle	   mass.	   An	  excess	   of	   this	   hormone	   can	   cause	   desensitization	   of	   its	   receptors	   for	   feedback	  down-­‐regulation	   and	   thus	   muscular	   weakness,	   tiredness,	   hyperglycemia	   and	  osteoporosis	  (112).	  p53	  can	  bind	   to	  pVHL	  avoiding	   the	  degradation	  of	   this	   tumor	  suppressor.	   Instead,	   it	   stimulates	   the	   apoptotic	   signal	   cascade	   via	   the	   p300	   co-­‐activator,	  which	  stimulates	  production	  of	  proteins	  enhancing	  the	  cell-­‐programmed	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death.	  If	  p53	  cannot	  bind	  pVHL,	  two	  more	  mechanisms	  are	  described	  in	  the	  model.	  One	   is	   its	   modification	   and	   degradation	   by	   Mdm2	   and	   the	   other	   is	   the	   pVHL-­‐independent	   degradation	   of	   HIF-­‐1α.	   Interaction	   with	   Mdm2	   is	   needed	   in	   both	  cases(113,114).	  Jade1	  is	  a	  short-­‐lived	  protein	  whose	  main	  function	  is	  to	  stimulate	  the	  phosphorylation-­‐dependent	  degradation	  of	   β-­‐catenin.	  This	   is	   a	   subunit	   of	   the	  cadherin	   protein	   complex	   acting	   as	   an	   intracellular	   signal	   transducer	   in	   the	  Wnt	  signaling	  pathway.	  It	  seems	  that	  β-­‐catenin	  is	  able	  to	  stop	  cell	  division	  via	  a	  contact-­‐dependent	   inhibition	   signal,	   whereas	   in	   Wnt	   signaling	   it	   is	   also	   involved	   in	  proliferative	   transcription.	   When	   Wnt	   is	   not	   present,	   β-­‐catenin	   can	   be	  phosphorylated	  by	  Glycogen	  Synthetase	  Kinase,	   type	  3β	  (GSK3β)	   in	  complex	  with	  APC	  (Adenomatous	  Polyposis	  Coli)	  and	  Axin.	  β-­‐catenin	  can	  interact	  with	  Jade1	  and	  be	   only	   successfully	   degraded	   after	   this	   interactio(115).	   Related	   functions	   are	  represented	  in	  the	  macro	  node	  Jade1_pat.	  GSK3β	  seems	  to	  be	  a	  protein	  involved	  in	  many	   different	   pathways.	   GSK3β	   is	   involved	   in	   Glycogen	   Synthetase	   deactivation	  and	  can	  even	  phosphorylate	  pVHL	  and	  HIF-­‐1α.	  In	  the	  case	  of	  HIF-­‐1α,	  it	  generates	  a	  pVHL-­‐independent	   degradation	   pathway,	   where	   phosphorylation	   allows	  ubiquitination,	   whereas	   in	   the	   case	   of	   pVHL,	   it	   inhibits	   pVHL	   stabilization	   of	  microtubules	  (116).	  
3.5.5	  Structural	  Model	  Analysis	  	  Based	  also	  on	  previous	  observations	  of	  Heiner	  et	  al.,	  (117),	  in	  2008	  Grunwald	  et	  al.,	  demonstrated	   that	   PN	   can	   be	   used	   to	   describe	   large	   and	   complex	   metabolic	  pathways	  (51).	  They	  postulated	  the	  following	  set	  of	  minimal	  rules	  that	  a	  PN	  should	  satisfy	   to	   be	   considered	   biologically	   reliable:	   (i)	   the	   network	   should	   be	   entirely	  connected,	   (ii)	   the	   network	   should	   be	   covered	   by	   T-­‐invariants,	   and	   (iii)	   each	   T-­‐invariant	  and	  P-­‐invariant	   should	  have	  a	  biological	  meaning.	  The	  model	  described	  here	   was	   tested	   with	   respect	   to	   what	   previously	   done	   by	   Grunwald	   and	   co-­‐workers	  (51)	  and	  resulted	  to	  be	  covered	  by	  T-­‐invariants,	  connected,	  homogeneous	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and	  each	  place	  has	  a	  pre-­‐transition	  and	  a	  post-­‐transition.	  Transitions	  without	  pre-­‐	  or	  post-­‐places	  were	  used	  to	  simulate	  the	  system	  interface	  to	  the	  surroundings.	  The	  network	   is	  alive,	   in	  other	  words,	   it	  continues	  to	  work	  forever,	  with	  all	   transitions	  contributing	   to	   the	  net	   behavior	   forever,	   and	  no	  dead	   transitions.	   The	  MCTS	   and	  Cluster	  analysis	  were	  used	  due	  to	  the	  large	  number	  of	  T-­‐	  and	  P-­‐invariants	  included	  in	   the	   model.	   Both	   methods	   are	   used	   in	   PN	   theory	   to	   reduce	   the	   complexity	  connected	   with	   such	   a	   large	   network	   and	   to	   reduce	   the	   errors	   connected	   with	  manual	   investigation.	   From	   the	   238	   transitions	   present	   at	   the	   beginning	   in	   the	  model,	  393	  T-­‐invariants	  were	  computed	  without	  considering	  10	  trivial	   invariants.	  The	   latter	   consist	   in	   a	   pair	   of	   transitions	   that	   usually	   represent	   a	   forward	   and	  backward	   reaction,	   such	   as	   the	   active	   and	   inactive	   state	   of	   a	   protein.	   Trivial	  invariants	   could	   be	   erased	   to	   reduce	   the	   dimension	   of	   the	   network	   without	  disturbing	   the	   overall	   system	   when	   the	   interest	   is	   focused	   on	   the	   steady	   state	  behavior	  (95).	   T-­‐invariants	   were	   grouped	   into	   44	   Clusters	   using	   the	   Tanimoto	  coefficient	  with	  similarity	  threshold	  of	  65%,	  as	  described	  in	  (51).	  Only	  11	  of	  these	  44	   comprised	   more	   than	   one	   T-­‐invariant.	   The	   three	   biggest	   Clusters	   are	   C9,	  composed	  of	  144	  T-­‐invariants,	  C8	  of	  72	  and	  C11	  of	  64	  T-­‐invariants.	  Separation	  into	  clusters	   allows	   easier	   analysis	   of	   networks	   pathways	   represented	   by	   each	   T-­‐invariant,	  since	  they	  are	  grouped	  by	  similarity,	  specifically	  the	  common	  transitions	  by	  which	  they	  are	  composed.	  T-­‐invariants	  named	  in	  the	  text	  are	  shown	  in	  Table	  S3	  (see	   Appendix),	   while	   T-­‐invariants	   grouped	   in	   C8,	   C9,	   C10,	   C11	   are	   explained	  in	  Table	  S4	  (see	  Appendix)	  and	  described	  as	  follows.	  
3.5.5.1	  Cluster	  C8	  
Cluster	   C8	   groups	   all	   transitions	   included	   in	   HIF-­‐1α	   pathways,	   including	  transcription,	   signaling	   cascades,	   degradation	   via	   pVHL,	   p53	   and	   GSK3β,	   and	  eventually	   the	   Krebs	   cycle.	   For	   the	   EPO	   signaling	   pathway,	   two	   transitions	   (t_35	  and	   t_36)	   are	   not	   included	   which	   cause	   Jak	   activation	   and	   consequent	   Stat5	  activation	  to	  stimulate	  DNA	  transcription.	  Matrix	  stability	  regulation	  is	  also	  part	  of	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the	  cluster	  due	   to	   the	  destabilization	   induced	  by	  HIF-­‐1α	   transcription	  of	  metallo-­‐proteinase	  (MMP),	  transitions	  from	  t_134	  to	  t_140.	  The	  largest	  T-­‐invariant	  in	  C8	  is	  Inv_280	   (93	   transitions)	   while	   the	   smallest	   is	   Inv_377	   (81	   transitions).	   The	  differences	   between	   T-­‐invariants	   show	   the	   possibility	   of	   alternative	   pathways	  inside	  the	  model.	  For	  example,	  the	  VEGF	  dependent	  signal	  cascade	  can	  proceed	  in	  three	  different	  ways:	  t_13,	  t_14	  and	  t_15,	  which	  lead	  to	  the	  pathways	  being	  merged	  in	   the	   coarse	   nodes	   Vegf_path3,	   Vegf_path2	   and	   Vegf_path1,	   respectively.	   The	  occurrence	   rate	   in	   C8	   is	   24	   transitions	   for	   each	   path.	   The	   Endothelin,	   VEGF	   and	  Erythropoietin	  pathways	  are	  not	  in	  conflict	  and	  occurring	  together.	  Disaggregation	  of	   the	  matrix	  via	  MMPs	   is	  present	   in	  18	  T-­‐invariants,	  whereas	   inhibition	  of	   these	  proteins,	   i.e.	   matrix	   stabilization,	   is	   present	   in	   the	   remaining	   54	   transitions.	  Regarding	  the	  Krebs	  cycle,	  47	  T-­‐invariants	  have	  t_91,	  of	  which	  only	  24	  reach	  t_92	  and	   t_93,	   representing	   the	   last	   three	   steps	   of	   the	   cycle:	   succinate	   to	   fumarate,	  fumarate	   to	  malate,	   and	  malate	   to	   oxalacetate.	   All	   the	  malate	   being	   produced	   is	  used	  to	  regenerate	  oxalacetate.	  Degradation	  of	  HIF-­‐1α	  occurs	  in	  any	  T-­‐invariant	  of	  the	   cluster.	   The	   pVHL-­‐dependent	   degradation	   of	   HIF-­‐1α	   is	   always	   present	  (transitions	   t_116	   to	   t_119).	   In	   19	   T-­‐invariants	   degradation	   takes	   place	   via	   p53	  (t_191	   to	   t_193)	  or,	  alternatively,	  via	  phosphorylation	  by	  GSK3β	   in	  another	  17	  T-­‐	  invariants.	  Two	  of	  the	  three	  pathways	  can	  be	  present	  in	  the	  same	  T-­‐invariant,	  as	  in	  Inv_227,	  where	  degradation	   via	   pVHL	   and	  degradation	   via	   p53	   are	   both	  present.	  This	  was	  considered	  as	  the	  HIF-­‐1α	  dependence	  on	  the	  lack	  of	  degradation	  by	  these	  proteins.	  All	  three	  degradation	  pathways	  never	  appear	  in	  the	  same	  T-­‐invariant.	  The	  p53	  and	  GSK3β	  paths	  are	  never	  present	  together	  but	  each	  of	  them	  is	  accompanied	  by	   pVHL-­‐dependent	   proteasomal	   degradation.	   Inv_377	   lacks	   the	   EPO	   signaling	  pathway	   but	   is	   the	   only	   one	   in	   this	   cluster	   to	   have	   t_34,	   t_33	   and	   t_37.	   These	  invariants	   have	   all	   input	   and	   output	   transitions.	   For	   example,	   t_202	   the	   second	  input	   for	   pVHL,	   is	   present	   in	   only	   18	   invariants.	   Other	   inputs	   are	   t_98,	   always	  present,	  leading	  to	  formation	  of	  HIF-­‐1α	  and	  pVHL,	  t_192,	  producing	  p53	  and	  t_216,	  representing	   other	   pyruvate	   generating	   metabolic	   pathways.	   The	   latter	   is	   also	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present	   in	   each	   invariant	   allowing	   formation	   of	   the	   pyruvate	   needed	   for	   Krebs	  cycle	  progression.	  
3.5.5.2	  Cluster	  C9	  
Cluster	  C9	   is	   the	   largest	   cluster	   in	  our	  model	   and	   includes	  144	  T-­‐invariants.	   It	   is	  characterized	  by	  complete	  EPO	  pathway	  abrogation	  which	  goes	  through	  formation	  of	  the	  Shc-­‐Grb-­‐Sos	  complex	  and	  the	  consequent	  mapk-­‐dependent	  phosphorylation	  cascade.	   Transition	   t_127,	   representing	   EPO	   effects	   on	   oxygen	   production,	   is	  absent.	   In	   its	   place,	   t_35	   and	   t_36	   are	   considered,	   which	   are	   present	   in	   72	   T-­‐invariants.	   In	   cluster	   C9,	   the	   largest	   T-­‐invariants	   are	   Inv_278	   and	   Inv_279	   (74	  transitions)	   while	   the	   shortest	   ones	   are	   Inv_101,	   Inv_105,	   Inv_144	   and	   Inv_148	  with	  65	  transitions	  each.	  
3.5.5.3	  Cluster	  C10	  
Cluster	   C10,	   composed	   of	   52	   T-­‐invariants,	   is	   characterized	   by	   the	   presence	   of	  glycolysis	  between	  many	  transitions	  grouped	  in	  the	  cluster.	  This	  is	  also	  the	  cluster	  containing	   the	   most	   populated	   T-­‐invariant	   of	   all	   computed	   393	   non-­‐trivial	   T-­‐invariants.	   This	   is	   Inv_245,	   including	   101	   transitions	   and	   covering	   almost	   half	   of	  the	  whole	  model.	  Cluster	  C10	  also	   includes	   Inv_125,	   the	  shortest	   invariant	  of	   this	  model,	   composed	   by	   85	   transitions	   due	   to	   lack	   of	   the	   Krebs	   cycle.	   Another	  difference	   with	   the	   other	   three	   major	   clusters	   is	   that	   here	   both	   EPO	   paths	   are	  present,	  specifically,	  the	  Jak	  pathway	  belongs	  to	  4	  T-­‐invariants	  and	  Shc-­‐Grb-­‐Sos	  is	  observed	   throughout	   the	   cluster.	   Vegf_path1	   seems	   to	   be	   more	   common	   in	   this	  cluster,	   being	   present	   in	   36	   T-­‐invariants,	   whereas	   the	   other	   two	   are	   present	   12	  times	   each.	   This	   time	   they	   are	  present	   even	   in	   the	   same	   invariant,	   as	   for	   Inv_60,	  Inv_129,	   Inv_172	  and	  Inv_215,	  with	  both	  t_13	  and	  t_15,	  and	  Inv_142,	   Inv_185	  and	  Inv_228	   with	   t_14	   and	   t_15	   and	   all	   subsequent	   signaling	   appearing	   at	   the	   same	  time.	   Despite	   glycolysis	   being	   present	   in	   all	   cluster	   invariants,	   the	   Krebs	   cycle	  appears	  only	  in	  11	  cases.	  p53-­‐dependent	  degradation	  of	  HIF-­‐1α	  occurs	  in	  11	  cases	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while	   the	   phosphorylation-­‐dependent	   one	   appears	   in	   13.	   An	   input	   transition	   has	  been	   added	   with	   respect	   to	   the	   other	   major	   clusters	   so	   far	   analyzed	   (i.e.	  t_69_eating)	  without	  which	  glycolysis	  could	  never	  take	  place.	  
3.5.5.4	  Cluster	  C11	  
Cluster	   C11	   is	   composed	   of	   64	   T-­‐invariants.	   Only	   part	   of	   the	   EPO	   pathway	   is	  described	   here,	   with	   the	   major	   difference	   that	   the	   Krebs	   cycle	   is	   completely	  abrogated	   while	   Prolyl	   Hydroxylase	   type	   2	   (PHD2)	   regulation	   by	   oxalacetate	   is	  included.	  HIF-­‐1α	  interaction	  with	  Nur77	  and	  transcription	  of	  VEGF	  by	  Sp1	  are	  also	  present.	  t_80	  (transformation	  of	  pyruvate	  in	  oxalacetate)	  is	  not	  present	  in	  the	  first	  42	   cluster	   T-­‐invariants.	   Nur77	   interaction	   with	   HIF-­‐1α	   is	   present	   only	   in	   8	   T-­‐invariants,	   specifically	   Inv_87	   to	   Inv_94.	  Sp1	   transcription	  activity	   is	  appearing	   in	  twice	   the	   amount,	   including	   the	   same	   8	   invariants	   just	   mentioned.	   VEGF	  transcription	   via	   Sp1	   activity	   is	   aPKCζ2	   phosphorylation	   dependent,	   which	   does	  however	  not	   appear	   in	   the	   cluster.	  When	  VEGF	   is	   synthesized,	   it	   is	   subsequently	  stabilized	  by	  Hur,	  followed	  by	  t_178	  and	  Hur	  is	  recreated	  to	  allow	  other	  functions.	  Indeed,	   it	   is	   one	  of	   the	   few	  places	  without	   input	   transition	  but	  with	   a	   token	   that	  goes	  forward	  and	  backward	  again.	  Compared	  to	  the	  other	  clusters,	  C11	  also	  shows	  one	   less	   transition	   in	   the	   coarse	   PHD	   regulation	   node,	   specifically	   t_81,	   which	  shows	   the	   transformation	   of	   pyruvate	   by	  pyrDH	   into	   acetyl-­‐Coenzyme	  A,	   needed	  for	  the	  Krebs	  cycle.	  The	  four	  clusters	  C-­‐8	  to	  C12	  are	  very	  similar	  to	  each	  other,	  as	  can	   be	   seen	   from	   the	   distance	   tree	   in	   Figure	   10.	   They	   all	   contain	   the	   HIF-­‐1α	  transcription	  activity	  and	  signaling	  pathways	  caused	  by	  EPO,	  VEGF	  and	  the	  HIF-­‐1α	  degradation	   options.	   They	   include	   the	   effects	   of	   other	   transcription	   activity	  products,	   like	   metallo-­‐proteinase	   and	   pyruvate	   dehydrogenase	   kinase,	   which	  regulate	   the	  activation	  state	  of	  PyrDH.	  All	   include	  part	  of	   the	  glucidic	  metabolism	  but	   not	   Glycogen	   formation	   itself.	   Other	   five	   clusters	   from	   C12	   to	   C16	   have	   a	  smaller	   number	   of	   T-­‐invariants	   and	   fewer	   transitions	   present	   in	   each	   invariant.	  They	   do	   not	   include	   transcription	   activity	   but	   are	   only	   formed	   by	   the	   VEGF	   and	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glycolytic	   pathways.	   The	   information	   contents	   of	   these	   clusters	   turned	   out	   to	   be	  uninformative	   and	   their	   analysis	   was	   not	   included.	   The	   same	   applies	   to	   clusters	  composed	   by	   1–3	   T-­‐invariants.	   Finally,	   some	   transitions	   are	   not	   present	   in	   the	  clusters	  and	  not	  listed	  in	  the	  T-­‐invariants	  because	  trivial	  invariants	  were	  excluded	  from	  cluster	  analysis.	  These	  transitions	  are	  shown	  in	  Table	  1	  with	  their	  respective	  biological	  meaning.	  
	  	  
 




Figure	   	   10:	  PinA	  Distance	  Matrix	   clustering,	   using	   Tanimoto	   coefficient	   and	   65%	   threshold.	  The	  
numbers	  indicates	  clusters.	  In	  C8,	  C9,	  C10,	  C11	  are	  highlighted	  a	  red	  square.	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3.5.6	  MCTS	  Analysis	  	  Another	  way	  to	  group	  invariants	   is	  by	  the	  amount	  of	  single	  transitions	  present	   in	  them.	   Maximal	   common	   transition	   set	   (MCTS)	   analysis	   provides	   a	   PN	  decomposition	   into	   non-­‐overlapping	   subnets,	   sharing	   parts	   of	   the	   same	   T-­‐invariants	  (53).	   In	   a	   biochemical	   network,	  MCTS	   could	   be	   interpreted	   as	   enzyme	  subsets	  operating	  together	  under	  steady	  state	  conditions,	  computed	  based	  on	  the	  support	   of	   a	   T-­‐invariant.	   MCTS	   computation	   does	   not	   consider	   stoichiometric	  relations,	  describing	  exclusively	  sets	  of	  reactions	  present	   in	  a	  maximal	  number	  of	  T-­‐invariants	   resulting	   shared	  by	  different	   signaling	  pathways	  (118).	  A	   total	   of	   40	  non-­‐trivial	  MCTS	  were	  identified,	  with	  results	  and	  related	  biological	  means	  shown	  in	  Table	  2	   (see	  Appendix).	   Some	   transitions	  do	  not	   belong	   to	   a	  non-­‐trivial	  MCTS,	  because	   their	  occurrence	  has	  no	  similarity	  with	  other	   transitions	  and	   they	  create	  separate	  MCTS	   (specifically:	   t_69,	   t_82,	   t_91,	   t_94,	   t_98,	   t_114,	   t_116,	   t_120,	   t_121,	  t_122,	   t_179,	   t_202,	   t_209,	   t_212,	   t_216,	   t_225	  and	  t_229).	  MCTS	  define	  transitions	  that	   always	   take	   place	   together,	   but	   are	   not	   necessarily	   connected,	   thus	  representing	   disjunct	   building	   blocks	   constituting	   the	   network.	   Considering	   both	  analyses,	   a	   table	   was	   automatically	   built	   in	   PInA	  (53)	  showing	   a	   correlation	  between	  clusters	  and	  MCTS.	  Transitions	  (t)	  or	  MCTS	  (M)	  are	  compared	  to	  evaluate	  how	  many	  T-­‐invariants	   clusters	   cover	   the	   selected	  M	  or	   t	   (if	   the	   transition	   is	  not	  already	  part	  of	  the	  MCTS,	  as	  listed	  above).	  The	  more	  covered	  a	  transition	  or	  set	  is,	  the	   more	   central	   it	   could	   be	   considered	   for	   the	   network	   behavior.	   Recently,	   a	  network	   coarsening	   method	   based	   on	   abstract	   dependent	   transition	   sets	   (ADT)	  was	  presented	  ((119).	  It	  is	  formulated	  without	  the	  requirement	  of	  pre-­‐computation	  of	   the	   T-­‐invariants	   and	   is	   a	   tool	   commonly	   used	   for	   the	   decomposition	   of	   large	  biochemical	  networks	  into	  smaller	  subnets.	  Due	  to	  the	  manually	  designed	  nature	  of	  our	   model,	   we	   preferred	   to	   maintain	   a	   logic	   hierarchy	   based	   on	   metabolic	  pathways	   in	  order	  to	  maintain	  the	  network	  centered	  on	  pVHL	  and	  its	   interaction.	  The	   MCTS	   calculation	   results	   shows	   that	   the	   most	   covered	   set	   by	   cluster	   T-­‐
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invariants	   is	   M20	   with	   358	   T-­‐invariants	   covering	   all	   transitions	   in	   the	   set,	  indicating	   that	   this	   MCTS	   corresponds	   to	   more	   T-­‐invariants	   than	   the	   others.	   All	  transition	   sets	   are	   an	   important	   link	   to	   the	   others,	   as	   tokens	   pass	   through	   these	  transitions	  more	  often.	  A	  transition	  not	  present	  in	  any	  set	  but	  most	  covered	  by	  T-­‐invariants	  is	  t_98,	  which	  is	  also	  the	  most	  frequently	  occurring	  transition,	  see	  Figure	  11.	  The	  10	  most	  occurring	  transitions	  are	  listed	  in	  the	  Table	  3.	  	  	  	  	  	  	  	  
	  	  	  
Figure	  	  11:	  Transitions	  occurrence	  T-­‐invariants.	  




Table	  	  2:	  List	  of	  MCTS	  and	  transitions	  from	  PInA.	  
	  	  
	   59	  	  
	  
Table	  	  3:	  	  Ranking	  of	  the	  10	  most	  occurring	  transitions	  with	  biological	  meaning	  and	  percentage	  of	  occurrence.	  
3.5.7	  P-­‐invariant	  Analysis	  	  Although	  the	  network	  is	  not	  covered	  by	  P-­‐invariants,	  it	  has	  130	  P-­‐invariants.	  47	  of	  these	  are	  trivial	  P-­‐invariants,	  comprising	  a	  single	  place,	  connected	  with	  double	  arcs	  to	  imitate	  an	  activator	  arc	  function.	  Another	  object	  represented	  with	  double	  arcs	  is	  the	   enzymatic	   activity	   catalysing	   a	   reaction	   and	   immediately	   going	   back	   to	   the	  steady	   state.	   P-­‐invariants	   show	   places	   or	   sets	   of	   places	   where	   token	   numbers	  always	   remain	  equal	  and	  do	  not	  move	  outside	   the	  subnetwork	   induced	  by	   the	  P-­‐invariant	  in	  the	  initial	  marking.	  In	  other	  words,	  they	  do	  not	  grow	  nor	  diminish.	  The	  remaining	  P-­‐invariants	  are	  mostly	  located	  in	  signal	  transduction	  pathways,	  such	  as	  situations	   in	  which	  a	  protein	   is	  sequestered	   from	   its	   function	  and	   then	  goes	  back	  after	  a	  second	  reactivation	  mechanism.	  This	  scenario	  is	  present	  in	  p_41,	  p_42	  and	  p_45	  located	  in	  invariant	  P_58.	  It	  is	  important	  to	  notice	  that	  ATP	  and	  ADP,	  as	  well	  as	  NAD	   and	  NADH,	   are	  modeled	   as	   P-­‐invariants.	   P_90,	   P_91	   and	   t_97	   are	   able	   to	  transform	   ATP	   and	   ADP.	   More	   in	   general,	   all	   energy	   consuming	   transitions	   are	  considered	  to	  be	  backward	  transitions	  of	  invariants.	  Invariants	  not	  related	  to	  signal	  transduction	  are	  places	  located	  in	  the	  Hur	  system,	  where	  Hur	  is	  removed	  from	  its	  function	  by	  pVHL.	  This	   is	   a	  good	  approximation	   for	   sequential	  modifications	   that	  momentarily	  activate	  proteins.	  Afterwards,	  Hur	  can	  go	  back	  and	  stabilize	  VEGF	  to	  increase	  its	  transcription	  activity.	  
	  60	  
3.5.8	  In	  Silico	  Knock	  Out	  Experiments	  	  The	  previously	  described	  clustering	  and	  MCTS	  analysis	  for	  T-­‐invariants	  allowed	  us	  to	   identify	  the	  most	  common	  transitions	  and	  to	  understand	  which	  transitions	  can	  be	   depleted	   in	   our	   knock	   out	   experiments	   in	   order	   to	   get	   the	   most	   important	  biological	   effect.	   The	   knock	   out	   experiments	   were	   performed	   erasing	   selected	  transitions	  or	  tokens	  and	  observing	  which	  transitions	  or	  MCTS	  become	  inactivated.	  Considering	  our	  results	  and	   the	   literature,	  we	  decided	   to	  knock	  out	   the	   following	  pathway	  elements:	  (i)	  pVHL,	  (ii)	  HIF1α	  alone	  and	  with	  Sp1,	  (iii)	  t_98,	  (iv)	  PHD2,	  (v)	  MCTS1,	   (vi)	   t_97	  and	  (vii)	  GSK3β.	   In	   the	   following,	  we	  describe	   the	  effect	  of	  each	  knock	  out	  scenario	  on	  our	  model.	  (i)	  pVHL	  knock	  out.	  
Degradation	  of	  HIF-­‐1α	  is	  not	  completely	  depleted	  due	  to	  presence	  of	  both	  p53-­‐	  and	  GSK3β-­‐dependent	   alternative	   degradation	   pathways.	   All	   other	   processes	   usually	  inhibited	  by	  pVHL	  take	  place	  in	  an	  uncontrolled	  way,	  including	  creation	  of	  VEGF	  via	  Sp1	  transcription	  activity	  and	  increased	  matrix	  regulation	  due	  to	  lack	  of	  fibronectin	  crosslinking.	  Hur	  resulted	  constantly	  activated	  and	  nur77	  can	  stimulate	  synthesis	  of	   Proopiomelanocortin,	   precursor	   for	   the	   Adrenocorticotropic	   hormone.	   Card9	  increases	  release	  of	  tumor	  necrosis	  factor,	  and	  NF-­‐kB	  when	  not	  inhibited	  by	  pVHL.	  Instead,	   Jade1	   is	  unable	   to	  survive	   long	  enough	   to	   inhibit	  β−catenin,	  generating	  a	  proliferation	  signal	  with	  Wnt.	  Lactic	  acid	  is	  also	  not	  produced	  due	  to	  LDH	  enzyme	  production	  being	  HIF-­‐1α	  transcription	  activity	  dependent.	  (ii)	  HIF-­‐1α	  knock	  out.	  
VEGF	  is	  still	  created	  thanks	  to	  Sp1,	   thus	  oxygen	   is	  still	  generated	  even	   if	   in	   lower	  proportion.	   If	   HIF-­‐1α	   and	   Sp1	   are	   both	   knocked	   out	   at	   the	   same	   time,	   oxygen	   is	  quickly	  consumed	  and	  the	  metabolism	  is	  soon	  unable	  to	  proceed.	  Lactic	  acid	  is	  not	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produced	   due	   to	   LDH	   enzyme	   production	   being	   HIF-­‐1α	   transcription	   activity	  dependent.	  Glycolysis	  and	  glycogen	  are	  produced	  normally	  and	  the	  metabolism	  is	  not	  inhibited	  by	  PyrDH	  negative	  regulation	  and	  lactic	  acid	  formation.	  Since	  pVHL	  is	  present,	   other	   tumor	   suppressor	   activities	   are	   enabled,	   except	   for	   proteasomal	  degradation	  of	  HIF-­‐1α	  due	  to	  the	  substrate	  being	  non-­‐existent.	  (iii)	  HIF-­‐1α	  and	  pVHL	  double	  knock	  out.	  
This	   generates	   a	   situation	   where	   the	   metabolism	   is	   normal	   but	   oxygen	  regeneration	   is	   less	   productive,	   with	   only	   Sp1	   acting	   for	   transcription.	   Due	   to	  absence	   of	   pVHL,	   all	   proliferation-­‐stimulating	   processes	   are	   active,	   causing	   an	  unbalanced	   consumption	   of	   resources.	   Our	   model	   shows	   that	   this	   condition	   is	  compatible	  with	  cell	  growth	  and	  multiplication,	  but	  new	  blood	  vessel	  generation	  is	  consistently	   slower	   and	   glucidic	   metabolism	   appears	   principally	   based	   on	   the	  glycolysis	   reaction.	   Similar	   activity	   reduction	   applies	   to	   both	   tight	   junction	   and	  cellular	  external	  matrix	  (ECM)	  pathway	  regulation.	  It	  cannot	  be	  excluded	  that	  some	  observed	  effects	  could	  be	  mitigated	  by	  both	  HIF-­‐2α	  and	  HIF-­‐3α	  activity	  in	  vivo.	  (iv)	  PHD2	  knock	  out.	  
The	   protein	   is	   involved	   in	   pVHL	  mediated	   and	   oxygen	  dependent	   degradation	   of	  HIF-­‐1α.	   Further,	   PHD2	   is	   involved	   in	   hydroxylation	   of	   the	   RNA	   polymerase	   II	  subunit	  Rpb1	  to	  allow	  its	  translocation	  to	  less	  chromatin-­‐concentrated	  areas	  of	  the	  nucleus.	  When	   it	   is	  knocked	  out,	  HIF-­‐1α	  degradation	  can	  continue	  via	  alternative	  pathways	   as	   seen	   in	   the	   pVHL	   knock	   out	   experiment	   and	   there	   is	   more	   RNA	  polymerase	  II	  activity,	  even	  if	  rpb7	  can	  still	  be	  inactivated	  by	  pVHL.	  (v)	  MCTS1	  knock	  out.	  
MCTS1	  groups	  some	  reactions	  involved	  in	  the	  HIF-­‐1α	  p53-­‐dependent	  degradation	  pathway	   (Table	   S2,	   see	   Appendix).	   To	   perform	   this	   knock	   out,	   we	   erased	   the	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necessary	  token	  in	  mdm2,	  making	  the	  precondition	  insufficient	  to	  enable	  the	  MCTS	  transitions.	   p53	   is	   not	   degraded	   and	   can	   continue	   its	   proapoptotic	   signal.	  On	   the	  other	  hand,	   a	  HIF-­‐1α	  degradation	  mechanism	   is	   also	   knocked	  out	   resulting	   in	   an	  increased	  HIF-­‐1α	  transcription	  activity.	  (vi)	  t_97	  knock	  out.	  
This	   is	   the	  ATPase	   transition,	   allowing	   the	  model	   to	   imitate	  oxygen	   consumption	  for	  ATP	   synthesis.	   If	   this	   transition	   is	   inactive,	   oxygen	   accumulates	   infinitely	   and	  ATP	  is	  not	  regenerated	  after	  few	  simulation	  steps.	  At	  the	  beginning,	  ATP	  is	  formed	  during	   the	   first	   step	   of	   glycolysis	   but	   afterwards	   it	   is	   consumed	   again.	   At	   some	  point,	   these	   reactions	   do	   not	   have	   any	   ATP	   available	   to	   allow	   the	   system	   to	   re-­‐balance	  the	  consumed	  ATP.	  After	  few	  simulation	  steps,	  oxygen	  reaches	  a	  high	  level	  due	  to	  slower	  consumption	  in	  the	  PHD2	  regulation	  process.	  Biologically,	  this	  means	  that	  the	  metabolism	  stops	  and	  the	  cell	  is	  not	  able	  to	  create	  energy	  to	  survive.	  There	  is	   no	   accumulation	   other	   than	   glucose	   in	   the	   model.	   A	   few	   oxygen	   creation	  processes	  are	  blocked	  as	  well	  due	  to	  absence	  of	  ATP,	  e.g.	  t_15,	  t_41	  and	  t_57.	  (vii)	  GSK3β	  knock	  out.	  
This	   enzyme	   is	   involved	   in	   negative	   glycogen	   synthetase	   (GS)	   regulation	   and	   is	  inactivated	   when	   phosphorylated.	   When	   GSK3β	   is	   knocked	   out,	   glycogen	   is	  continuously	   produced	   due	   to	   the	   enzyme	   remaining	   in	   an	   active	   state.	   In	   a	   real	  organism	  there	  are	  alternative	  forms	  of	  GSK3β	  which	  can	  inactivate	  GS,	  hence	  the	  effect	   will	   be	   less	   sharp.	   GSK3β	   is	   also	   involved	   in	   the	   degradation	   of	   HIF-­‐1α,	  causing	  its	  phosphorylation	  and	  following	  ubiquitination.	  It	   is	  also	  involved	  in	  the	  degradation	   of	   β-­‐catenin,	  where	   it	   is	   responsible	   for	   primary	   phosphorylation.	   If	  knocked	  out,	  even	  if	  Jade1	  can	  be	  stabilized	  by	  pVHL,	  the	  effect	  will	  be	  similar	  to	  a	  knock	   out	   of	   Jade1,	  where	   β-­‐catenin	   is	   free	   to	   continue	   proliferation	   stimulating	  transcription	  activity.	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3.6	  Discussion	  	  We	  started	  from	  a	  core	  model	  of	  hypoxia	  response	  (95)	  and	  extended	  the	  original	  network	  with	   functional	   data	   derived	   from	   the	   literature	   in	   order	   to	   represent	   a	  complete	   description	   of	   the	   pVHL	   interaction	   pathway	   according	   to	   current	  knowledge.	  VHL	  syndrome	   is	   characterized	  by	   the	   formation	  of	   tumors	  and	  cysts	  affecting	   different	   organism	   districts	   and	   tissues.	   Indeed,	   pVHL	   is	   a	   tumor	  suppressor	   whose	   functions	   are	   connected	   to	   inhibition	   of	   proliferation	   and	  survival,	  growth	  and	  stability	  of	  extracellular	  matrix	  and	  microtubules,	  as	  well	  as	  cell	  polarity	  and	  migration.	  The	  IntAct	  database	  reports	  more	  than	  200	  suspected	  pVHL	   interactors	   and	   for	   most	   of	   them	   interaction	   and	   function	   details	   remain	  largely	  unknown.	  We	   chose	   to	  model	   the	  pVHL	   interactions	   in	   a	   credible	   cellular	  context	  with	  many	  protein	  activities	  occurring	  at	  the	  same	  time.	  The	  main	  idea	  was	  to	   create	   a	   novel	   manually	   curated	   PN	   description	   of	   the	   entire	   VHL	   disease	  pathway,	   including	   glucidic	   metabolism	   and	   signaling	   pathways.	   The	   model	   was	  designed	   as	   a	   standard	   PN	   and	   is	   composed	   of	   238	   transitions	   and	   323	   places,	  connected	  by	  801	  edges.	  A	  biologically	  realistic	  PN	  model	  needs	  to	  be	  covered	  by	  T-­‐invariants,	  meaning	  each	  transition	  in	  the	  model	  has	  to	  be	  included	  in	  a	  T-­‐invariant,	  and	   each	   invariant	   needs	   to	   have	   a	   biological	  meaning	  (51,117).	  We	   used	   the	   T-­‐invariant	  analysis	   to	  validate	   the	   reliability	  of	   the	  model.	  We	  computed	  a	   total	  of	  393	   T-­‐invariants,	   plus	   10	   trivial	   invariants,	   which	   were	   excluded	   from	   analysis.	  These	  were	  grouped	  into	  44	  Clusters	  and,	  through	  use	  of	  T-­‐invariants,	  transitions	  were	   grouped	   into	   40	   MCTS.	   The	   model	   obtained	   is	   connected,	   covered	   by	   T-­‐invariants	   with	   each	   invariant	   holding	   a	   biological	   meaning.	   MCTS	   analysis	   was	  used	  to	  identify	  the	  most	  frequent	  crucial	  transitions	  occurring	  in	  the	  model.	  This	  specific	  subset	  was	  further	  used	  to	  plan	  in	  silico	  knock	  out	  experiments	  and	  for	  the	  model	  validation	  and	  analysis	  of	  expected	  biological	  behavior.	  The	  model	  was	  then	  used	   to	   perform	  in	   silico	  knock	   out	   experiments	   inactivating	   specific	   transitions	  during	  qualitative	  network	  analysis.	  Our	  results	  showed	  that	   the	  model	   is	  able	   to	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represent	  important	  transitions	  reflecting	  real	  biological	  outcomes,	   i.e.	  transitions	  involving	   species	   such	   as	   oxygen	   or	   ATP	   are	   correctly	   inactivated	   under	   certain	  circumstances	   as	   expected	   from	   the	   bibliographic	   data.	   Biological	   energy-­‐related	  reactions	  (e.g.	  ATP	  production	  from	  ADP)	  were	  modeled	  as	  P-­‐invariants.	  Although	  the	  network	   is	   intentionally	  not	  covered	  by	  P-­‐invariants,	  P-­‐invariant	  analysis	  was	  used	  to	  verify	  all	  modeled	  energy	  consuming	  transitions.	  Both	  the	  ATP	  and	  NADH	  balances	   appeared	   constant	   during	   the	   simulation,	   with	   irrelevant	   P-­‐invariants	  located	   in	   the	   Hur	   system.	   This	   approximation	   was	   used	   to	   verify	   the	   Hur-­‐dependent	  regulation	  of	  VEGF,	  with	  results	   in	  accordance	  with	  (120).	  The	  specific	  pVHL	  knock	  out	  suggests	  that	  this	  protein	  alone	  is	  not	  sufficient	  for	  complete	  HIF-­‐1α	  inactivation.	  Indeed,	  other	  concurrent	  HIF-­‐1α	  degradation	  pathways	  promote	  a	  sort	   of	   cell	   cycle	   regulation	   backup.	   On	   the	   contrary,	   simple	   deletion	   of	   pVHL	  turned	   out	   to	   be	   sufficient	   to	   increase	   all	   its	   other	   inhibitory	   functions,	   showing	  similar	   effects	   to	   pathological	   VHL	   symptoms.	   Indeed,	   ECM	   destabilization	  increases	   cell	  migration	   to	  other	  areas,	  promoting	  metastasis	  outbreak	   in	   case	  of	  tumor	   cells.	   Further,	   pVHL-­‐dependent	   inhibition	   of	   tight	   junction	   formation	   by	  aPKCζII	   participates	   in	   an	   easier	   cellular	   detachment.	   The	   interactions	   of	   Nur77	  could	   be	   considered	   a	   good	   example	   for	   pathological	   effects.	   It	   is	   a	   stimulator	   of	  Proopiomelanocortin	   production,	   a	   precursor	   for	   the	   Adrenocorticotropic	  hormone.	   If	   excessively	   released,	   it	   promotes	   an	   overproduction	   of	   adrenergic	  neurotransmitters	   by	   adrenal	   glands.	   Coming	   at	   clinical	   condition	   known	   as	  Cushing	  syndrome.	  On	   the	  very	   long	   term,	  Nur77	  deregulation	   is	  known	  to	  cause	  tumors	   of	   the	   pituitary	   and	   adrenal	   glands	  ((121,122).	   This	   happens	   in	  pheochromocytoma,	   which	   is	   one	   of	   the	   main	   VHL	   disease	   manifestations.	   We	  speculate	  that	  continuous	  VEGF	  transcription,	  even	  in	  situations	  where	  HIF-­‐1α	  (but	  not	  Sp1)	  is	  knocked	  out,	  could	  be	  the	  explanation	  for	  clinical	  studies	  where	  VEGF-­‐targeting	   drugs	   have	   turned	   out	   to	   be	   effective	   in	   kidney	   cancer	   treatment	   as	  reported	   in	  (123).	   Although	   we	   used	   only	   confirmed	   data	   from	   the	   literature,	  Nur77	  may	  be	  involved	  in	  other	  regulation	  systems	  which	  were	  not	  considered	  in	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our	   model.	   The	   transitions	   for	   pVHL	   fibronectin	   stabilization	   show	   a	   behaviour	  which	  is	  coherent	  with	  biochemical	  experiments,	  illustrating	  a	  complete	  abrogation	  of	  ECM	  stabilization	  and	  an	   increased	  matrix	  metallo-­‐proteinase	  action.	  Although	  the	  results	  are	  encouraging,	  the	  presented	  model	  will	  need	  further	  improvements	  since	   standard	  PNs	  do	  neither	   allow	  a	   complete	   transition	   control	  nor	   enzymatic	  activity	  modulation.	  Nevertheless,	  thanks	  to	  its	  manual	  curation	  our	  model	  can	  be	  used	   to	   plan	   new	  in	   vitro	  and	  in	   vivo	   experiments.	   The	   results	   are	   convincing	  enough	   to	  suggest	  our	  model	  as	  a	  comprehensive	  pathway	  model	   to	  simulate	   the	  main	  pVHL	  functions.	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4.	  Evaluation	  of	   the	  steric	   impact	  of	   flavin	  adenine	  
dinucleotide	   in	   Drosophila	   melanogaster	  
cryptochrome	  function.	  	  	  This	  chapter	  has	  been	  published	  in	  (124)	  Masiero	  A,	  Aufiero	  S,	  Minervini	  G,	  Moro	  S,	  Costa	  R,	  Tosatto	  SCE.	  Evaluation	  of	  the	  steric	  impact	  of	  flavin	  adenine	  dinucleotide	  in	   Drosophila	   melanogaster	   cryptochrome	   function.	   Biochem	   Biophys	   Res	  Commun.	  2014	  Aug	  8;450(4):1606–11.	  	  
4.1	  Summary	  
	  	  Photoreceptors	   are	   crucial	   components	   for	   circadian	   rhythm	   entrainment	   in	  animals,	  plants,	  fungi	  and	  cyanobacteria.	  Cryptochromes	  (CRYs)	  are	  flavin	  adenine	  dinucleotide	   (FAD)	   containing	   photoreceptors,	   and	   FAD	   is	   responsible	   for	   signal	  transduction,	  in	  contrast	  to	  photolyases	  where	  it	  promotes	  DNA-­‐damage	  repair.	  In	  this	   work,	   we	   investigated	   an	   alternative	   role	   for	   FAD	   in	   CRY.	  We	   analyzed	   the	  
Drosophila	  melanogaster	   CRY	   crystal	   structure	   by	  means	   of	   molecular	   dynamics,	  elucidating	   how	   this	   large	   co-­‐factor	  within	   the	   receptor	   could	   be	   crucial	   for	   CRY	  structural	   stability.	   The	   co-­‐factor	   appears	   indeed	   to	   improve	   receptor	   motility,	  providing	  steric	  hindrance.	  Moreover,	  multiple	  sequence	  alignments	  revealed	  that	  conserved	  motifs	   in	  the	  C-­‐terminal	   tail	  could	  be	  necessary	   for	   functional	  stability.	  Four	   systems	  were	   tested:	   (i)	  dCRY-­‐FAD-­‐Mg2+,	   (ii)	  dCRY-­‐Mg2+,	   (iii)	  dCRY	  and	   (iv)	  dCRY-­‐FAD-­‐Mg2+	  with	   S526-­‐PO33-­‐.	   All	   simulations	  were	   carried	   out	  with	   NAMD	   v	  2.9,	  using	  the	  CHARMM-­‐27	  force	  field,	  and	  were	  20	  ns	  long.	  The	  multiple	  sequence	  alignment	  was	   constructed	  with	   T-­‐Coffee	   using	   a	   BLOSUM62	  matrix.	   The	   overall	  fluctuations	   of	   the	   holoreceptor	   and	   phosphorylated	   system,	   in	   absence	   of	   light,	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suggest	  that	  the	  steric	   impact	  of	  the	  co-­‐factor	  inside	  its	  binding	  pocket	  could	  be	  a	  feature	  required	  for	  receptor	  activation.	  Interestingly,	  the	  receptor	  is	  globally	  less	  rigid	  when	   the	   co-­‐factor	   is	   contained	   in	   its	   pocket	   as	   reported	   by	   the	   RMSF	   and	  RMSD	  plots	  shown.	  Thus,	  we	  cannot	  exclude	  FAD	  from	  also	  having	  a	  role	  due	  to	  its	  molecular	   structure	   and	   hindrance,	   rather	   than	   only	   being	   involved	   in	   photo	  reduction	  and	  receptor	  activation	   itself.	  The	  S526	  phosphorylation	  site	   is	  close	  to	  the	   CTT,	   and	   provides	   higher	   fluctuations	   in	   this	   region.	   Our	   results	   suggest	  phosphorylation	   could	   occur	   before	   receptor	   activation,	   further	   facilitating	  receptor	  activation.	  This	  could	  explain	  the	  crucially	  close	  CTT	  position,	  suggesting	  a	  DNA	   mimicking	   role	   for	   CTT	   and	   TIM,	   result	   also	   reinforced	   by	   sequence	  alignment.	  In	   this	   work,	   I	   designed	   and	   performed	   the	   molecular	   dynamics	  simulations,	   implementing	   the	  cofactor	  parameters	   in	   the	   force	   field,	   I	  performed	  the	   analyses	   of	   the	   obtained	   trajectories	   and	   the	   structural	   comparison	   between	  Cryptochrome	  and	  (6-­‐4)-­‐Photolyase	  crystal	  structures.	  	  	  
4.2	  Abstract	  	  	  Photoreceptors	   are	   crucial	   components	   for	   circadian	   rhythm	   entrainment	   in	  animals,	  plants,	  fungi	  and	  cyanobacteria.	  Cryptochromes	  (CRYs)	  are	  flavin	  adenine	  dinucleotide	   (FAD)	   containing	   photoreceptors,	   and	   FAD	   is	   responsible	   for	   signal	  transduction,	  in	  contrast	  to	  photolyases	  where	  it	  promotes	  DNA-­‐damage	  repair.	  In	  this	   work,	   we	   investigated	   an	   alternative	   role	   for	   FAD	   in	   CRY.	  We	   analyzed	   the	  Drosophila	  melanogaster	   CRY	   crystal	   structure	   by	  means	   of	  molecular	   dynamics,	  elucidating	   how	   this	   large	   co-­‐factor	  within	   the	   receptor	   could	   be	   crucial	   for	   CRY	  structural	   stability.	   The	   co-­‐factor	   appears	   indeed	   to	   improve	   receptor	   motility,	  providing	  steric	  hindrance.	  Moreover,	  multiple	  sequence	  alignments	  revealed	  that	  conserved	  motifs	  in	  the	  C-­‐terminal	  tail	  could	  be	  necessary	  for	  functional	  stability.	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4.3	  Introduction	  	  Light	   sensing	   is	   a	   fundamental	   task	   of	   living	   organisms,	  which	   have	   evolved	   in	   a	  rhythmic	  environment	  characterized	  by	  endless	  light–dark	  cycles.	  Light	  sensing	  is	  present	   in	  all	  kingdoms	  of	   life,	  due	   to	  several	  evolutionary	  strategies,	  which	  have	  provided	  organisms	  with	  this	  capability.	  One	  of	  these	  is	  light	  sensing	  by	  means	  of	  a	  protein	   termed	   photoreceptor	  (19).	   Cryptochromes	   (CRYs)	   are	   blue-­‐light	   sensing	  receptors,	  first	  identified	  in	  Arabidopsis	  thaliana	  in	  1993	  (23).	  The	  hidden	  nature	  of	  their	   co-­‐factor,	   which	   remained	   unknown	   for	   a	   long	   time,	   gave	   name	   to	   this	  particular	   class	   of	   proteins	  (19).	   They	   are	   classified	   as	   close	   relatives	   to	  photolyases	   (PLs),	   with	   whom	   they	   share	   a	   major	   structural	   part	   termed	  photolyase	  domain	  and	   the	  presence	  of	  a	  FAD	  co-­‐factor,	  which	   is	  contained	   in	  an	  alpha-­‐helix	   domain	   in	   both	   PLs	   and	   CRYs.	   PLs	   work	   by	   capturing	   electrons	   and	  providing	   them	   to	   reverse	   DNA	   damage,	   particularly	   removing	   pyrimidinic	   base	  dimerizations.	   In	   the	  receptor	  region,	  where	  PLs	   interact	  with	  DNA,	  CRYs	  show	  a	  longer	   C-­‐Terminal	   Tail	   (CTT)	  (30).	   In	   spite	   of	   their	   structural	   and	   sequence	  similarity	   to	   photolyases,	   CRYs	   show	   a	   different	   kind	   of	   activity	  (31,32).	   Indeed,	  they	   are	   involved	   in	   Insects	   in	   circadian	   rhythm	   entrainment	   and	  magnetosensitivity	  while	   in	  mammals	   they	   act	   as	   transcription	   repressors	   in	   the	  main	   negative	   feedback	   loop	   at	   the	   core	   of	   the	   clock.	   Moreover	   they	   lack	   DNA-­‐repair	   activity	   in	   animals	  (29).	   CRYs	   are	   therefore	   widely	   present	   in	   eukaryotic	  organisms,	  with	  a	   flavin-­‐adenine-­‐dinucleotide	   (FAD)	  co-­‐factor	  (19)	  providing	  blue	  light	  sensing	  activity.	  FAD	  works	  as	  an	  antenna,	  capturing	  photons	  and	  transducing	  them	   in	   a	   chemical	   reduction	   response.	   Unlike	   mammals,	   CRY	   has	   only	   one	  ortholog	  Drosophila	   melanogaster(dCRY).	   dCRY	   is	   rhythmically	   expressed	   in	  both	  Drosophila	  clock	   neurons	   and	   the	   compound	   eye,	   responding	   to	   light/dark	  variations	  (36).	   During	   light	   exposure,	   dCRY	   gets	   activated	   and	   opens	   its	  CTT(30,32),	   thus	   binding	   to	   TIMELESS	   (TIM)	   and	   promoting	   its	   proteasomal	  degradation,	   a	   process	   which	   the	   F-­‐Box	   protein	   Jetlag	   (Jet)	  (34,35).	   In	   darkness,	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TIM	   forms	   a	   dimer	   with	   PERIOD	   (PER).	   The	   TIM–PER	   heterodimer	   enters	   the	  nucleus,	  inhibiting	  the	  CLOCK	  and	  CYCLE	  protein	  interaction	  (95,98).	  On	  the	  other	  hand,	  when	  dCRY	  is	  binding	  TIM,	  it	  inhibits	  formation	  of	  the	  TIM-­‐PER	  heterodimer,	  allowing	   CLOCK	   and	   CYCLE	   to	   interact	   with	   a	   specific	   E-­‐box	   DNA	   segment	  promoting	  transcription	  of	  clock	  genes	  (33,36).	  This	  pathway	  is	  located	  at	  the	  core	  of	  the	  circadian	  clock	  in	  D.melanogaster,	  and	  is	  responsible	  for	  its	  synchronization	  to	  the	  natural	  light–dark	  cycles	  characterized	  by	  a	  24	  h	  period	  through	  dCRY	  light	  sensing	  (36).	  At	  a	  molecular	  level,	  receptor	  activation	  passes	  through	  absorption	  of	  a	   photon	   by	   FAD,	   causing	   its	   reduction	   with	   electrons	   towards	   a	   radical	  semiquinone	   state.	   FAD	   chemical	   reduction	   appears	   to	   play	   a	   role	   in	   receptor	   C-­‐terminal	   tail	   (CTT)	   opening.	   The	   CTT	   seems	   to	   be	   involved	   in	   protein–protein	  interactions	  under	  light	  exposure,	  as	  it	  contains	  plenty	  of	  known	  linear	  motifs	  (29),	  in	  particular	  PDZ	  motifs.	  One	  crucial	   interaction	  between	  dCRY	  CTT	  and	  the	  CTT-­‐coupled	  motif	  appears	  to	  be	  mediated	  by	  a	  motif	  involving	  the	  residues	  FFW	  on	  the	  CTT,	   as	   demonstrated	   in	  (30).	   Flavin	   ring	   reduction	   after	   light	   exposure	   and	  subsequent	   CTT	   opening	   allows	   TIM,	  which	   contains	   the	   FFWL	  motif	   as	  well,	   to	  interact	  with	   dCRY,	   putatively	   in	   the	   CTT-­‐coupled	  motif	  (30).	   In	   2011,	   Zoltowski	  and	  co-­‐workers	  solved	  a	  2.30	  Å	  resolution	  X-­‐ray	  dCRY	  crystal	  structure	  in	  the	  dark	  state	   (PDB	   identifier:	  4GU5,	   former	   3TVS,	  Fig.	   12)	  (27).	   This	   provided	   a	   basis	   for	  deeper	  understanding	  of	  the	  photoreceptor	  structure	  and	  function.	  FAD	  is	  required	  for	  receptor	  activation,	  as	  it	  works	  like	  an	  antenna.	  However,	  its	  structural	  role	  in	  the	  receptor	  has	  not	  been	  widely	  investigated	  so	  far.	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  To	  explain	  the	  role	  of	  the	  co-­‐factor	  and	  of	  the	  close	  Mg2+	  ion	  contained	  in	  the	  dCRY	  FAD	  binding	  pocket	  and	  their	  impact	  on	  the	  protein	  structure,	  we	  investigated	  the	  time	  dependent	  behavior	  of	  the	  holoprotein	  (HdCRY),	  the	  apoprotein	  (AdCRY)	  and	  the	   system	   containing	   only	   Mg2+	  (MdCRY)	   with	   molecular	   dynamics	   (MD)	  simulations.	   Moreover,	   a	   multiple	   sequence	   alignment	   was	   performed,	   adding	  value	  and	  providing	  new	  clues	  on	  dCRY	  activation	  and	  mechanism.	  The	  results	  of	  this	  work	  suggest	  that	  FAD	  presence	  has	  not	  only	  a	  functional	  meaning,	  but	  it	  may	  be	  required	  to	  provide	  an	  overall	  increase	  in	  fluctuation,	  decreasing	  the	  amount	  of	  necessary	  light	  input	  energy	  to	  activate	  the	  photoreceptor.	  	  
4.4	  Methods	  
4.4.1	  Molecular	  dynamics	  simulations	  	  The	  crystal	  structure	  of	  dCRY	  containing	  two	  539	  residues	  long	  chains	  was	  used	  as	  starting	   model	   for	   all	   simulations	   (PDB	   code:	  4GU5,	  Fig.	   12)	  (27).	   The	   structure	  contains	   30	  α-­‐helices	   (267	   residues,	   49%	  of	   the	   sequence)	   and	  10	  β-­‐strands	   (37	  residues,	   6%)	   and	   is	   characterized	   by	   the	   presence	   of	   one	   FAD	  molecule	   in	   bent	  
Figure	  	  12:	  Drosophila	  melanogaster	  cryptochrome	  structure,	  PDB	  identifier:	  4GU5.	  FAD	  co-­‐factor	  is	  represented	  
in	  spheres,	  while	  the	  receptor	  is	  depicted	  in	  ribbons.	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conformation	  (125)	   and	  one	  Mg2+	  ion	   in	   the	  binding	  pocket.	  All	   simulations	  were	  carried	   out	   with	   NAMD	   v	   2.9	  (47),	   using	   the	   CHARMM-­‐27	   force	   field	  (38)	  on	   a	  standard	   x86	   Linux	  workstation.	   A	   phosphorylation	   on	   S536	  was	   added	   through	  the	  available	  NAMD	  stream	  files	  for	  phosphoserine,	  which	  were	  added	  to	  both	  the	  topology	  and	  parameter	  files.	  We	  used	  an	  explicit	  TIP3p	  solvent	  model	  with	  cubic	  boxes	   of	   100	  Å	  ×	  94	  Å	  ×	  81	  Å,	   containing	   ∼22,500	   water	   molecules.	   Periodic	  boundaries	   were	   set	   at	   10	  Å	   from	   the	   most	   external	   protein	   atom	   in	   the	  corresponding	  cartesian	  axis.	  All	  boxes	  were	  placed	  in	  particle-­‐mesh	  Ewalds	  (PME)	  grids	   and	   the	   overall	   system	   charge	  was	   neutralized	   in	   a	   0.150	  M	  NaCl	  medium.	  Solvent	   ions	   were	   added	   with	   VMD	  (126),	   which	   was	   also	   used	   to	   generate	  topology	   files.	   The	   co-­‐factor	  was	   kept	   in	   its	   quinonic	   form	   in	   order	   to	   avoid	   any	  activation-­‐prone	   movement.	   The	   bent	   conformation	  (127)	  was	   kept	   during	   the	  entire	   simulations.	   Oxidized	   FAD	   parameters	   were	   derived	   from	  (128)	   and	  implemented	   in	   the	   CHARMM-­‐27	  (129).	   All	   simulation	   runs	   consisted	   of	   100	  conjugate	   gradient	  minimization	   steps,	   100	  ps	   in	   NVT	   conditions,	   100	  ps	   in	   NPT	  conditions	  and	  20	  ns	  of	  classical	  molecular	  dynamics	  simulation.	  In	  all	  simulations,	  the	   temperature	   was	   kept	   at	   300	  K	   and	   pressure	   at	   1.01325	  bar,	   excluding	   NVT	  pre-­‐simulation	   steps.	   The	   integration	   timestep	   was	   2	  fs	   and	   the	   integrator	   was	  based	   on	   the	  Verlet	  method	  (47).	   The	   system	  was	   analyzed	  by	   four	   different	  MD	  simulations,	  consisting	  in	  the	  holoprotein	  crystal	  structure	  simulation,	  a	  simulation	  containing	  a	  phosphorylation	  in	  Ser526	  previously	  reported	  by	  Hemsley	  et	  al.	  (29),	  a	   simulation	   containing	   only	   the	   Mg2+	  ion	   and	   a	   last	   one	   without	   FAD,	   Mg2+	  and	  containing	   no	   PTMs.	   The	   four	   runs	   were	   then	   compared	   in	   terms	   of	   root	   mean	  square	  deviation	  (RMSD)	  and	  root	  mean	  square	  fluctuation	  (RMSF)	  to	  explain	  the	  role	  of	  each	  different	  system	  component.	  RMSF	  indexes	  are	  reported	  as	  both	  plots	  and	  structure	  coloring	  and	  thickening.	  
4.4.2	  Trajectory	  analysis	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All	  obtained	   trajectories	   first	  went	   through	  visual	   inspection	  with	  Chimera	  (130),	  cleaning	  and	  analysis	  with	  Carma	  (131)	  and	  EUCB	  (132).	  The	  first	  step	  consisted	  in	  water,	   ion	   and	   co-­‐factor	   removal	   and	   system	   recentering	   with	   Carma,	   obtaining	  trajectory	  files	  containing	  only	  the	  protein	  structure	  and	  a	  constant	  fitted	  center	  of	  mass.	   The	   second	   step	   consisted	   in	   backbone	   RMSD	   and	   RMSF	   index	   calculation	  and	  plot	  generation	  with	  EUCB.	  In	  order	  to	  obtain	  information	  about	  the	  flexibility	  of	  protein	  regions	  in	  the	  structures,	  images	  were	  generated	  coloring	  and	  thickening	  residue	  ribbons	  proportionally	  to	  their	  RMSF	  values	  with	  Chimera.	  To	  obtain	  these	  images,	   the	   occupancy	   column	   of	   the	   structure	   files	  was	   replaced	   by	   the	   residue	  RMSF	  value	  with	  an	  ad	  hoc	  script.	  All	   colored	  structures	  refer	   to	   the	   last	   frame	  of	  the	  respective	  run.	  
4.4.3	  Structure	  analysis	  	  Both	  dCRY	  (27)	  and	  (6–4)-­‐Photolyase	  (PL)	  (28)	  structures	  went	  through	  RING(52)	  and	  BLUUES	  (133)	   analysis.	  RING	  generates	   a	  network	  with	   residues	  depicted	   as	  nodes	   and	   interactions	   depicted	   as	   edges,	   and	   provides	   information	   on	  conservation	   and	   residue	   interactions.	   RING	   found	   33	   sequences,	   and	   calculated	  overall	   residue	   conservation	   among	   them.	   BLUUES	   provides	   an	   electrostatic	  potential	  analysis.	  
4.4.4	  Multiple	  sequence	  and	  structure	  alignments	  	  The	   previously	   considered	  Drosophila-­‐like-­‐CRY	   sequences	  (31)	  were	   retrieved	   by	  Blast	  search	  using	  dCRY	  as	  a	  query.	  TIM	  sequences	  were	  collected	  from	  the	  same	  species	  with	  the	  same	  approach.	  The	  multiple	  sequence	  alignment	  was	  constructed	  with	  T-­‐Coffee	  (134)	  using	  a	  BLOSUM62	  matrix.	  The	  number	  of	  extracted	  sequences	  is	  36	  of	  which	  18	  are	  available	  for	  both	  dCRY	  and	  TIM.	  A	  sequence	  logo	  was	  built	  with	   Weblogo(81))	   from	   this	   data	   and	   overlaid	   with	   the	   experimental	   dCRY	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peptide	   structure	   (PDB	   ID:	  4GU5).	   Intrinsic	   disorder	   for	   dCRY	   CTT	   and	   TIM	  sequences	  and	  secondary	  structures	  for	  TIM	  was	  predicted	  with	  CSpritz	  (82).	  The	  structures	   (PDB	   IDs:	  4GU5	  and	  2WB2)	  were	   superposed	  with	   Chimera,	   using	   the	  Needleman-­‐Wunsch	  algorithm	  with	  the	  BLOSUM62	  matrix.	  The	  RMSD	  between	  the	  protein	  structures	  was	  0.963	  Å.	  
4.5	  Results	  
4.5.1	  Structural	  impact	  of	  the	  co-­‐factor	  	  The	   rationale	   for	   this	  work	  was	   first	   the	   clarification	  of	  FAD	   impact	  on	   structure	  stability	   by	   better	   investigating	   the	   behavior	   of	   its	   surrounding.	   To	   have	   a	  comparison	  between	  two	  FAD	  containing	  systems	  and	  to	  better	  highlight	  its	  impact	  on	  the	  structure,	  we	  performed	  a	  comparison	  between	  the	  holoreceptor,	  kept	  as	  a	  blank,	   and	   the	   holoreceptor	   containing	   a	   previously	   reported	   phosphorylation	   in	  S526	  (PdCRY),	  which	  is	  a	  known	  occurring	  event	  (29)).	  In	  order	  to	  investigate	  the	  co-­‐factor	  impact	  on	  its	  surrounding	  protein	  elements,	  MD	  simulation	  outputs	  were	  evaluated	   in	   terms	   of	   RMSD	   and	   RMSF.	  A	   priori,	   we	   hypothesized	   that	   FAD	  presence	   would	   improve	   the	   overall	   receptor	   stability	   through	   intermolecular	  interactions	   and	   its	   removal	   from	   the	   binding	   pocket	   would	   yield	   receptor	  misfolding.	  To	  evaluate	  the	  structural	  role	  of	  the	  co-­‐factor,	  the	  first	  index	  used	  was	  RMSD	  from	  trajectory	  files	  obtained	  by	  20	  ns	  MD	  simulations.	  RMSD	  evaluates	  the	  mean	  receptor	  backbone	  distance	  between	  the	  first	  and	  other	  frames	  generated	  for	  a	   given	   trajectory.	   RMSD	   plots	   of	   the	   systems	   showed	   how	   the	   more	   stable	  conformations	   are	   those	   not	   containing	   the	   co-­‐factor	   (see	  SM	   2,	   Appendix).	   Very	  recently,	  Vaidya	  and	  co-­‐workers	  demonstrated	  in	  vitro	  that	  the	  structural	  elements	  surrounding	   the	   CTT	   are	   exposed	   to	   Trypsin	   cleavage	   under	   light	   conditions,	  suggesting	   disorder	  (30).	   They	   also	   report	   a	   general	   photoreceptor	   structure	  involvement	   after	   light	   exposure.	   Our	   study	   focuses	   on	   the	   effect	   of	   FAD	   itself	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before	   the	   reaction,	   considering	   its	   effect	   on	   the	   overall	   structure.	   HdCRY	   RMSD	  plot	  reveals	  a	  mean	  plateau	  value	  of	  4.5	  Å,	  and	  the	  phosphorylated	  system	  an	  even	  higher	  peak	  of	   almost	  5.0	  Å.	   In	   the	   latter	   system,	   the	  RMSD	  slope	   is	  much	  higher	  compared	  to	  other	  systems	  (see	  SM	  2,	  Appendix),	  highlighting	  the	  strong	  impact	  of	  the	   post-­‐translational	  modification	   on	   the	   system.	   RMSD	   values	   of	   the	   other	   two	  systems	  containing	  no	  FAD	  and	  neither	  FAD	  nor	  Mg2+	  are	   lower,	  suggesting	  more	  rigid	   behaviors.	   The	   second	   output	   analysis	   was	   RMSF,	   measuring	   the	   mean	  backbone	  RMSD	  value	   for	  each	  residue	  during	  an	  entire	   run,	  distinguishing	  more	  fluctuating	   and	  more	   rigid	   regions	   of	   a	   system.	   The	  RMSF	   plots	   showed	   that	   the	  overall	   structures	   not	   containing	   the	   FAD	   co-­‐factor	   are	   more	   rigid	   and	   the	  fluctuations	  minimized	  (see	  SM	  3,	  Appendix).	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  The	  regions	  more	  affected	  by	  FAD	  presence,	  according	  to	  RMSF	  plots,	  are	  residues	  200–300	  and	  the	  CTT	  region.	  The	  first	  corresponds	  to	  the	  FAD	  phosphate	  binding	  pocket	  surface	  moiety	  boundaries,	  a	  solvent	  exposed	  segment	  and	   the	  protrusion	  motif	   (see	  SM	   1,	   Appendix).	   A	   comparison	   between	   HdCRY,	   AdCRY	   and	   MdCRY	  dynamics	   clearly	   shows	   that	   the	   holoreceptor	   region	   between	   residues	   200	   and	  300	   is	   fluctuating	   with	   peaks	   reaching	   4.0	  Å,	   while	   in	   AdCRY	   and	   MdCRY	   these	  values	   are	   lower	   at	   3.5	  Å	   and	   2.5	  Å	   respectively	   (see	  SM	   3,	   Appendix).	   Another	  
Figure	  	  13:	  RMSF	  thickening	  and	  coloring	  for	  (A)	  holoprotein,	  (B)	  cryptochrome	  without	  FAD,	  (C)	  cryptochrome	  
without	  both	  FAD	  and	  Mg2+,	  (D)	  cryptochrome	  with	  phosphorylated	  S526.	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region	   deeply	   biased	   by	   FAD	   presence/absence	   is	   the	   so-­‐called	   CTT	   base	   loop	  (residues	  154–160)	  (30).	  The	  highest	  motility	  was	  found	  in	  the	  system	  containing	  a	  phosphorylation	   in	   S526,	   the	  Mg2+	  ion	   and	   the	   FAD	   co-­‐factor.	   The	  phosphoserine	  forms	   hydrogen	   bonds	  with	   both	   the	   Phe428	   and	   Glu429	   backbone	   (C-­‐Terminal	  lid)	   for	   almost	   all	   analyzed	   frames.	   The	   RMSF	   plot	   of	   this	   system	   shows	   slightly	  lower	   peaks	   in	   the	   200–300	   region,	  with	   values	   reaching	   3.5	  Å,	   but	   an	   improved	  CTT	  motility	  compared	  to	  all	  other	  RMSF	  plots	  (see	  SM	  3,	  Appendix).	  These	  results	  show	   that	  FAD	  presence	   in	   the	   receptor	   improves	  overall	  motility,	   as	  well	   as	   the	  kinetic	  energy	  of	   the	   system.	  AdCRY	  and	  MdCRY	  were	  definitely	  more	  stable	  and	  rigid	  (see	  SM	  3,	  Appendix,	  and	  Fig.	  13).	  This	  can	  be	  explained	  with	  steric	  effects	  and	  is	  clearly	  noticeable	  by	  RMSD	  plot	  comparison	  (see	  SM	  2,	  Appendix).	  The	  slope	  of	  the	  RMSD	  plot	  for	  systems	  without	  FAD	  is	  dramatically	   lower.	  Interestingly,	  RING	  network	   analysis	   revealed	   that	   residues	   with	   more	   than	   80%	   conservation	   (87	  residues)	  are	  mostly	  kept	  in	  the	  hydrophobic	  protein	  core	  (see	  SM	  1,	  Appendix).	  Of	  those	   87	   residues,	   16	   are	   in	   close	   contact	   with	   the	   cofactor.	   This	   analysis	   was	  complemented	   with	   a	   multiple	   sequence	   alignment,	   which	   also	   revealed	   high	  conservation	   also	   for	   some	   CTT	   residues.	   The	   conservation	   rate	   decreases	  proportionally	   to	   Phylum	   distance.	   BLUUES	   electrostatic	   potential	   map	  comparisons	   between	   dCRY	   and	   (6–4)-­‐PL	   revealed	   a	   positive	   potential	   in	   both	  dCRY	   and	   (6–4)-­‐PL,	   (see	  SM	   4,	   Appendix).	   In	   this	   region,	   (6–4)-­‐PL	   contains	  positively	  charged	  residues	  interacting	  with	  DNA.	  In	  dCRY,	  this	  region	  corresponds	  to	  the	  CTT	  lid,	  which	  remained	  rigid	  during	  the	  simulation.	  This	  result,	  in	  addition	  to	  structural	  superposition,	  could	  suggest	  a	  DNA	  mimicking	  role	  of	  this	  region.	  
4.5.2	  The	  FFW	  motif	  and	  S526	  phosphorylation	  effect	  	  S526	   superposes	   to	   a	   DNA	   phosphate	   moiety	   in	   the	  D.melanogaster	  PL	   crystal	  structure.	  The	  same	  DNA	  phosphate	  moiety	  was	  found	  to	  partially	  superpose	  with	  dCRY	  E530	  as	  well,	  suggesting	  a	  DNA-­‐mimicking	  role	  of	  the	  CTT.	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Furthermore,	  the	  mainly	  aromatic	  ring	  nature	  of	  the	  residues	  of	  the	  FFWL	  motif	  is	  suggesting	   some	   similarity	  with	   nucleic	   acid	   base	   rings.	   The	   importance	   of	   these	  motif	   residues	   can	   find	   partial	   confirmation	   in	   the	  multiple	   sequence	   alignment,	  which	  revealed	  a	  high	  conservation	  of	  both	  the	  SNEEE	  and	  FFW	  motifs	  through	  all	  analyzed	   Drosophila-­‐like-­‐CRYs	   (see	  Fig.	   14).	   S526	   is	   100%	   conserved,	   while	   the	  FFW	  motif	  the	  residues	  are	  100%,	  88%,	  100%	  conserved,	  respectively	  (see	  Fig.	  13).	  The	  sequence	  logo	  shows	  how	  the	  CTT	  linear	  motifs	  are	  located	  in	  a	  segment	  with	  strong	   sequence	   conservation,	   in	   a	   putative	   α-­‐helix	   inside	   an	   intrinsically	  disordered	  region	  (see	  Fig.	  13).	  
4.5.3	  TIM	  sequence	  analysis	  	  Starting	   from	   the	   reported	   FFW	   motif	   correspondence	   between	   TIM	   and	   dCRY	  CTT	  (30),	   we	   extended	   the	   analysis	   to	   TIM	   sequences	   belonging	   to	   the	   same	  
Figure	  	  14:	  (A)	  Schematic	  representation	  of	  dCRY,	  below	  the	  regions	  Photolyase-­‐like,	  above	  the	  most	  important	  
regions	   influenced	  by	  presence/absence	  of	  FAD	  co-­‐factor.	   (B)	  Overview	  of	   the	   dCRY	  CTT	   features.	   dCRY	  CTT	  
sequence	   logo	   shows	   the	   conserved	   motifs	   above,	   features	   from	   the	   crystallographic	   dCRY	   structure	   (PDB	  
identifier	  4GU5)	   and	   predicted	   disorder	   are	   showed	   below.	   The	   secondary	   structure	   is	   shown	   as	   helix.	  
Predicted	  disorder	  is	  shown	  as	  a	  yellow	  line.	  (C)	  TIM	  sequence	  logo	  shows	  the	  FFW	  conserved	  motif	  suggested	  
to	  interact	  with	  dCRY	  receptor	  region,	  secondary	  structures	  (S.S.)	  prediction	  and	  structured	  region	  are	  showed	  
below.	   (For	   interpretation	   of	   the	   references	   to	   color	   in	   this	   figure	   legend,	   the	   reader	   is	   referred	   to	   the	  web	  
version	  of	  this	  article.)	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species.	  We	  found	  that	  TIM	  keeps	  the	  FFW	  motif	  highly	  conserved	  (100%)	  among	  all	  explored	  species	  (Fig.	  14).	  This	  suggests	  that	  the	  conserved	  tryptophan	  of	  TIM	  and	   the	   dCRY	   CTT	   FFW	   motif	   could	   interact	   in	   the	   same	   manner	   with	   dCRY.	  Conversely,	  neither	  motif	  was	  found	  among	  D.melanogaster	  Photolyase	  orthologs.	  
4.6	  Discussion	  	  Light	   signal	   transduction	   into	   chemical	   responses	   is	   frequent	   in	   nature.	  Here	  we	  investigated	  whether	  the	  presence	  of	  FAD	  could	  have	  not	  only	  a	  light	  sensing	  role	  within	   photoreceptors,	   but	   could	   be	   also	   required	   to	   provide	   a	   more	   suitable	  overall	   structure	   to	   maximize	   receptor	   reactivity	   towards	   light	   impulses.	   The	  overall	   fluctuations	  of	  the	  holoreceptor	  and	  phosphorylated	  system,	   in	  absence	  of	  light,	  suggest	  that	  the	  steric	  impact	  of	  the	  co-­‐factor	  inside	  its	  binding	  pocket	  could	  be	  a	  feature	  required	  for	  receptor	  activation.	  Interestingly,	  the	  receptor	  is	  globally	  less	  rigid	  when	  the	  co-­‐factor	  is	  contained	  in	  its	  pocket	  as	  reported	  by	  the	  RMSF	  and	  RMSD	  plots	  shown.	  Thus,	  we	  cannot	  exclude	  FAD	  from	  also	  having	  a	  role	  due	  to	  its	  molecular	   structure	   and	   hindrance,	   rather	   than	   only	   being	   involved	   in	   photo	  reduction	   and	   receptor	   activation	   itself.	   This	   could	   be	   explained	   considering	   the	  more	   fluctuation-­‐prone	  HdCRY	   behavior,	   likely	   requiring	   less	   input	   energy	   to	   go	  towards	   a	   state	   transition	   and	   activation.	   The	   RMSF	   value	   of	   the	   CTT	   preceding	  region	  is	  reinforcing	  this	  hypothesis.	  All	  systems	  containing	  FAD	  have	  higher	  RMSF	  values	  towards	  the	  CTT	  between	  residues	  450	  and	  525.	  Whenever	  FAD	  is	  lacking,	  this	   region	   is	   more	   rigid	   and	   less	   ready	   to	   move.	   Given	   that	   receptor	   activation	  appears	  to	  be	  dependent	  on	  this	  residue	  segment,	  we	  can	  speculate	  that	  FAD	  could	  also	  have	  a	  prominent	  role	  before	  receptor	  activation	  unconnected	  to	   its	   intrinsic	  light	  exposure	  reactivity.	  Analysis	  of	  the	  phosphorylated	  system	  (P-­‐dCRY)	  revealed	  an	   even	   higher	   overall	   fluctuation	   compared	   to	   all	   other	   systems.	   The	   S526	  phosphorylation	   site	   is	   close	   to	   the	   CTT,	   and	  provides	   higher	   fluctuations	   in	   this	  region.	  Our	  results	  suggest	  phosphorylation	  could	  occur	  before	  receptor	  activation,	  further	   facilitating	   receptor	   activation.	   This	   could	   explain	   the	   crucially	   close	   CTT	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position,	   suggesting	   a	   DNA	  mimicking	   role	   for	   CTT	   and	   TIM.	   Furthermore,	   dCRY	  E530	  and	  S526	  are	  close	  to	  a	  PL	  phosphate	  DNA	  moiety	  after	  superposition	  (0.98	  Å	  and	   2.25	  Å,	   respectively	   for	   the	   closest	   atoms),	   thus	   reinforcing	  what	   previously	  demonstrated	   in	  (135).	   On	   the	   other	   hand,	   multiple	   sequence	   and	   structural	  alignments	  also	  revealed	  that	  the	  CTT	  could	  mimic	  the	  damaged	  DNA	  Photolyase-­‐DNA	  interaction	  and	  establish	  contacts	  with	  the	  FAD	  binding	  pocket.	  In	  particular,	  the	  aromatic	  rings	  of	  the	  FFW	  motif	  residues	  show	  similarity	  with	  nucleic	  acid	  base	  rings	  and	  are	  conserved	  in	  the	  main	  dCRY	  interactor	  TIM	  (30).	  In	  the	  end,	  our	  data	  suggest	  that	  even	  if	  chemical	  reactivity	  of	  the	  co-­‐factor	   is	  the	  main	  reason	  behind	  receptor	  activation,	  steric	  hindrance	  of	  the	  molecule	  could	  be	  a	  required	  feature	  as	  well.	  The	  multiple	  sequence	  alignment	  also	  showed	  that	  the	  SNEEE	  and	  FFW	  motifs	  are	   conserved	   in	   CRY	   ortholog	   CTTs.	   These	   conserved	   species-­‐specific	   motifs,	  which	  are	  not	  present	   in	   the	  Photolyase	   family,	  could	  suggest	  a	   functional	  role	   in	  the	  photoreceptor.	  Light	  exposure	  induces	  dCRY	  activation,	  opening	  its	  CTT	  (29,30)	  and	   allowing	   binding	   to	   TIM,	   which	   it	   is	   subsequently	   degraded	   by	   the	  proteasome	  (34,35).	   Further	  in	   vitro	  validation	   of	   the	   obtained	   results	   should	   be	  carried	  out	  in	  order	  to	  shed	  light	  on	  these	  issues,	  due	  to	  the	  in	  silico	  origin	  of	  data.	  Our	  results	  nevertheless	  suggest	  that	  presence	  of	  the	  conserved	  FFW	  motif	  in	  both	  TIM	   and	   dCRY	   and	   SNEEE,	   once	   phosphorylated,	   and	   FFW	  motifs	   in	   dCRY	   could	  mimic	   DNA	   interaction	   with	   the	   CTT	   coupled	   motif.	   Finally,	   these	   findings	   are	  suggesting	  an	  additional	  prominent	  structural	  role	  of	  the	  co-­‐factor	  in	  the	  receptor	  activation	   process,	   providing	   another	   small	   piece	   to	   the	   enormous	   light	   stimuli	  response	  mechanism	  jigsaw.	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5.	   Structural	   protein	   reorganization	   and	   fold	  
emergence	   investigated	   through	   amino	   acid	  
sequence	  permutations	  	  	  This	   chapter	   has	   been	   published	   in	   (136)	   Minervini	   G,	   Masiero	   A,	   Potenza	   E,	  Tosatto	   SCE.	   Structural	   protein	   reorganization	   and	   fold	   emergence	   investigated	  through	  amino	  acid	  sequence	  permutations.	  Amino	  Acids.	  2015	  Jan;47(1):147–52.	  	  
5.1	  Summary	  	  	  Correlation	  between	  random	  amino	  acid	  sequences	  and	  protein	  folds	  suggests	  that	  proteins	   autonomously	   evolved	   the	  most	   stable	   folds,	  with	   stability	   and	   function	  evolving	  subsequently,	  suggesting	  the	  existence	  of	  common	  protein	  ancestors	  from	  which	   all	   modern	   proteins	   evolved.	   To	   test	   this	   hypothesis,	   we	   shuffled	   the	  sequences	   of	   10	   natural	   proteins	   and	   obtained	   40	   different	   and	   apparently	  unrelated	  folds.	  Our	  results	  suggest	  that	  shuffled	  sequences	  are	  sufficiently	  stable	  and	   may	   act	   as	   a	   basis	   to	   evolve	   functional	   proteins.	   The	   common	   secondary	  structure	   of	   modern	   proteins	   is	   well	   represented	   by	   a	   small	   set	   of	   permuted	  sequences,	  which	  also	  show	  the	  emergence	  of	   intrinsic	  disorder	  and	  aggregation-­‐prone	  stretches	  of	  the	  polypeptide	  chain.	  Sequences	  were	  permuted	  following	  this	  crossing	   scheme:	   ABCA'B'C'	   becoming	   A'AB'BC'C	   and	   so	   on.	   Fold	   prediction	   was	  carried	  out	  with	  Rosetta	  ab	   initio	  software,	  and	  all	  4	  ns	   long	  molecular	  dynamics	  simulations	  of	  all	  the	  proteins	  were	  carried	  out	  with	  GROMACS,	  with	  CHARMM-­‐27	  all	   atoms	   force-­‐field.	   The	   disorder	   predictions,	   aggregation	   predictions	   and	  secondary	   structure	   predictions	   were	   carried	   out	   with	   PASTA2.0	   software.	   	   Our	  opinion	  is	  that	  the	  modern	  folds	  may	  result	  from	  biological	  evolution	  operating	  in	  the	  form	  of	  continuous	  finishing	  of	  a	   finite	  set	  of	  randomly	  generated	  proto-­‐folds.	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We	  demonstrated	  that	  shuffled	  sequences	  might	  act	  as	  a	  basis	  to	  evolve	  functional	  proteins,	   with	   the	   common	   secondary	   structure	   of	   modern	   proteins	   well	  represented	   by	   a	   small	   set	   of	   permuted	   sequences.	   Although	   meaningful,	   the	  results	  presented	  here	  are	  theoretical	  and	  their	  reliability	  is	  related	  to	  the	  validity	  of	  the	  underlying	  in	  silico	  predictions.	  In	  this	  work,	  I	  performed	  the	  analysis	  of	  the	  molecular	  dynamics	  simulations	  trajectories	  of	  the	  predictions,	  and	  I	  performed	  the	  disorder,	   electrostatic,	   aggregation	   and	   secondary	   structure	   calculations	   with	  PASTA	  2.0.	  	  	  
5.2	  Abstract	  	  Correlation	  between	  random	  amino	  acid	  sequences	  and	  protein	  folds	  suggests	  that	  proteins	   autonomously	   evolved	   the	  most	   stable	   folds,	  with	   stability	   and	   function	  evolving	  subsequently,	  suggesting	  the	  existence	  of	  common	  protein	  ancestors	  from	  which	   all	   modern	   proteins	   evolved.	   To	   test	   this	   hypothesis,	   we	   shuffled	   the	  sequences	   of	   10	   natural	   proteins	   and	   obtained	   40	   different	   and	   apparently	  unrelated	  folds.	  Our	  results	  suggest	  that	  shuffled	  sequences	  are	  sufficiently	  stable	  and	   may	   act	   as	   a	   basis	   to	   evolve	   functional	   proteins.	   The	   common	   secondary	  structure	   of	   modern	   proteins	   is	   well	   represented	   by	   a	   small	   set	   of	   permuted	  sequences,	  which	  also	  show	  the	  emergence	  of	   intrinsic	  disorder	  and	  aggregation-­‐prone	  stretches	  of	  the	  polypeptide	  chain.	  	  
5.3	  Introduction	  	  Proteins	   are	   considered	  as	   the	  building	  blocks	  of	   life	   owing	   to	   their	   stability	   and	  functional	   plasticity.	   At	   the	   molecular	   level,	   proteins	   are	   heteropolymers	   of	   20	  different	  amino	  acids.	  Simple	  dipeptides	  such	  as	  Gly-­‐Gly	  or	  Ser-­‐His	  were	  reported	  to	   catalyze	   both	   proteolytic	   and	   peptide	   bond	   formation	   (115,116).	   It	   is	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conceivable	   that	   small	   catalytic	   proto-­‐enzymes	   contributed	   to	   the	   evolution	   of	  longer	  copolymers,	   triggering	   the	  race	   for	   the	  most	  stable	  polypeptide	  chain.	   It	   is	  also	  conceivable	  that	  a	  stable	  chain	  incorporated	  the	  same	  catalytic	  motifs,	  perhaps	  yielding	   a	   first	   complex	   enzyme	   (e.g.,	   a	   catalytic	   center	   coupled	   with	   a	   stable	  scaffold).	   Over	   time	   proteins	   evolved	   different	   and	   complex	   functions	   such	   as	  enzymatic	  catalysis,	  structural,	  and	  signaling	  functions.	  Current	  theories	  regarding	  the	   origin	   of	   life	   suggest	   that	   amino	   acid	   chains	   co-­‐evolved	  with,	   or	   immediately	  after,	  the	  emergence	  of	  autocatalytic	  RNA	  (139,140).	  On	  the	  basis	  of	  these	  theories,	  primordial	   proteins,	   also	   known	  as	  proteinoids,	   promoted	   the	  nucleic	   acid	   onset,	  allowing	   their	   stabilization	   and	   conferring	   the	   ability	   to	   adapt	   to	   environmental	  changes(141)).	   Ideally,	   primordial	   RNA–polypeptide	   association	   could	   have	  enlarged	   the	   spectrum	   of	   different	   catalyses	   allowing	   the	   formation	   of	   more	  complex	  reactions.	  Notably,	  in	  modern	  organisms	  peptide	  bond	  formation	  is	  driven	  by	   the	   ribosome,	   a	  highly	   efficient	  RNA–protein	   complex.	  Considering	  a	  prebiotic	  scenario	  where	  rigid	  environmental	  conditions	  coupled	  with	  an	  unstable	  chemical	  surrounding	  promoted	  protein	  degradation,	  a	  stable	  structure	  could	  be	  considered	  as	  a	   favorable	  requirement	   for	  protein	  evolution.	   Indeed,	  since	   the	  appearance	  of	  proteins,	   only	   few	   folds	   became	   fixed,	   perhaps	   as	   a	   result	   of	   thermodynamic	   (or	  biological	  ante	  litteram?)	  selection	  of	  the	  most	  stable	  three-­‐dimensional	  structures.	  Correlations	   between	   random	   amino	   acid	   sequences	   and	   protein	   folds	   were	  investigated	   by	   Weiss	   et	   al.(142),	   suggesting	   the	   general	   idea	   that	   proteins	  autonomously	  evolved	  the	  most	  stable	  folds	  only	  after	  sequence	  evolution	  “refined”	  the	   surviving	   folds	   in	   order	   to	   acquire	   stability	   and	   function	   (143,144).	   Indeed,	  modern	   proteins	   are	   characterized	   by	   a	   large	   number	   of	   different	   sequences	   not	  balanced	   by	   the	   same	   number	   of	   different	   fold(145)).	   Unexpectedly,	   structural	  analysis	   in	   silico	  on	   random	  proteins	   suggested	   that	  polypeptide	   chains	  may	   fold	  and	   adopt	   conformations	   comparable	   to	   natural	   proteins	   (37).	   Proteinoid	   theory	  assumes	   that	   simple	   enzymatic	   function	   evolved	   spontaneously	   from	   simple	   and	  not	  biologically	  generated	  polypeptides	  (146).	  On	  the	  other	  hand,	  it	  is	  credible	  that	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the	  first	  proteins	  were	  generated	  through	  ligation	  of	  small	  and	  stable	  “amino	  acid	  modules”	   operated	   by	   proto-­‐enzymes	   characterized	   by	   both	   low	   specificity	   and	  efficiency.	   In	   this	   scenario,	   small	   proto-­‐proteins	   should	   be	   responsible	   for	   all	  resulting	  modern	   folds.	   In	   this	  work,	  we	   investigated	   the	   occurrence	   of	   different	  folds	   using	   an	   in	   silico	   combinatorial	   approach.	  We	   shuffled	   the	   sequences	   of	   10	  natural	   proteins	   and	   obtained	   40	   unrelated	   different	   folds.	   A	   large	   spectrum	   of	  different	   organizations	   were	   observed,	   including	   all-­‐α,	   β-­‐barrel,	   and	   disorder.	  Finally,	  our	  results	  suggest	  that	  abiotic	  complex	  fold	  emergence	  may	  have	  resulted	  from	  stochastic	  sequence	  rearrangement.	  	  
5.4	  Methods	  	  Permutations	   were	   manually	   performed	   starting	   from	   10	   different	   sequences	   in	  Fasta	  format	  of	  the	  same	  number	  of	  natural	  proteins	  selected	  from	  the	  Protein	  Data	  Bank	  (PDB	  codes:	  1ARK,	  1HX2,	  1KV0,	  1PPT,	  1TCP,	  1UOY,	  1ZFI,	  2BHI,	  2CDX,	  2KJF)	  (39).	   In	  order	   to	  minimize	  both	   the	  error	  and	  computational	  demands	  associated	  with	  the	  ab	  initio	  methodology,	  we	  selected	  proteins	  with	  a	  maximum	  length	  of	  66	  amino	  acids.	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Each	  sequence	  was	  initially	  split	  into	  20	  blocks	  of	  three	  amino	  acids	  long	  and	  then	  divided	  into	  two	  halves,	  termed	  A	  and	  B.	  The	  first	  block	  of	  group	  B	  was	  placed	  at	  the	   beginning	   of	   the	   new	   permuted	   sequence	   and	   the	   first	   block	   of	   A	   was	   then	  placed	   second.	   The	   same	  was	   applied	   for	   the	   other	   blocks	   until	   a	   new	  permuted	  sequence	   was	   obtained.	   A	   schematic	   explanation	   of	   the	   permutation	   schema	   is	  shown	   in	   Fig.	  15.	   The	   three-­‐dimensional	   model	   structures	   of	   both	   natural	   and	  permuted	  proteins	  were	  predicted	  using	  Rosetta	  (147),	  a	  piece	  of	  ab	  initio	  protein	  structure	  prediction	  software	  based	  on	  the	  assumption	  that	  local	  interactions	  bias	  the	   conformation	   of	   sequence	   fragments	   in	   a	   polypeptide	   chain,	   while	   global	  interactions	  determine	  the	  three-­‐dimensional	  structure	  with	  minimal	  energy	  (147).	  For	   each	   sequence,	   25,000	   decoys	   were	   generated	   and	   clustered	   using	   the	  integrated	   clustering	   module.	   Only	   the	   best	   ranked	   model	   proposed	   for	   each	  sequence	   was	   considered.	   The	   predicted	   three-­‐dimensional	   structures	   of	   native	  sequences	   were	   calculated	   and	   used	   to	   test	   the	   setup	   applied	   in	   the	   ab	   initio	  protocol.	  A	  comparison	  between	  experimental	  and	  predicted	  structures	  is	  shown	  in	  Supplementary	  Fig.	  1.	  The	  overall	   fold	  stability	  was	  studied	  by	  performing	  4	  ns	  of	  
Figure	  	  15:	  Shuffling	  schema.	  Each	  sequence	  was	  initially	  split	  into	  20	  blocks	  of	  three	  amino	  acids	  long	  and	  then	  
divided	   in	   two	   groups	   termed	   A	   and	   B.	   The	   first	   block	   of	   group	   B	   was	   placed	   at	   the	   beginning	   of	   the	   new	  
permuted	  sequence	  and	  the	   first	  block	  of	  A	  was	   then	  placed	  second.	  The	  same	  was	  applied	   for	   the	  other	  blocks	  
until	  a	  new	  permuted	  sequence	  was	  obtained.	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molecular	   dynamics	   (MD)	   simulation	   with	   Gromacs	   (46)	   using	   the	   CHARMM	   27	  force	   field	   (38).	  At	  4	  ns	  per	  system	  the	  overall	   simulation	   time	   for	  all	  predictions	  was	  200	  ns.	  The	  total	  energy	  of	  the	  protein	  in	  solution	  was	  calculated	  with	  BLUUES	  (133).	   Disorder	  was	   predicted	   using	   ESpritz	   (148)	   and	   both	   secondary	   structure	  and	  aggregation	  propensity	  with	  PASTA	  2.0	  (129).	  
	  
5.5	  Results	   	  	  The	   aim	   of	   the	   present	   work	   was	   to	   elucidate	   the	   way	   evolution	   generated	   the	  variability	  observed	  among	  existing	  protein	  folds.	  In	  this	  sense,	  we	  hypothesized	  a	  credible	  scenario	  where	  several	  different	  sequences	  arose	  from	  a	  common	  mixture	  of	   short	   prebiotic	   polypeptide	   chains	   (e.g.,	   a	   primordial	   broth).	   Starting	   from	   an	  existing	  protein,	  we	  split	  the	  sequence	  into	  smaller	  segments	  of	  three	  amino	  acids	  each,	   then	   reassembled	   the	   blocks	   to	   obtain	   four	   new	   shuffled	   sequences.	   The	  resulting	   sequences	   conserved	   the	   same	   overall	   amino	   acid	   composition	   as	   the	  natural	  one,	  but	  different	  internal	  organization,	  as	  shown	  in	  Fig.	  16.	  
5.5.1	  Fold	  analysis	  The	   propensity	   of	   shuffled	   proteins	   to	   generate	   stable	   folds	   was	   measured	   by	  calculating	  a	  three-­‐dimensional	  structure	  for	  each	  permuted	  sequence	  with	  Rosetta	  (147).	   Interpretations	   of	   the	   results	   described	   here	   are	   heavily	   related	   to	   the	  validity	  of	   structures	  predicted	  using	   the	   ab	   initio	  method.	   In	   a	  number	  of	   cases,	  Rosetta	   was	   shown	   to	   perform	   fairly	   well	   and	   even	   produced	   near-­‐atomic	  resolution	   structures	   (150,151).	   Our	   results	   for	   the	   natural	   proteins	   used	   in	   this	  research	  confirm	  that	  the	  predictions	  are	  in	  most	  cases	  accurate	  in	  terms	  of	  overall	  fold,	  secondary	  structure	  content,	  and	  topology	  (Supplementary	  Fig.	  1(136))).	  The	  same	  protocol	  was	  also	  applied	  to	  the	  shuffled	  sequences.	  The	  structures	  obtained	  show	   that	   pseudo-­‐proteins	   tend	   to	   assume	   a	   well-­‐ordered	   three-­‐dimensional	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structure,	  with	  almost	  all	  predictions	  promoting	  a	  compact	  fold	  (Fig.	  16).	  Notably,	  in	  several	  tests	  the	  structure	  obtained	  at	  permutation	  four	  resulted	  in	  a	  completely	  different	   secondary	   structure	   content	  with	   respect	   to	   the	   starting	   structure.	   This	  finding	   reinforces	   the	   idea	   that	   the	   propensity	   to	   evolve	   different	   folds	   is	   an	  emergent	  property	   of	   amino	   acid	   chains	   and	   clearly	   showed	   that	   a	   sequence	   can	  freely	   evolve	   different	   three-­‐dimensional	   shapes	   when	   not	   constrained	   by	   the	  requirements	  of	  biological	   evolution	   (37).	  An	   illustration	  of	   this	  evidence	  may	  be	  given	   by	   the	   permutation	   of	   carnocyclin	   (PDB	   code	   2KJF)	   (Fig.	  16).	   The	   native	  protein	  folds	  in	  an	  all-­‐α	  structure	  and	  is	  known	  to	  be	  very	  stable,	  with	  a	  fold	  shared	  with	   other	   proteins	   of	   the	   bacteriocin	   family	   (152).	   Owing	   to	   its	   important	  biological	   function,	   the	   general	   fold	   of	   this	   protein	   family	   is	   largely	   conserved	  between	  bacteria.	  When	  permuted,	   the	  protein	  gave	  a	  wide	  spectrum	  of	  different	  organizations.	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   Figure	   	   16:	   Prediction	   of	   permuted	   proteins.	   Comparison	   between	   experimental	   structure	   and	  
predicted	   structures	   after	   permutation.	  Brown	  represents	   the	   experimental	  
structure;	  blue,	  purple,	  green,	   and	  orange	  represent	   permutations	   1,	   2,	   3,	   and	   4,	   respectively.	   The	  
corresponding	  PDB	  code	  is	  reported	  on	  the	  left	  
	  
	   89	  	  
Indeed,	   its	   permutation	   generates	   a	   β-­‐barrel-­‐like,	   plain	   β-­‐sheet,	   α–β	   mixed,	   and	  finally	  an	  all-­‐α	  structure,	  at	  permutation	  steps	  1,	  2,	  3,	  and	  4,	   respectively.	  Similar	  permutation	  behavior	  was	  obtained	  for	  a	   trypsin	   inhibitor	  (PDB	  1HX2)	  and	  avian	  pancreatic	  polypeptide	  (PDB	  1PPT).	  More	  generally,	  in	  all	  simulations	  we	  observed	  an	  alternation	  between	  several	  folds	  with	  the	  protein	  structure	  suddenly	  changing	  between	  permutations.	  The	  result	  confirms	   in	  part	  what	  was	  previously	  reported	  by	   Luisi	   and	   co-­‐workers(153),	   i.e.,	   the	   identification	   of	   folded	   proteins	   emerging	  from	   a	   random	   library.	   On	   the	   other	   hand,	   variability	  may	   suggest	   that	   different	  folds	  can	  spontaneously	  derive	  from	  a	  small	  sequence	  subset	  as	  obtained	  from	  only	  four	  permutation	  events.	  
5.5.2	  Stability	  analysis	  Every	   predicted	   protein,	   native	   or	   shuffled,	   went	   through	   a	   short	   (4	  ns)	   MD	  simulation	  with	  the	  aim	  of	  evaluating	  the	  stability	  of	  the	  generated	  folds	  in	  aqueous	  solution.	   Counting	   every	   generated	   sequence	   and	   prediction,	   50	   MD	   simulations	  were	   carried	   out	   and	   evaluated	   through	   both	   visual	   inspection	   and	   root	   mean	  square	   deviation	   (RMSD)	   plots.	   This	   helped	   direct	   visual	   detection	   of	   the	   most	  widely	   fluctuating	   systems.	   For	   the	  majority	   of	   the	   targets	   this	   revealed	   no	  wide	  nor	  fast	  misfolding	  behavior	  (Supplementary	  Fig.	  2	  (136)).	  The	  plots	  of	  the	  shuffled	  predictions	  in	  some	  cases	  show	  slightly	  higher	  values	  than	  the	  predictions,	  which	  is	  probably	   due	   to	   structural	   relaxation	   and	   energy	  minimization.	   This	   behavior	   is	  also	  confirmed	  by	  the	  total	  BLUUES	  (133)	  energy	  (see	  Fig.	  17).	  A	  clear	  example	  can	  be	   seen	   in	   carnocyclin	   (PDB	   code	   2KJF),	   where	   RMSD	   variation	   of	   the	   shuffled	  proteins	  reaches	  500	  %	  the	  native	  prediction,	  the	  highest	  overall	  value.	  This	  can	  be	  partially	   explained	   by	   the	   non-­‐shuffled	   prediction	   RMSD	   plot,	   which	   has	   a	   rigid	  overall	   structure.	   This	   protein	   also	   shows	   the	  highest	   variability	   among	  different	  folds.	  However,	  no	  misfolding	  was	  observed	  during	   the	  simulations.	  Although	   the	  simulation	   time	   for	   each	   model	   was	   kept	   short	   because	   of	   the	   large	   number	   of	  systems	  to	  test,	  no	  misfolding	  events	  were	  observed	  and	  in	  almost	  all	  cases	  RMSD	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values	   were	   lower	   than	   0.4	  nm.	   Considering	   this	   result	   we	   can	   assume	   that	  permuted	  polypeptide	  chains	  show	  a	  structural	  stability	  comparable	  to	  the	  natural	  proteins.	  
5.5.3	  Homology	  search	  and	  disorder	  analysis	  In	  order	   to	  evaluate	   the	  effect	  of	  sequence	  similarity	  on	  the	  permuted	  sequences,	  we	  performed	  a	  similarity	  search	  with	  Blast	  (154).	  The	  native	  sequences	  were	  all	  identified,	   but	   the	   search	   for	   permuted	   sequences	   gave	   no	   significant	   results.	   In	  other	  words,	  this	  finding	  confirmed	  that	  the	  tested	  sequences	  should	  be	  considered	  non-­‐natural.	   Indeed,	   we	   were	   confident	   that	   structural	   predictions	   were	   not	   (or	  minimally)	  influenced	  by	  homology	  with	  other	  known	  proteins.	  The	  permutation	  of	  leech	   carboxypeptidase	   inhibitor	   (PDB	   1ZFI)	   presents	   another	   peculiar	   result,	  showing	   a	   disordered	   fold	   for	   permutation	  2	   (Fig.	  16).	   Similar	   results	   were	   also	  obtained	   for	   both	   avian	   pancreatic	   polypeptide	   (PDB	   1PPT)	   and	   the	   so-­‐called	  bubble	  protein	  (PDB	  1UOY)	  at	  permutation	  1.	  Intrinsically	  disordered	  proteins	  are	  biological	   entities	   showing	   important	   biological	   activities	   (i.e.,	   protein–protein	  interaction)	   characterized	  by	   existing	   in	   a	   constitutively	   unfolded	   state	   (155).	   As	  Rosetta	  was	  not	  originally	  developed	  to	  predict	  disorder,	  we	  tested	  the	  sequences	  with	  ESpritz	  (148)	  to	  confirm	  this	  finding	  (see	  Fig.	  17).	  The	  analysis	  revealed	  that	  only	  few	  pseudo-­‐proteins	  tend	  to	  assume	  a	  disordered	  state	  as	  the	  main	  secondary	  structure	  organization.	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   Figure	   	  17:	  Sequence	   features	  and	  energy	  of	   the	  permuted	  proteins.	  A	  sequence	  diagram	  is	   shown	   for	  
each	   experimental	   protein	   and	   its	   four	   permutations,	   highlighting	   predicted	   secondary	   structure	  
(spirals	  for	   helices	   and	  arrows	  for	   strands),	   disorder	   (thick	   red	   line),	   and	   aggregation	   propensity	  
(narrow	   yellow	  andgreen	   lines)	   according	   to	   the	   symbols	   explained	   at	   the	   bottom	   of	   the	   figure.	   The	  
total	  BLUUES	  energy	  of	  the	  protein	  structure	  is	  shown	  after	  the	  sequence	  identifier.	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The	   average	   disorder	   content	   (17.1	  %)	   is	   slightly	   higher	   than	   the	   wild-­‐type	   one	  (16	  %),	  with	  the	  notable	  exception	  of	  PDB	  code	  1PPT.	  A	  similar	  but	  stronger	  trend	  is	   also	   observed	   for	   aggregation	   propensities	   measured	   with	   PASTA	   2.0	   (149),	  where	  the	  overall	  percentage	  of	  aggregating	  residues	  rises	  from	  11.45	  to	  20.16	  %,	  suggesting	  a	  negative	  selection	  for	  aggregating	  sequences.	  Although	  consistent	  with	  structure	  prediction,	  this	  finding	  should	  be	  considered	  only	  as	  preliminary,	  as	  low	  sequence	  similarity	  may	  induce	  the	  disorder	  and	  aggregation	  predictors	  to	  produce	  false	  positive	  output.	  Considering	  all	  results	  in	  a	  prebiotic	  context,	  we	  can	  speculate	  that	  the	  major	  structural	  organization	  observed	  in	  modern	  natural	  proteins	  can	  be	  evolved	  from	  a	  simple	  rearrangement	  of	  the	  same	  building	  blocks.	  	  
5.6	  Discussion	  	  Shared	   fold	   and	   sequence	   similarity	   are	   common	   traits	   of	   modern	   proteins	   as	  shown	   in,	   e.g.,	   the	  SCOP	   database	   (136).	   Current	   accepted	   theories	   explain	   this	  finding	   assuming	   a	   hypothetical	   common	   ancestor	   from	   which	   all	   modern	  organisms	   derived	   (157,158).	   In	   other	   words,	   all	   current	   folds	   could	   have	   been	  fixed	  when	  life	  emerged	  on	  Earth	  and	  survived	  until	  today	  owing	  to	  their	  intrinsic	  stability.	  In	  this	  work,	  we	  explored	  one	  of	  the	  possible	  solutions	  adopted	  by	  nature	  to	  generate	  different	  folds	  from	  prebiotic-­‐compatible	  building	  blocks.	  We	  shuffled	  the	  sequences	  of	  natural	  proteins	   in	  order	   to	  obtain	  new	  permutated	  proteins.	   In	  2002,	   spontaneous	   formation	   of	   a	   chain	   of	   10–15	   amino	   acids	   long	   in	   rigid	  prebiotic	   conditions	  was	   reported(159).	   The	   authors	   suggested	   that	   evolution	   of	  large	  proteins	  is	  compatible	  with	  a	  fickle	  environment,	  at	  least	  chemically	  speaking.	  In	   this	   sense,	   we	   hypothesized	   a	   scenario	   where	   different	   proto-­‐proteins	   arose	  from	  a	  mixture	  of	   short	  prebiotic	  polypeptides.	   In	  previous	  work,	  Kauffman(160)	  argued	   that	   the	   ability	   to	   act	   autonomously	   in	   an	   environment	   is	   a	   fundamental	  characteristic	   of	   life.	   In	   other	   words,	   both	   diverse	   and	   stable	   folds	   provide	   the	  stability	   needed	   for	   effective	   biological	   evolution.	   In	   2006,	   Luisi	   and	   co-­‐workers	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reported	   that	   random	   small	   polypeptides	   spontaneously	   tend	  to	   assume	   both	   a	  compact	  and	  stable	  conformation	  (153).	  It	  is	  useful	  to	  recall	  that	  modern	  proteins	  share	   only	   a	   limited	   number	   of	   folds,	   generally	   combined	   to	   form	  multi-­‐domain	  architectures(145).	  One	  can	  argue	  that	  this	  is	  due	  to	  the	  biological	  evolution,	  with	  modern	  folds	  representing	  the	  best	  solution	  found	  by	  the	  nature	  to	  solve	  a	  specific	  problem.	  Our	  opinion	  is	  that	  the	  modern	  folds	  may	  result	  from	  biological	  evolution	  operating	  in	  the	  form	  of	  continuous	  finishing	  of	  a	  finite	  set	  of	  randomly	  generated	  proto-­‐folds.	  We	  demonstrated	  that	  shuffled	  sequences	  may	  act	  as	  a	  basis	  to	  evolve	  functional	  proteins,	  with	  the	  common	  secondary	  structure	  of	  modern	  proteins	  well	  represented	   by	   a	   small	   set	   of	   permuted	   sequences.	   Although	   meaningful,	   the	  results	  presented	  here	  are	  theoretical	  and	  their	  reliability	  is	  related	  to	  the	  validity	  of	   the	  underlying	   in	  silico	  predictions.	  Previous	  work	  suggested	  that	   folding	   is	  an	  innate	   property	   of	   amino	   acid	   chains(143,153,161)).	   Nevertheless,	   we	   found	  several	   sequences	   apparently	   promoting	   disorder	   and	   characterized	   by	   low	  complexity.	  During	  the	  last	  decade,	  disorder	  assumed	  relevance	  in	  protein	  science	  with	   a	   large	   number	   of	   intrinsically	   unstructured	   proteins	   discovered	   to	   be	  involved	   in	   fundamental	   cellular	   processes	   such	   as	   protein–protein	   interactions,	  scaffolding,	   signaling,	   and	   transcription	   (155).	   Our	   research	   suggested	   that	   both	  structured	  and	  intrinsically	  unfolded	  proteins	  can	  evolve	  by	  means	  of	  simple	  amino	  acid	  recombination.	  This	  finding,	  if	  experimentally	  validated,	  will	  perhaps	  provide	  a	  better	  understanding	  of	  the	  driving	  forces	  favoring	  the	  emergence	  of	  Life.	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6.	  RING	  MD:	  gathering	  time	  into	  structures	  	  
6.1	  Summary	  
	  Several	   methods	   have	   been	   developed	   and	   tested	   for	   molecular	   dynamics	   (MD)	  simulations	   output	   analysis.	  Most	   of	   them	   focus	   on	   Root	  Mean	   Square	   Deviation	  (RMSD)	  and	  Root	  Mean	  Square	  Fluctuation	  (RMSF).	  The	  main	  idea	  of	  this	  work	  is	  to	  provide	  the	  scientific	  community	  a	  method	  that	  directly	  analyses	  a	  MD	  simulation	  trajectory	   file.	   The	   method	   performs	   RMSD	   and	   RMSF	   calculations,	   as	   other	  methods	   do.	   It	  will	   also	   provide	   per-­‐residue	   calculation	   of	   H-­‐bonds,	   salt	   bridges,	  disulphide	  bridges,	  π-­‐π	  stacks,	  cation-­‐π	  interactions,	  van	  der	  Waals	  contacts	  and	  a	  comprehensive	   interaction	   calculation	   of	   the	   frequencies	   of	   occurrence	   of	   these	  interactions.	  The	  method	   is	  based	  on	  RING	  networks.	  A	  network	   is	  generated	   for	  every	  given	  frame	  of	   the	  trajectory,	  and	  extract	   information	  that	  can	  discriminate	  key	   events	   of	   the	   MD	   simulation.	   Finally,	   the	   user	   is	   also	   provided	   of	   a	   PDB	  structure	  with	  residues	  coloured	  proportionally	  to	  the	  frequency	  of	  occurrence	  of	  the	   selected	   type	   of	   interaction,	   and	   of	   a	   contact	   map	   highlighting	   the	   most	  important	   interactions	   responsible	   for	   protein	   structural	   maintenance.	   The	  comparison	   between	   classical	   MD	   analysis	   and	   RING	   MD	   analysis	   has	   been	  performed	   on	   three	   well	   studied	   targets.	   The	   first	   one,	   human	   erythrocitic	  ubiquitin	   is	  76	  residues	   long	  and	  is	  composed	  by	  23%	  of	  α-­‐helices	  and	  34%	  of	  β-­‐sheets.	   The	   second	   one,	   bacteriophage	   T4	   lysozime,	   is	   164	   residues	   long	   and	   is	  composed	  by	  66%	  of	  α-­‐helices	  and	  9%	  of	  β-­‐sheets.	  The	  third	  target,	  bacteriophage	  T4	  glutaredoxin,	  is	  an	  NMR	  solution	  structures	  ensemble,	  is	  87	  residues	  long	  and	  is	  composed	  by	  35%	  of	  α-­‐helices	  and	  22%	  of	  β-­‐sheets.	  In	  the	  latter	  case,	  we	  chose	  the	  first	  model	  in	  the	  PDB	  file	  for	  the	  simulations.	  All	  MD	  simulations	  were	  carried	  out	  with	  NAMD	  v	  2.9,	   using	  CHARMM-­‐27	   force	   field.	  All	   clusterings	  were	   carried	  out	  with	   kmeans	   algorithm.	   The	   results	   of	   proteins	   analyses	   are:	   (i)	   Ubiquitin:	  Considering	   all	   the	   computed	   interaction	   and	   all	   the	   obtained	   clusters,	   the	   key	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residues	   involved	   in	   conformational	   transitions	   for	   Ubiquitin	   appear	   to	   be	   D39,	  Q40,	  R42,	  R72	  and	  L73.	  These	  residues	  appear	  to	  be	  involved	  in	  every	  clustering	  as	  driving	   conformational	   changes	   residues,	   moreover	   R72	   has	   been	   proven	   to	   be	  target	   for	   Insulin	  Degrading	  Enzyme	  (IDE)	  and	   the	  difference	  between	  clusters	   is	  providing	   insights	   for	   the	   activity	   of	   this	   enzyme	   simply	   from	   strcture.	   (ii)	  Lysozyme:	  At	  a	  more	  comprehensive	  level,	  considering	  all	  the	  interactions,	  the	  key	  residues	   driving	   conformational	   changes	   appear	   to	   be	   E22,	   G30,	   E45,	   D47,	   K48,	  V87,	   D92,	   N101,	   K124,	   R137	   and	   D159.	   (iii)	   Glutaredoxin:	   a	   comprehensive	  evaluation	  of	   the	  whole	  set	  of	   the	  considered	   interaction	   lead	  to	   identify	  Y5,	  D18,	  R22,	  E32,	  N35,	  F43,	  T64,	  Q67,	  D72,	  S74,	  D80	  and	  Y85	  as	  key	  residues	   for	  overall	  conformational	  transitions	  during	  the	  entire	  50	  ns	  MD	  simulation.	  The	  capability	  of	  this	  work-­‐flow	  to	  speed	  up	   the	  analysis	  of	  an	  MD	  trajectory,	   could	   turn	  out	   to	  be	  very	   useful	   to	   the	   scientific	   community	   facing	   more	   and	   more	   MD	   simulation	  experiments.	  As	   an	   example,	   the	  parameters	  obtained	   from	   the	   clustering	   can	  be	  interpreted	   as	   the	   parameters	   of	   a	   mixture	   model.	   Therefore,	   one	   can	   use	   such	  model	   to	   test	   if	  a	  new	  MD	   is	  generated	   from	  the	  same	  stochastic	  process.	  A	  clear	  instance	  of	  this	  idea	  is	  the	  evaluation	  of	  mutations	  impact	  in	  the	  protein	  dynamic	  or	  in	   its	   stability.	   There	   are	   plenty	   of	   cases	   where	   the	   recognition	   of	   protein	  conformers	  can	  be	  of	  interest,	  and	  RING	  MD	  clearly	  establish	  a	  solid	  framework	  for	  a	  sound	  MD	  analysis.	  As	  a	  future	  work,	  we	  plan	  to	  improve	  conformers	  assigned	  to	  clusters.	  In	  this	  work,	  I	  provided	  the	  idea	  for	  the	  design	  of	  the	  tool	  and	  performed	  all	   the	   simulations,	   relating	   the	   results	   with	   biological	   evidence	   I	   found	   in	   the	  literature.	  I	  also	  performed	  the	  comparison	  between	  the	  classical	  and	  the	  proposed	  MD	  trajectory	  analyses.	  
6.2	  Abstract	  	  	  Molecular	   Dynamics	   (MD)	   simulations	   gained	   increasing	   relevance	   over	   the	   last	  years,	  but	  the	  complexity	  related	  to	  their	  interpretation	  and	  analysis	  is	  still	  one	  of	  the	  major	  challenges	  for	  most	  users.	  In	  this	  work	  we	  introduce	  RING	  MD,	  a	  tool	  for	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the	  analyses	  and	  interpretation	  of	  MD	  simulations.	  RING	  MD	  is	  able	  to	  identify	  the	  most	   important	   frames	   (PDB	   structures)	   and	   key	   residues	   that	   cause	   different	  conformers	  to	  be	  observed,	  providing	  a	  simple	  interpretation	  useful	  for	  non-­‐expert	  users.	   Comparison	  with	   the	   classical	   analysis	   of	   three	  MD	   simulations	   confirmed	  RING	  MD	  results	  and	  effectiveness.	  	  
6.3	  Introduction	  and	  methods	  
	  Molecular	  dynamics	  (MD)	  is	  nowadays	  a	  key	  toolbox	  for	  disease	  studies	  (54,162–164)	   and	   protein	   characterization	   (124,165–167).	   MD	   gained	   further	   relevance	  after	  a	  Nobel	  Prize	  award	  for	  Chemistry	  was	  assigned	  for	  insights	  in	  this	  field	  ((38).	  Despite	   its	   proven	   effectiveness,	   the	   knowledge	   required	   to	   interpret	   and	   gather	  information	   from	   classical	   MD	   output	   still	   represents	   the	   greatest	   issue	   for	   the	  scientific	   community.	   RING	   MD	   is	   a	   tool	   designed	   to	   simplify	   the	   analysis	   and	  interpretation	   of	   MD	   experiments,	   which	   are	   otherwise	   dependent	   on	   human	  expertise.	  Networks	  ((52,168)	  are	  increasingly	  used	  in	  biology,	  but	  little	  work	  was	  done	  to	  analyze	  MD	  simulations	  ((169,170).	  Residue	  Interaction	  Networks	  (RINs)	  forms	  the	  basis	  of	  this	  work,	  thanks	  to	  their	  proven	  ability	  in	  the	  representation	  of	  key	   protein	   features	   and	   contacts	   (52,168).	   Every	  MD	   simulation	   can	   be	   seen	   as	  multiple	   snapshots	   of	   the	   same	   structure,	   changing	   its	   conformation	   and	  fluctuating	   around	   the	   so-­‐called	   equilibrium	   state.	   As	   the	   conformation	   changes,	  the	  respective	  RIN	  changes	  as	  well.	  The	  RING	  web	  server	  computes	  a	  RIN	  where	  6	  different	   chemical	   interactions	   are	   identified,	   namely	   hydrogen	   bonds,	   π-­‐cation	  interactions,	   π-­‐π	   stacks,	   ionic	   bonds,	   disulfide	   bonds	   and	   van-­‐der-­‐Waals	  interactions.	  Generating	  a	  network	  from	  a	  single	  experimental	  PDB	  is	  nevertheless	  a	  rough	  approximation	  of	  the	  true	  RIN,	  as	  the	  stochastic	  molecular	  fluctuations	  can	  modify	   the	   edges	   in	   the	   protein	   network.	   Ideally,	   RIN	   interactions	   should	   be	  extended	   to	   highlight	   (i)	   possible	   or	   (ii)	   time-­‐dependent	   edges	   (see	   Fig.	   18).	   We	  performed	   RING	   MD	   analysis	   on	   50ns	   MD	   simulations(47,126,131,132)of	   three	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well-­‐known	   targets,	  Ubiquitin	   (171),	  Glutaredoxin(172)and	  T4	  Lysozyme	   (173)to	  validate	   the	   tool	   (see	   Appendix).	   For	   each	   snapshot	   of	   the	   simulation,	   RING	  MD	  computes	   different	   conformer	   networks	   called	   Time-­‐Dependent	   Contact-­‐Maps	  (TDCM)	   (169,174,175),	  which	   describes	   the	  possible	   states	   explored	   during	   time.	  These	  networks	  are	  different,	  as	  the	  intrinsic	  protein	  flexibility	  highlights	  different	  protein	  states.	  To	  address	  the	  high	  sparcity	  of	  amino	  acid	  interactions,	  we	  encoded	  RINs	  to	  a	  set	  of	  binary	  values	  associated	  with	  each	  residue.	  Amino	  acids	  involved	  in	  a	  chemical	  bond	  are	  the	  only	  active	  variables	  (see	  Fig	  1	  and	  online	  methods).	  We	  captured	   protein	   variability	   using	   k-­‐means	   clustering	   algorithm	   (174),	   which	  grouped	   RINs	   into	   k	   similar	   protein	   conformers	   that	  model	   part	   of	   the	  MD.	   The	  amount	   of	   clusters	   k	   is	   a	   tradeoff	   between	   model	   likelihood	   and	   number	   of	  parameters	   as	   defined	   by	   the	   Bayesian	   information	   criterion	   (see	   Appendix	   for	  details).	  
	  
Figure	  	  18:	  Starting	  from	  a	  MD,	  a	  user	  can	  easily	  sample	  PDB	  structures	  as	  representative	  of	  the	  whole	  simulation.	  
With	  RING	  MD,	  the	  corresponding	  Residue	  Interaction	  Networks	  and	  contact	  maps	  are	  computed,	  and	  converted	  
into	   a	   novel	   data	   structure	   called	   contact	   vector.	   Such	   representation	   emphasizes	   at	   the	   residue	   level	   the	  
interacting	  amino	  acids	  by	   removing	   the	   sparse	   information	  about	   the	  contact	  partners.	  A	   clustering	  procedure	  
then	  is	  used	  to	  select	  different	  conformers	  based	  on	  contact	  vectors.	  Structures	  belonging	  to	  highly	  diverse	  protein	  
states	   are	   provided	   to	   the	   user,	   along	  with	   a	   prioritization	   of	   the	   amino	   acids	   explaining	   conformers	   diversity.	  
Finally,	   the	   interaction	   frequency	   for	   each	   residue	   is	   reported	   in	   the	   selected	   structures,	   which	   summarize	   the	  
intra-­‐cluster	  contacts	  variability.	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6.4	  Results	  	  A	  comparison	  between	  classical	  MD	  analysis	  and	  RING	  MD	  output	  is	  shown	  in	  Fig.	  18.	  The	  RMSD	   [Fig.	  18a]	  of	   two	  Ubiquitin	   (171)	   ionic	   interactions	   (residues	  K27-­‐D52	  and	  D39-­‐R72)	  is	  compared	  with	  the	  RING	  MD	  summary	  structure	  [Fig.	  19d-­‐e].	  We	   focused	  on	  R72	  as	   it	  has	  widely	  been	  demonstrated	   to	  be	   involved	   in	  several	  ubiquitin	   interactions	   and	   cleavage	   phenomena	   (176–178).	   Particularly,	   in	   2011	  Ralat	  and	  co-­‐workers	  demonstrated	  that	  Ubiquitin	  is	  a	  target	  of	  Insulin-­‐degrading-­‐enzyme	  (IDE).	  The	  catalytic	  activity	  of	  this	  enzyme	  passes	  through	  a	  first	  cleavage,	  involving	   the	   terminal	   glycine	   dimer	   and	   forming	   the	   1-­‐74	   Ubiquitin	   segment,	  being	  R74	  exposed	  to	  solvent.	  A	  second	  and	  slower	  cleavage	  follows	  the	  first	  one,	  and	  targets	  R72	  forming	  the	  1-­‐72	  Ubiquitin	  segment	  (176).	  In	  RING	  MD	  summary	  structure,	  residues	  are	  highlighted	  based	  on	  their	  interaction	  frequencies	  (see	  Fig.	  19).	  The	   interaction	  between	  residues	  D39	  and	  R72	   is	   less	   frequent	  compared	   to	  K27-­‐D52,	  which	  instead	  occurs	  almost	  in	  every	  frame.	  Therefore,	  according	  to	  RING	  MD,	   the	  slower	   IDE	  activity	   towards	  R72	  could	  be	  explained	  by	  the	   formation	   for	  the	  37%	  of	  the	  frames	  of	  R72-­‐D39	  ionic	  interaction,	  not	  allowing	  R72	  to	  participate	  in	   the	   cleavage	   reaction.	   Indeed,	   IDE	   catalytic	   chamber	  has	  been	  proven	   to	   show	  protease	   activity	   towards	   highly	   flexible	   chains	   (179).	   Furthermore,	   RING	   MD	  provides	  an	  interaction-­‐based	  trajectory	  clustering,	  with	  the	  conformers	  observed	  during	   the	   MD	   described	   by	   a	   linear	   combination	   of	   the	   contact-­‐maps.	   In	   the	  reported	  case	  study,	  4	  clusters	  were	  obtained	  (see	  Fig.	  19c).	  Particularly,	  structural	  clusters	   3	   and	   4	   represent	   molecular	   conformers	   not	   suitable	   for	   the	   cleavage	  reaction,	  containing	  R72	  tightly	  locked	  with	  D39.	  On	  the	  contrary,	  in	  clusters	  1	  and	  2	   R72	   is	   not	   involved	   in	   ionic	   interactions,	   and	   free	   to	   participate	   in	   other	  biochemical	   mechanisms.	   These	   protein	   states	   can	   clearly	   coexist,	   with	   the	  probability	   of	   observing	   them	   changing	   during	   time.	   Figure	   19c	   represents	   the	  stochastic	  dynamic	  process,	  and	  facilitate	  in	  finding	  relationships	  among	  conformer	  transitions	  and	  periodicity.	  Extending	   the	  concept	  of	  RINs	  over	  a	   time	  dependent	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scenario	   proved	   that	   the	   joint	   combination	   of	   multiple	   simplified	   contact	   maps	  contains	   all	   the	   initial	   RIN	   information.	   In	   fact,	   RING	   MD	   can	   reconstruct	  automatically	   the	   initial	   contacts	   with	   no	   information	   loss	   (see	   automatically	  coloured	   interacting	   residues	   in	   [Fig.	   19b]).	   Moreover,	   the	   integration	   of	   the	  clustering	   results	   with	   the	   structural	   view	   can	   explain	   in	   detail	   the	   reasons	   of	  conformational	   changes.	   The	   output	   of	   the	   entire	   analysis	   is	   provided	   in	  supplementary	  information	  Fig.	  1,	  highlighting	  changes	  in	  ionic,	  h-­‐bond,	  and	  overall	  interactions.	  Conformational	  changes	  identified	  by	  the	  RING	  MD	  clustering	  show	  a	  good	  agreement	  with	  structure-­‐based	  analysis	  (Sup	  Mat	  Tab	  1)	  (176),	  and	  can	  be	  used	  to	  highlight	  the	  type	  of	  interactions	  relevant	  for	  these	  changes.	  It	  is	  important	  to	   note	   that	   classical	   clustering	   is	   based	   on	   3D	   coordinates	   comparison	   of	   the	  structure,	  while	   TDCM	   compare	   graphs.	  Highly	   fluctuating	   residues,	   like	  N	   and	  C	  termini	   have	   high	   impact	   in	   terms	   of	   coordinates	   change,	   leading	   to	   a	   potential	  overestimation	  of	  structural	  distance.	  On	  the	  other	  hand,	  contact	  maps	  are	  robust	  to	   these	   irrelevant	   fluctuations	   and	   therefore	  more	   likely	   to	   provide	   a	   good	   final	  clustering.	   In	   this	   context,	   RING	   MD	   can	   play	   a	   key	   role	   in	   Conformational	  Ensembles	   for	   the	  analysis	  of	   intrinsic	  disorder	  proteins	  (180),	  since	   the	  classical	  structural	   comparison	   is	   known	   to	   be	   ineffective.	   We	   also	   observed	   that	   Inter-­‐atomic	   interaction	   probabilities	   calculated	   with	   RING	   MD	   correlate	   significantly	  with	   Root	  Means	   Squared	   Fluctuations	   (RMSF)	   (Sup	  Mat	   Tab	   2),	   thus	   explaining	  well	  the	  degrees	  of	  freedom	  of	  protein	  residues.	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Figure	  	  18:	  results	  of	  Ubiquitin	  RING	  MD	  analysis.	  a)	  Root	  mean	  square	  deviations	  (RMSDs)	  of	  ASP52-­‐LYS27	  (red)	  
and	   ASP39-­‐ARG72	   (black),	   and	   ASP58-­‐ARG54	   (green)	   interactions.	   The	   distance	   in	   the	   plot	   is	   expressed	   in	  
angstroms.	   b)	   Time	   Dependent	   Contact	   Map	   (TDCM)	   of	   the	   ionic	   interactions	   occurring	   in	   Ubiquitin	   MD	  
simulation.	  Highlighted	  in	  red	  ASP52	  and	  LYS27,	  in	  black	  ASP39-­‐ARG72	  and	  in	  green	  ASP58	  and	  ARG54.	  c)	  Clusters	  
deriving	   from	   k-­‐means	   analysis	   of	   1000	   frames.	   a,	   b	   and	   c	   share	   the	   x	   axis,	   which	   is	   time	   (frames)	   of	   the	  MD	  
simulation.	  The	  colouring	  scheme	  is	  the	  following:	  cluster	  1	  is	  light	  orange,	  cluster	  2	  is	  violet,	  cluster	  3	  is	  light	  blue	  
and	  cluster	  4	  is	  light	  green.	  d)	  Summary	  structure	  reporting	  the	  frequencies	  of	  interaction	  between	  ASP39-­‐ARG72	  
(light	   blue),	   LYS27-­‐ASP52	   (red)	   and	  ASP58-­‐ARG54	   (light	   blue	   and	   red,	   respectively).	   The	   thicker	   regions	   of	   this	  
structure	  depict	  where	  ionic	  interactions	  (not	  highlighted)	  are	  occurring	  more	  frequently.	  e)	  Clusters	  structures.	  In	  
cluster	  1	  ASP52-­‐LYS27	  is	  the	  only	  interaction	  occurring	  frequently.	  In	  cluster	  2	  ASP39-­‐ARG72	  and	  ASP52-­‐LYS27	  are	  
occurring.	  In	  cluster	  3	  ASP52-­‐LYS27	  and	  ASP58-­‐ARG54	  are	  interacting	  and	  no	  interaction	  is	  found	  for	  ASP39	  and	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7.	  Conclusions	  	  	  During	  my	  Ph.D.	  experience	  I	  have	  been	  involved	  in	  several	  projects,	  ranging	  from	  pure	   biochemistry	   to	   biomedical	   sciences.	   In	   most	   cases,	   molecular	   dynamics	  simulations	  were	  at	  the	  basis	  of	  my	  works.	  	  At	  first,	  with	  a	  great	  part	  of	  my	  work,	  highlights	  were	  proposed	  for	  VHL	  syndrome,	  starting	  from	  a	  new	  previously	  unreported	  role	  for	  hydroxyproline	  567.	  The	  crystal	  structure	  of	  pVHL	  complex	  allowed	  the	  design	  of	  experiments	  to	  investigate	  on	  the	  role	  of	   this	  peculiar	  and	  still	  not	  well	   studied	  posttranslational	  modification.	  This	  clue	   gave	   a	   hint	   on	   the	   mechanism	   of	   what	   reported	   by	   Fedulova	   in	   2007,	  suggesting	  a	  novel	  role	  for	  Prolyl-­‐Hidroxylases	  	  (PHDs)	  enzymatic	  family.	  Since,	  by	  a	  multiple	   sequence	   alignment	   experiment	   of	   HIF-­‐1α,	   we	   noticed	   that	   in	   several	  species	  of	  fish	  a	  serine	  residue	  is	  in	  the	  place	  of	  P567,	  we	  hypothesised	  a	  novel	  role	  in	   the	   oxygen-­‐sensing	   pathway	   for	   this	   residue.	   Both	   hydroxyproline	   and	   serine	  contain	  indeed	  a	  hydroxyl	  moiety.	  The	  rearrangement	  of	  hydrogen	  bond	  networks	  within	  the	  pVHL-­‐HIF-­‐1α	  HYP567	  chemical	  surrounding	  appeared	  plausible,	  and	  let	  us	  state	  that	  the	  pVHL	  residues	  involved	  in	  this	  new	  network	  could	  be	  considered	  as	   a	   putative	   novel	   binding	   surface.	   PHD-­‐3	   is	   expressed	   after	   a	   few	   hours	   of	  normoxyc	  conditions	  in	  cells	  where	  strong	  hypoxic	  stress	  occurred.	  This	  brought	  us	  to	   another	   question,	   still	   to	   be	   answered,	   about	   the	   involvement	   of	   PHD-­‐3	   in	  apoptosis.	  Molecular	  findings	  at	  this	  level	  shall	  be	  considered	  as	  suggestions,	  spots	  coming	  out	  from	  the	  messy	  cloud	  of	  cancer.	  The	  complex	  jigsaw	  of	  pVHL	  syndrome	  is	  relevant	  to	  a	  small	  percentage	  of	   the	  population,	  but	  still	   tracing	  the	  guidelines	  underneath	  this	  cancer	  is	  crucial.	  With	  these	  suggestions,	  in	  the	  framework	  of	  this	  thesis,	  we	  provided	  a	   small	   step	   forward	   towards	   the	   complete	  understanding	  of	  Von	   Hippel-­‐Lindau	   syndrome	   driving	   mechanisms.	   The	   timescale	   we	   used	   to	  investigate	   this	   issue	  was	  nanoseconds.	  We	  performed	  50	  ns	   long	  simulations.	   In	  this	   time	   interval,	   as	   reported	   in	   Appendix	   8.1,	   mutations	   of	   P567	   with	   bulky	  residues	  brings	  to	  complex	  disruption.	  This	  implies	  another	  small,	  and	  in	  a	  certain	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way	   obvious,	   answer.	  What	  we	   are	   used	   to	   consider	   a	   lifetime	   interval,	  which	   is	  supposed	   to	   be	   made	   of	   years,	   is	   driven	   by	   a	   huge	   amount	   of	   several	   different	  events	   occurring	   in	   timescales	   we	   are	   not	   even	   able	   to	   perceive.	   Enlarging	   the	  timescale,	   in	   the	  same	  subjects,	  we	  performed	  Petri	  net	   simulations	  of	   the,	  at	   the	  time	   of	   publishing	   (2014),	   almost	   entire	   pVHL	   known	   pathway.	   The	   transitions	  occurring	   in	   this	   second	   work,	   although	   the	   net	   was	   considered	   to	   be	   not	   time	  dependent,	   are	   belonging	   to	   a	   higher	   order	   of	   magnitude.	   In	   this	   case,	   what	   is	  noticeable	   is	   that	   apparently	   small	   changes,	   such	   as	   the	   lack	   of	   formation	   of	   a	  complex	  or	  a	  knockout	  of	  a	  single	  protein,	  could	  turn	  out	  to	  be	  fatal	  for	  cell	  life.	  The	  advantage	  of	  enlarging	  the	  view	  is	  that,	  by	  the	  usage	  of	  these	  particular	  networks,	  we	   were	   able	   to	   observe	   what	   could	   be	   thought	   as	   an	   interpretation	   of	   the	   Le	  Châtelier	   principle*.	   We	   were	   indeed	   able	   to	   observe	   all	   the	   transitions	   of	   the	  tokens	   caused	   by	   a	   system	   perturbation,	   undertaken	   by	   the	   system	   itself	   to	  minimize	  the	  damage	  brought	  by	  the	  change	  on	  the	  environment.	  In	  our	  case,	  the	  pVHL	  knockout	  system	  revealed	  that	  its	  role	  in	  oxygen	  sensing	  pathways,	  at	  least	  in	  short	   time	   ranges,	   is	   not	   sufficient	   to	   abolish	   HIF-­‐1α	   degradation,	   as	   the	   latter	  shows	   to	   have	   back	   up	   reactions	   bringing	   to	   its	   degradation.	   In	   spite	   of	   this	  relatively	  damage	  brought	  to	  this	  particular	  pathway,	  pVHL	  deletion	  in	  the	  network	  showed	   to	   be	   in	   agreement	   with	   other	   secondary	   manifestations	   of	   the	   pVHL	  syndrome,	  unrelated	  to	  oxygen	  sensing.	  The	  enlargement	  of	   the	  network	  we	  built	  would,	   in	   case,	   provide	   a	   yet	   sounder	   framework	   to	   evaluate	   the	   impact	   of	   this	  molecular	  character.	  	  Considering	   the	   impact	   that	   relatively	   small	   time	   intervals	   have	   on	   one	   complex	  and,	  in	  turn,	  on	  one	  pathway,	  an	  even	  smaller	  system	  can	  be	  brought	  as	  an	  example	  of	  small	  changes	  providing	  big	  effects.	  FAD	  is	  a	  relatively	  small	  molecule,	  compared	  with	   a	   massive	   protein	   structure	   such	   as	   Cryptochrome.	   This	   small	   molecule,	  weighing	   less	   than	   800	   Da,	   compared	   to	   dCry,	   weighing	   almost	   60000	   Da,	   have	  indeed	   a	   great	   as	   well	   as	   unexpected	   effect.	   The	   work	   we	   performed	   with	   this	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  *	  Le	  Châtelier	  principle	  :	  Any	  change	  in	  a	  status	  quo	  prompts	  an	  opposing	  reaction	  in	  the	  responding	  system.	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complex	  highlighted	  how	  such	  small	  molecule	  can	  provide	  a	  necessary	  effect	  on	  a	  huge	  structure.	  Being	  the	  FAD	  completely	  buried	  within	  dCry	  structure,	  and	  being	  the	   overall	   volume	   of	   the	   FAD	   containing	   system	   and	   the	   system	   without	   FAD	  comparable,	   it	   carries	   out	   its	   structural	   role	   in	   chain	   flexibility.	   The	   concept	   of	  flexibility	  implies	  the	  concept	  of	  time,	  as	  the	  fluctuation	  is	  nothing	  but	  a	  difference	  between	   positions.	   What	   we	   observed	   with	   20	   ns	   long	   MD	   simulations	   was	   an	  unexpected	   increase	   in	  mean	   fluctuation	  rate	   for	   the	  complex	  with	  respect	   to	   the	  apoprotein.	  This	  can	  be	  seen	  as	  potential	  energy	  for	  the	  apoprotein	  transformed	  in	  kinetic	   energy	   for	   the	   complex.	   As	   the	   receptor	   activation	   requires	   the	   opening	  motion	  of	  one	  part	  of	  the	  protein,	  particularly	  the	  C-­‐Terminal	  Tail,	  being	  in	  a	  more	  fluctuating	  situation	  could	  be	  intuitively	  thought	  as	  a	  strategy	  of	  nature	  to	  facilitate	  this	   event,	   and	   save	   time	   in	   reaching	   the	   transition	   state	   for	   activation.	   Light	  sensing	  is	  an	  event	  that	  shall	  not	  require	  long	  times	  to	  occur,	  otherwise	  becoming	  not	  useful.	  Due	  to	  the	  required	  computational	  power,	  we	  did	  not	  perform	  quanto-­‐mechanical	  simulations	  of	  the	  light	  state	  of	  dCry.	  In	  fact,	  simulating	  FAD	  in	  radical	  semiquinone	  state	  could	  turn	  out	  very	  interesting	  and	  insightful,	  but	  shall	  require	  longer	   computational	   times	   to	   simulate	   shorter	   time	   ranges,	   in	  which	  we	  would	  probably	   see	   nothing	   occurring,	   at	   least	   simulating	   short	   nanoseconds	   long	  intervals.	  	  In,	   talking	   about	   nanoseconds	   scale,	   short	   timescales	   what	   we	   can	   see	   is	   a	  structural	  relaxation	  of	  the	  target	  within	  the	  solvation	  box.	  In	  few	  nanoseconds,	  if	  a	  structure	  is	  not	  stable,	  the	  previously	  mentioned	  RMSD	  index	  tends	  to	  increase	  in	  a	  fast	  way.	  If	  one	  structure	  is,	  vice	  versa,	  stable,	  the	  RMSD	  index	  increases	  during	  the	  very	  beginning	  of	  the	  simulation,	  to	  later	  settle	  around	  a	  plateau	  value.	  In	  the	  case	  of	   the	  sequence	  permutations	  work,	  we	  predicted	  fifty	  different	  structures,	   trying	  to	  weigh	  the	  impact	  of	  different	  residue	  positions	  on	  sequences	  showing	  the	  same	  amino	  acidic	  percentage	  composition.	  The	  driving	  question	  was	  whether	  folds	  are	  kept	   because	   of	   evolution	   or	   they	   are	   the	   result	   of	   few	   stable	   folds	   formed	  randomly	  in	  the	  primordial	  broth	  and	  slightly	  improved	  by	  evolution.	  The	  shuffling	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schema	   was	   used	   to	   simulate	   the	   heaviest	   mutations	   on	   different	   structures	  showing	   sequences	   made	   of	   the	   same	   percentage	   of	   residues.	   At	   the	   end	   of	   the	  analysis,	   it	   appeared	   that	   starting	   from	   the	   same	   amino	   acidic	   composition,	  different	   sequences	  show	  very	  different	   structures.	  To	   test	   this,	  we	  used	  ab	  initio	  structure	  predictions,	  and	  the	  obtained	  structures	  were	  all	  minimized	  through	  4	  ns	  long	  molecular	  dynamics	  simulations	  in	  water,	  in	  order	  to	  simulate	  an	  environment	  resembling	   as	   much	   as	   possible	   to	   the	   primordial	   broth.	   What	   is	   observable	   in	  nature	  is	  that	  the	  modern	  protein	  architectures	  are	  mostly	  combinations	  of	  a	  small	  number	  of	  protofolds.	  In	  this	  work,	  what	  arose	  is	  that	  using	  the	  same	  small	  building	  blocks,	   it	   is	  possible	   to	  obtain	   several	  different	   folds.	  The	  great	   advantage	  of	   this	  kind	  of	   investigations	   is	   that	  whenever	  we	  will	  collect	  enough	   information	  on	  the	  building	  blocks	  of	  proteins	  and	  their	  interconnections,	  we	  will	  probably	  be	  able	  to	  design	  de	  novo	  protein	  architectures	  to	  be	  exploited	  in	  several	  fields.	  	  As	   one	   picture	   can	   not	   represent	   motion,	   so	   happens	   for	   crystal	   structures.	  Watching	  at	  a	  structure,	  which	  is	  not	  moving,	  can	  provide	  limited	  information.	  One	  structure	  shows	  indeed	  three	  dimensions.	  My	  last	  work,	  RING	  MD,	  focuses	  on	  this	  subject.	  The	  ratio	  under	  the	  tool	  is	  to	  provide	  information	  on	  motion	  by	  looking	  at	  a	  single	   representative	   snapshot.	   One	  molecule,	   being	   it	   a	   protein	   or	   a	   ligand	   or	   a	  DNA	  chain,	  whenever	  solvated	  moves	  around	  an	  equilibrium	  state,	  showing	  several	  different	  conformers.	  With	  RING	  MD,	  we	  performed	  contact	  based	  clusterization	  of	  three	  small	  targets	  trajectories.	  What	  we	  obtained	  were	  different	  conformations	  of	  the	   same	   proteins,	   characterized	   by	   different	   types	   of	   contacts.	   Two	   different	  conformers	   of	   one	   protein	   can	   act	   in	   different	  manners.	   A	   receptor	   can	   be	   in	   its	  active	  state,	  or	  inactive.	  A	  drug	  acts	  by	  locking	  a	  receptor	  in	  its	  active	  (agonist)	  or	  inactive	  (antagonist)	  state.	  Highlighting	  the	  structural	  key	  features	  of	  different	  pre-­‐equilibrium	  states	  of	  the	  same	  protein	  obtained	  by	  a	  molecular	  dynamics	  trajectory	  clusterization	  can	  provide	  a	  fast	  insight	  on	  the	  behaviour	  of	  the	  system.	  What	  RING	  MD	  does	   is	  choosing	  a	  representative	  structure	   for	  every	  state	  resulting	   from	  the	  clusterization,	  and	  highlight	  the	  main	  interactions	  driving	  that	  peculiar	  conformer	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by	  colour	  code.	  This	  provides	  a	  fast	  and	  immediate	  view	  of	  what	  happens	  during	  a	  molecular	  dynamics	  just	  with	  few	  structures.	  At	  the	  end,	  what	  we	  were	  able	  to	  do	  was	  trapping	  thousands	  of	  frames	  within	  few.	  	  Finally,	  the	  roles	  that	  Time	  plays	  in	  biological	  system	  are	  several.	  Depending	  on	  the	  observed	  timescale,	  different	  phenomena	  can	  occur.	  	  The	  variable	  of	  Time	  is	  often	  taken	  for	  grant,	  as	  it	  is	  an	  integrating	  part	  of	  our	  lives	  that	  often	  we	  do	  not	  even	  pay	  attention	  to.	  Despite	  this,	  it	  is	  worth	  to	  notice,	  by	  the	  different	  experiments	  I	  have	  been	  involved	  in	  and	  that	  I	  did	  design	  myself,	  that	  Time	  not	  only	  plays	  a	  major	  role	  as	   “couch”,	   but	   its	   role	   is	   active.	   It	   is	   not	   to	   be	   considered	   simply	   as	   something	  entraining	  the	  environment,	   it	   is	  what	   indeed	  modifies	  systems	  and	  environment.	  Different	   systems	   simply	   change	   in	   different	   ways,	   because	   of	   different	  mechanisms,	  but	  the	  main	  driving	  force	  should	  always	  be	  considered	  Time.	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8.	  Appendix	  of	  Supplementary	  Information	  	  
8.1	  In	  silico	  investigation	  of	  PHD-­‐3	  specific	  HIF1-­‐α	  proline	  567	  
hydroxylation:	   a	   new	   player	   in	   the	   VHL/HIF-­‐1α	   interaction	  
pathway?	  Supplementary	  Information.	  	  
Root	  Mean	  Square	  Fluctuation	  (RMSF)	  analysis	  	  In	   order	   to	   evaluate	   the	   effects	   of	   hydroxylation	   in	   P564	   and	   P567	   upon	   the	  complex	   stability,	   a	  RMSF	  plot	   for	   each	  protein	   in	   each	   run	  was	   carried	   out.	   The	  resulting	  graphs	  are	  shown	  in	  Supplementary	  Figure	  5.	  The	  system	  containing	  no	  hydroxylation	   in	   either	   proline	   residues	   (Supplementary	   Figure	   5-­‐A)	   shows,	   in	  pVHL,	   a	   mean	   fluctuation	   around	   0.25	   Å,	   with	   peaks	   corresponding	   to	   regions	  between	   residues	   69-­‐83,	   98-­‐111,	   and	   140-­‐150,	   reaching	   values	   of	   0.8	   Å.	   The	  resulting	   value	   was	   considered	   standard	   and	   used	   to	   evaluate	   the	   remaining	  systems.	   In	   the	  same	  complex,	  HIF-­‐1α	  shows	  a	  mean	  RMSF	  between	  2	  and	  2.6	  Å,	  which	   is	   in	   agreement	   with	   the	   importance	   of	   the	   previously	   reported	  hydroxylation	   in	   P564.	   The	   hydroxylation	   event	   in	   P564,	   according	   to	   the	   RMSF	  plots	  of	  the	  complex,	  appears	  to	  be	  stabilizing	  (Supplementary	  Figure	  5-­‐B).	  Indeed	  the	   mean	   RMSF	   of	   pVHL	   for	   this	   system	   fluctuates	   around	   0.3Å,	   with	   peaks	  corresponding	   to	   the	  previously	   reported	   regions	  but	   reaching	   lower	  values.	  The	  result	   seems	   to	   confirm	   the	   functional	   role	   of	   this	   modification	   to	   reinforce	   the	  pVHL/HIF-­‐1α	  interaction.	  HIF-­‐1α	  segment	  RMSF	  is	  slightly	  higher	  than	  2.1	  Å	  until	  residues	  501-­‐503,	   than	  the	  value	  becomes	   lower	  than	  2.0	  Å.	  The	  data	  shows	  how	  the	   hydrogen	   bonds	   network	   surrounding	   HYP564	   acts	   as	   a	   sort	   of	   lock,	   which	  retains	   the	   HIF-­‐1α	   in	   closer	   contact	   than	   the	   unmodified	   proline	   residue.	   The	  hydroxylation	   event	   in	   P567	   (Supplementary	   Figure	   5-­‐C)	   appears	   to	   be	   less	  stabilizing	  than	  the	  same	  event	  in	  P564,	  even	  if	  the	  RMSF	  plots	  of	  pVHL	  in	  the	  two	  complexes	  are	  comparable.	  Despite	   this,	  HIF-­‐1α	  RMSF	  plot	   for	   this	   system	  shows	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higher	  values,	  reaching	  peaks	  of	  2.8	  Å	  at	  the	  beginning	  of	  the	  crystallized	  segment,	  but	   lowering	   when	   getting	   closer	   to	   P567	   probably	   due	   to	   the	   new-­‐formed	  hydrogen	  bond	  network.	   The	  high	  RMSF	   value	   of	   the	   first	   residues	   is	   apparently	  related	   to	   the	   lack	   of	   usual	   hydrogen	   bonds	   network	   involving	   the	   hydroxylated	  P564.	  In	  the	  system	  containing	  both	  hydroxylated	  P564	  and	  P567	  (Supplementary	  Figure	   5-­‐D),	   pVHL	   manifestly	   gets	   more	   stable	   than	   all	   other	   analyzed	   systems,	  with	   a	  mean	   RMSF	   value	   lower	   than	   0.25	   Å,	   except	   for	   a	   peak	   corresponding	   to	  residues	   160,	   167-­‐172	   reaching	   values	   slightly	   higher	   than	   0.5	   Å,	   and	   a	   peak	  corresponding	  to	  residue	  181	  reaching	  a	  value	  of	  0.75	  Å.	  The	  corresponding	  double	  hydroxylated	   HIF-­‐1α	   segment	   is	   much	   more	   constrained	   than	   in	   other	   systems,	  with	   a	   fluctuation	   between	   0.8	   and	   0.2	   Å.	   Analysis	   of	   the	   latter	   system	   shows	   a	  likely	  stabilizing	  role	  of	  hydroxyproline	  567	  in	  the	  complex,	  when	  compared	  to	  the	  other	  tested	  systems.	  Hydroxylation	  of	  only	  P567	  appears	  to	  have	  no	  great	  role	  in	  the	   formation	   of	   the	   VHL-­‐HIF-­‐1	   complex,	   but	   when	   occurring	   with	   P564	  hydroxylation	  reinforcement	  of	   the	  complex	  stability	   seems	   to	  be	  relevant.	  Based	  on	  these	  results	  we	  tend	  to	  believe	  that	  hydroxylation	  in	  P567	  should	  require	  the	  contemporary	   modification	   of	   P564	   to	   be	   considered	   relevant	   for	   complex	  formation.	  	  
Control	  MD	  simulations	  In	  order	  to	  check	  the	  pVHL/HIF-­‐1α	  complex	  stability	   two	  control	  MD	  simulations	  were	   performed.	   The	   first	   one,	   derived	   from	   sequence	   analysis,	   containing	   the	  P567S	   mutant,	   the	   second	   one	   consisting	   in	   P564L	   and	   P567L	   mutants.	   RMSF	  calculations	  were	  performed	  for	  both	  systems.	  	  
Analysis	  of	  the	  P567S	  system	  revealed	  a	  RMSF	  pattern	  for	  pVHL	  comparable	  with	  the	  plot	  of	  pVHL	  with	  hydroxyproline	  564,	  showing	  plateaus	  between	  residues	  70-­‐80	  slightly	  higher	  than	  0.5	  Å,	  between	  residues	  100-­‐111	  reaching	  0.6	  Å,	  and	  140-­‐150,	  showing	  a	  peak	  RMSF	  value	  higher	  than	  0.8	  Å	  on	  residue	  143	  (Supplementary	  Figure	  2-­‐A).	  Interestingly,	  the	  RMSF	  of	  the	  HIF-­‐1α	  segment	  showed	  a	  higher	  mean	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value	  compared	  to	  the	  RMSF	  plot	  of	  HIF-­‐1α	  containing	  hydroxyproline	  564,	  floating	  around	  3.0	  Å	  and	  reaching	  peaks	  of	  almost	  3.5	  Å	  in	  residues	  562-­‐563.	  Thus,	  P567S	  cannot	   act	   as	   a	   hydroxyproline	   residue,	   but	   it	   suggests	   no	   destabilization	   of	   the	  pVHL/HIF-­‐1α	   complex.	   In	   biological	   terms,	   we	   can	   assume	   this	   HIF-­‐1α	   variant	  decrease	  hypoxia	  response	  in	  organisms	  living	  in	  a	  low	  oxygen	  environment.	  	  The	  pVHL	  RMSF	  plot	  for	  the	  P564L–P567L	  double	  mutant	  system	  showed	  a	  pattern	  comparable	   with	   no	   hydroxyprolines	   (Supplementary	   Figure	   2-­‐B).	   Plateaus	   are	  present	   between	   residues	   70-­‐80,	   floating	   between	   0.5	   Å	   and	   0.6	   Å,	   between	  residues	   100-­‐110	   floating	   around	   0.6	   Å,	   with	   a	   peak	   of	   0.8	   Å	   corresponding	   to	  residue	  108.	  Other	  plateaus	  are	  noticeable	  between	  residues	  140-­‐160,	  with	  values	  around	   0.5	   Å	   and	   a	   peak	   of	   0.8	   Å	   corresponding	   to	   residue	   144,	   and	   between	  residues	   180-­‐184,	   with	   average	   RMSF	   values	   around	   0.5	   Å.	   Interestingly,	   the	  corresponding	   HIF	   RMSF	   plot	   shows	   the	   highest	   values.	   The	   HIF-­‐1α	   segment	  between	   residues	   561-­‐566	   has	   RMSF	   values	   between	   3.3	   Å	   and	   3.5	   Å,	   and	   the	  remaining	  residues	  all	  have	  a	  RMSF	  value	  higher	   than	  3.0	  Å,	   showing	   the	  highest	  distance	   between	   the	   initial	   position	   of	   the	   HIF-­‐1α	   segment	   and	   the	   pVHL	   of	   all	  tested	   systems.	   These	   two	   bulky	   residues	   substitutions	   highly	   destabilize	   the	  interaction	  between	  pVHL	  and	  HIF-­‐1α	  (Supplementary	  Figure	  3).	  We	  can	  speculate	  that	   in	   longer	   simulations	   the	   complex	   would	   probably	   dissociate.	   Finally,	  considering	   these	   results,	   we	   are	   sufficiently	   confident	   with	   the	   range	   of	   the	  simulation	  time	  scales	  used	  (i.e.	  nanoseconds).	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Supplementary	  Figure	  1.	  Atomic	  charges	  for	  HYP	  residues	  from	  the	  CHARMM	  force	  field.	  	  Atom	   names	   corresponding	   to	   the	   PRO	   residue	   were	   kept,	   while	   the	   hydroxyl	   oxygen	   was	   added.	   	   Atomic	  charges	  were	  derived	  from	  MOPAC	  package.	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.	  Supplementary	  Figure	  2.	  RMSF	  plots	  of	  the	  tested	  complexes.	  Figures	  show	  the	  root	  mean	  square	  fluctuation	  (RMSF,	  y	  axis)	  against	  residue	  number	  (x	  axis)	  of	  the	  complexes	  (A)	  with	  no	  hydroxylation	  on	  P564	  and	  P567,	  (B)	  hydroxylated	  P564,	  (C)	  hydroxylated	  P567,	  and	  (D)	  both	  P564	  and	  P567	  hydroxylated	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Supplementary	  Figure	  3.	  RMSF	  plots	  of	   the	   control	  MD	  simulations.	  Figures	  show	  the	  root	  mean	  square	  fluctuation	  (RMSF,	  y	  axis)	  against	  residue	  number	  (x	  axis)	  of	  the	  P567S	  mutant	  and	  the	  P564L-­‐P567L	  double	  mutant	  systems.	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Supplementary	  Figure	  4.	  Wild-­‐type	  pVHL/HIF-­‐1α	  complex	  vs.	  P564L-­‐P567L	  double	  mutant	  after	  the	  MD	  
simulation.	  The	   figure	  shows	  a	  superimposition	  of	   the	  crystal	  structure	  of	   the	  pVHL/HIF-­‐1α	  complex,	   (blue,	  PDB	  code	  1LM8),	  and	  the	  P564L-­‐P567L	  mutant	  complex	  after	  50	  ns	  of	  MD	  simulation	  (light	  brown).	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8.2	   Design	   and	   analysis	   of	   a	   Petri	   net	   	   model	   of	   the	   Von	  
Hippel-­‐Lindau	   (VHL)	   tumor	   suppressor	   interaction	   network.	  
Supplementary	  Information.	  	  	  	  	  	  
ID Name 
Pre-Places and 
Post-Places Biological Meaning 
t_0 _trans_0 
 [Hif_IN + 1] & [hif - 
1]; 
Entrance of HIF in 
nucleus 
t_1 _trans_1 
 [_place_2 + 1] & 
[Hif_IN - 1] & [arnt - 
1]; Dimerization of HIF 
t_2 _trans_2 
 [hif + 1] & [Hif_IN - 
1]; 
Export of HIF from 
nucleus 
t_3 _trans_3 
 [_place_6 + 1] & 
[_place_2 - 1] & 
[p300 - 1] & [creb - 1]; 
Complex formation of 




 [_place_7 + 1] & 
[_place_6 - 1] & 
[cjun1 - 1]; 
Complex with cjun 
coactivator 
t_5 _trans_5 
 [_place_9 + 1] & 
[_place_7 - 1] & [hre - 
1]; 




 [_place_10 + 1] & 
[hre + 1] & 
[_place_11 + 1] & 
[_place_12 + 1] & 
[_place_13 + 1] & 
[_place_14 + 1] & 
[cjun1 + 1] & [p300 + 
1] & [arnt + 1] & [creb 
+ 1] & [Hif_IN + 1] & 
[_place_218 + 1] & 
[_place_9 - 1]; 
Transcription of 
growth factors' 
mRNA and others 
t_7 _trans_7 
 [VEGF + 1] & 
[_place_11 - 1]; 
Formation of protein 
from mRNA 
t_8 _trans_8 
 [EPO + 1] & 
[_place_12 - 1]; 
Formation of protein 
from mRNA 
t_9 _trans_9 
 [ET1 + 1] & 
[_place_10 - 1]; 
Formation of protein 
from mRNA 
t_10 _trans_10 
 [LDH + 1] & 
[_place_13 - 1]; 
Formation of protein 
from mRNA 
t_11 _trans_11 
 [pyrDHK + 1] & 
[_place_14 - 1]; 
Formation of protein 
from mRNA 
t_12 _trans_12 
 [rec_act + 1] & 
[_place_19 - 1] & 
[VEGF - 1]; 
Activation of GF 
receptor 
t_13 _trans_13 
 [_place_19 + 1] & 
[_place_21 + 1] & 
[rec_act - 1] & [PLC1 
- 1]; 
Activation of PLC by 
VEGF receptor 
t_14 _trans_14 
 [_place_19 + 1] & 
[PI3k_act + 1] & 
[rec_act - 1] & [PI3K - 
1]; 
Activation of PI3K by 
VEGF receptor 
t_15 _trans_15  [_place_19 + 1] & Activation of Ras 
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[_place_24 + 1] & 
[_place_55 + 1] & 
[ADP + 1] & [rec_act 
- 1] & [RAS1 - 1] & 
[gtp1 - 1] & [ATP - 1]; 
GTP-ase by VEGF 
receptor 
t_16 _trans_16 
 [ip31 + 1] & [DAG1 + 
1] & [PLC1 + 1] & 
[PI2P + 1] & [PI2P - 
1] & [_place_21 - 1]; 
Breaking of PI2P in 
DAG and IP3 by PLC 
t_17 _trans_17 
 [Ca_chan1 + 1] & 
[ca1 + 1] & [ip31 - 1] 
& [Ca_chan1 - 1]; 
Opening of Calcium 
channel by IP3 
t_18 _trans_18 
 [_place_32 + 1] & 
[cam_k_kk1 + 1] & 
[ca1 - 1] & 
[cam_k_kk1 - 1]; 
Formation of complex 
calmodulin kinase 
t_19 _trans_19 
 [_place_31 + 1] & 
[PKC1 - 1] & [DAG1 - 
1]; 
Activation of PKC by 
DAG 
t_20 _trans_20 
 [PKC1 + 1] & 
[_place_33 + 1] & 
[_place_31 - 1]; 
Signal tranduction by 
PKC 
t_21 _trans_21 
 [PI3K + 1] & [PIP3 + 
1] & [PI2P + 1] & 
[PI3k_act - 1] & [PI2P 
- 1]; 
PI3K phosphorilates 
PI2P in PI3P 
t_22 _trans_22 
 [RAS1 + 1] & 
[_place_49 + 1] & 
[_place_24 - 1] & 
[mapkkk - 1]; 




 [pdk_PP + 1] & 
[PKB_PP + 1] & 
[PIP3 - 1] & [PDK - 1] 
& [PKB - 1]; 
PI3P activates PKB 
and PDK via 
phosphorilation 
t_24 _trans_24 
 [PDK + 1] & [pkb_act 
+ 1] & [pdk_PP - 1] & 
[PKB_PP - 1]; 
PDK activates 
completely PKB to 
act on apoptosis 
signal 
t_25 _trans_25 
 [BAP_DIP + 1] & 
[inhib + 1] & 
[_place_43 - 1] & 




 [bad_inact + 1] & 
[inhib - 1] & [BAD - 1]; 
Inactivation of BAD 
via inhibitor 
t_27 _trans_27 
 [_place_43 + 1] & 
[_place_47 + 1] & 
[DIP - 1]; 
Signal of survival by 
DIP 
t_28 _trans_28 
 [mapkkk + 1] & 
[_place_51 + 1] & 
[_place_49 - 1] & 




 [mapkk + 1] & 
[_place_53 + 1] & 
[_place_51 - 1] & 




 [mapk + 1] & 
[_place_59 + 1] & 
[_place_53 - 1]; 
Proliferation signal by 
MAPK cascade 
t_31 _trans_31 
 [DIP + 1] & [BAD + 
1] & [PKB + 1] & 
[pkb_act - 1] & 
[BAP_DIP - 1]; 
PKB breaks BAD DIP 
binding to avoid 
apoptosis 
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t_32 _trans_32 
 [EPOR + 1] & 
[_place_61 - 1] & 
[EPO - 1]; 




 [PLC_ACT + 1] & 
[EPOR - 1] & 
[_place_63 - 1]; 
Activation of PLC by 
EPOR 
t_34 _trans_34 
 [STATx2 + 1] & 
[_place_63 + 1] & 
[_place_61 + 1] & 
[PLC_ACT - 1] & 
[stat5 - 1]; 
PLC allows formation 
of dimer STAT5 
activating monomer 
t_35 _trans_35 
 [jak2 + 1] & 
[_place_61 + 1] & 
[EPOR - 1] & [jak - 1]; 
Activation of jak by 
EPOR 
t_36 _trans_36 
 [STATx2 + 1] & [jak 
+ 1] & [jak2 - 1] & 
[stat5 - 1]; 
Jak allows formation 
of dimer STAT5 
activating monomer 
t_37 _trans_37 
 [stat5 + 2] & 
[_place_89 + 1] & 
[_place_87 + 1] & 
[STATx2 - 2] & 




 [_place_70 + 1] & 
[_place_61 + 1] & 
[EPOR - 1] & [shc2 - 
1]; 
Activation of shc by 
EPOR 
t_39 _trans_39 
 [complex1 + 1] & 
[_place_70 - 1] & 
[SOS12 - 1] & [GRB2 
- 1]; 
Complex formation of 
sos1 and grb2 
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t_40 _trans_40 
 [SOS12 + 1] & 
[GRB2 + 1] & [RAS3 
+ 1] & [_place_83 + 
1] & [shc2 + 1] & 
[complex1 - 1] & 
[GTP2 - 1] & 
[_place_82 - 1]; 
The SOS and GRB 
complex activates ras 
protein 
t_41 _trans_41 
 [GTP2 + 1] & [RAF2 
+ 1] & [_place_82 + 
1] & [ADP + 1] & 
[RAS3 - 1] & 
[_place_76 - 1] & 
[_place_83 - 1] & 
[ATP - 1]; 
Ras activates raf 
protein with 
consumption of ATP 
t_42 _trans_42 
 [_place_76 + 1] & 
[MEk1 + 1] & [RAF2 - 




 [_place_78 + 1] & 
[ERK1 + 1] & [MEk1 - 
1] & [_place_80 - 1]; 
Erk is activated by 
MEk 
t_44 _trans_44 
 [_place_84 + 1] & 
[ERK1 - 1]; Erk activate ELK 
t_45 _trans_45 
 [ELK1 + 1] & 
[_place_80 + 1] & 
[_place_84 - 1] & 
[_place_86 - 1]; 
ELK is moved in the 
nucleus while 
separating from ERK 
t_46 _trans_46 
 [_place_88 + 1] & 
[_place_86 + 1] & 
[_place_87 + 1] & 
[ELK1 - 1] & 




 [CFOS + 1] & 
[_place_88 - 1]; 
mRNA translation for 
CFOS protein 
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t_48 _trans_48 
 [_place_92 + 1] & 
[CFOS - 1] & [cjun - 
1]; 
Complex of cfos and 
cjun 
t_49 _trans_49 
 [cjun + 1] & 
[_place_95 + 1] & 
[_place_93 - 1] & 
[_place_95 - 1]; Activation of cjun 
t_50 _trans_50 
 [_place_93 + 1] & 
[_place_94 + 1] & 
[_place_87 + 1] & 
[_place_87 - 1] & 




 [_place_98 + 1] & 
[ET1 - 1] & [ETRa2 - 
1]; 
Activation of ET 
receptor b by 
endotelin 
t_52 _trans_52 
 [_place_97 + 1] & 
[ET1 - 1] & [ETRa - 
1]; 
Activation of ET 
receptor a 
t_53 _trans_53 
 [ETRa2 + 1] & 
[_place_100 + 1] & 
[_place_97 - 1] & [PG 
- 1]; 
Activation of PG by 
ETRa 
t_54 _trans_54 
 [ETRb + 1] & 
[_place_101 + 1] & 
[PI3k + 1] & [csrc1 + 
1] & [_place_98 - 1] & 
[shc1 - 1] & [PI3k - 1] 
& [csrc1 - 1]; 
ETRb, PI3K and csrc 
activates shc1 
t_55 _trans_55 
 [PG + 1] & 
[_place_105 + 1] & 
[_place_100 - 1] & 
[PLC2 - 1]; PG activate PLC 
	  124	  
t_56 _trans_56 
 [_place_110 + 1] & 
[DAG - 1] & [PKC2 - 
1]; DAG activates PKC 
t_57 _trans_57 
 [PKC2 + 1] & 
[_place_114 + 1] & 
[RAs2 + 1] & [ADP + 
1] & [_place_110 - 1] 
& [ATP - 1] & [raf2 - 
1] & [_place_111 - 1]; 
PKC activates raf 
together with ras to 
start MAPK cascade 
t_58 _trans_58 
 [raf2 + 1] & 
[_place_116 + 1] & 
[_place_114 - 1] & 
[mapkk2 - 1]; Raf activates MAPKK 
t_59 _trans_59 
 [mapkk2 + 1] & 
[_place_118 + 1] & 
[_place_116 - 1] & 




 [mapk2 + 1] & 
[Et_eff2 + 1] & 
[_place_313 + 1] & 
[_place_118 - 1] & 






 [DAG + 1] & [PLC2 + 
1] & [IP3 + 1] & [pip + 
1] & [pip - 1] & 
[_place_105 - 1]; 
PLC creates DAG 
and IP3 from PIP 
t_62 _trans_62 
 [camk_pp + 1] & [ca 
- 1] & [cam_k_kk2 - 
1]; 
Calcium allows 
binding of calmodulin 
and kinases 
t_63 _trans_63 
 [CREB_P + 1] & 
[cam_k_kk2 + 1] & 
[_place_123 - 1] & 
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t_64 _trans_64 
 [_place_123 + 1] & 
[Et_eff1 + 1] & 
[_place_313 + 1] & 
[CREB_P - 1] & 
[_place_313 - 1]; 
CREB generates 
other effects of 
endothelin 
t_65 _trans_65 
 [complex + 1] & 
[sos1 - 1] & [grb1 - 1] 
& [_place_101 - 1]; 
Complex formation of 
shc, sos and GRB2 
t_66 _trans_66 
 [shc1 + 1] & [grb1 + 
1] & [sos1 + 1] & 
[_place_111 + 1] & 
[complex - 1] & [RAs2 
- 1]; 
Activation of ras by 
grb/sos/shc complex 
t_67 _trans_67 
 [ca + 1] & 
[_place_314 + 1] & 
[IP3 - 1] & 
[_place_314 - 1]; 




 [_place_130 + 1] & 
[glu1 - 1]; 
Glucose enters cells 
for glycolysis 




 [G6P + 1] & [ADP + 
1] & [exokinase + 1] 
& [_place_130 - 1] & 
[ATP - 1] & 




 [F6P + 1] & 
[Isomerase + 1] & 
[G6P - 1] & 
[Isomerase - 1]; 





 [F16BP + 1] & [PFK 
+ 1] & [ADP + 1] & 
[F6P - 1] & [PFK - 1] 




 [DHAP + 1] & [ALDO 
+ 1] & [GADP + 1] & 
[F16BP - 1] & [ALDO 
- 1]; 






 [TPI + 1] & [GADP + 
1] & [DHAP - 1] & 
[TPI - 1]; 
DAHP is modified in 
GADP 
t_75 _trans_75 
 [GAPDH + 1] & 
[BPG + 1] & [NADH + 
1] & [P + 1] & [GADP 
- 1] & [GAPDH - 1] & 






 [ATP + 1] & [PG3 + 
1] & [PGK + 1] & 
[BPG - 1] & [ADP - 1] 




 [ENO + 1] & [pep + 
1] & [ENO - 1] & 




 [ATP + 1] & [Pyr_kin 
+ 1] & [pyr + 1] & 
[pep - 1] & [Pyr_kin - 
1] & [ADP - 1]; 
Hydrolization of PEP 
in pyruvate, formation 
of a ATP 
t_79 _trans_79 
 [lactic_acid + 1] & 
[pyr - 1] & [LDH - 1]; 
Pyruvate to lactic 
acid 
t_80 _trans_80 
 [_place_152 + 1] & 
[oxa + 1] & [pyr - 1] & 
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t_81 _trans_81 
 [COA + 1] & 
[AChCOA + 1] & 
[_place_157 + 1] & 
[pyr - 1] & [COA - 1] 




 [_place_156 + 1] & 




 [_place_157 + 1] & 
[pyrDHK - 1] & 
[_place_156 - 1]; 
PyrDH activation by 
Kinase 
t_84 _trans_84 
 [cit_synt + 1] & [Cyt 
+ 1] & [oxa - 1] & 
[AChCOA - 1] & 
[cit_synt - 1]; Krebs step 1: citrate 
t_85 _trans_85 
 [cisAco + 1] & [Cyt - 
1] & [aconitase - 1]; 
Krebs step 2: cis-
aconitate 
t_86 _trans_86 
 [isocyt + 1] & 
[aconitase + 1] & 
[cisAco - 1]; 
Krebs step 3: 
isocitrate 
t_87 _trans_87 
 [oxasu + 1] & [NADH 
+ 1] & [isocyt - 1] & 
[isocyt_DH - 1] & 
[NAD - 1]; 
Krebs step 4a: 
oxalsuccinate 
t_88 _trans_88 
 [a_cheto + 1] & 
[isocyt_DH + 1] & 
[oxasu - 1]; 
Krebs step 4b: a-
chetoglutarate 
t_89 _trans_89 
 [SuCoA + 1] & 
[acheto_DH + 1] & 
[NADH + 1] & 
[a_cheto - 1] & 
[acheto_DH - 1] & 
[NAD - 1]; 




 [su + 1] & 
[SuCoA_synth + 1] & 
[GTP3 + 1] & [SuCoA 
- 1] & [SuCoA_synth - 
1] & [p2 - 1] & [GDP2 
- 1]; 
Krebs step 6: 
Succinate 
t_91 _trans_91 
 [fum + 1] & [su_DH + 
1] & [su - 1] & [su_DH 
- 1]; 
Krebs step 7: 
fumarate 
t_92 _trans_92 
 [mal + 1] & 
[fumarase + 1] & [fum 
- 1] & [fumarase - 1]; Krebs step 8 malate 
t_93 _trans_93 
 [oxa + 1] & [mal_DH 
+ 1] & [mal - 1] & 
[mal_DH - 1]; 
Krebs step 9 
oxalacetate 
t_94 _trans_94 
 [glut2 + 1] & 
[_place_176 + 1] & 
[glu1 - 1] & [glut2 - 1]; Activation of GLUT2 
t_95 _trans_95 
 [insulin + 1] & 
[_place_188 + 1] & 
[_place_176 - 1] & 
[_place_187 - 1]; Synthesis of insulin 
t_96 _trans_96 
 [glicogen + 1] & 
[GS_act + 1] & 





 [H2O + 1] & [ATP + 
1] & [NAD + 1] & 
[NADH - 1] & [O2 - 1] 
& [ADP - 1]; ATP synthesis 
t_98 _trans_98  [vhl + 1] & [hif + 1]; 
Input for VHL and 
HIF 
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t_99 _trans_99 
 [GS_act + 1] & 
[_place_180 + 1] & 
[insulin + 1] & 
[GS_inact - 1] & 
[_place_180 - 1] & 





 [GS_inact + 1] & 
[gsk3b_act + 1] & 
[GS_act - 1] & 
[gsk3b_act - 1]; 
Inactivation of GS by 
GSK3β 
t_101 _trans_101 
 [PKB_akt + 1] & 
[PKB_AKT - 1]; 
Protein Kinase B 
inactivation 
t_102 _trans_102 
 [PKB_AKT + 1] & 
[insulin + 1] & 
[PKB_akt - 1] & 
[insulin - 1]; 
Activation of PKB by 
insulin 
t_103 _trans_103 
 [gsk3b_act + 1] & 
[P_ase + 1] & 
[gsk3b_inact - 1] & 





 [_place_187 + 1] & 
[_place_188 - 1]; 
Inhibition of insulin 
production 
t_105 glut4_musc 
 [insulin + 1] & [glu2 + 
1] & [insulin - 1] & 
[_place_176 - 1]; 
Insulin activation of 
GLUT4 
t_106 _trans_106 
 [gsk3b_act + 1] & 
[hif_ppp + 1] & [hif - 
1] & [gsk3b_act - 1]; 
Phosphorylation of Hif 
by GSK3β 
t_107 _trans_107 
 [ub_ase + 1] & 
[hif_ppp_ub + 1] & 
[ub_ase - 1] & 
[hif_ppp - 1]; 
Ubiquitination of 
phosphorylated Hif 




 [gsk3b_act + 1] & 
[vhl_pp + 1] & 
[gsk3b_act - 1] & [vhl 
- 1]; 
Phosphorylation of 
Vhl by GSK 
t_110 mt_instab 
 [tubulin + 1] & 




 [PHD2_act + 1] & 
[O2 - 1] & 
[_place_195 - 1]; 
Activation of PHD2 
by oxygen 
t_112 _trans_112 
 [_place_195 + 1] & 
[PHD2 - 1] & 
[_place_205 - 1]; 
Inhibition of PHD by 
Krebs species 
t_113 _trans_113 
 [_place_197 + 1] & 
[O2 - 1] & [ARD - 1]; 
Activation of ARD by 
oxygen 
t_114 _trans_114 
 [PHD2_act + 1] & 
[O2 - 1] & [PHD2 - 1]; 
Activation of PHD2 
by oxygen 
t_115 _trans_115 
 [ARD + 1] & [PHD2 + 
1] & [Hy_Ac_HIF1a + 
1] & [hif - 1] & 
[PHD2_act - 1] & 
[_place_197 - 1]; 
Modification of Hif in 
normoxia 
t_116 _trans_116 
 [vcb + 1] & [elob + 1] 
& [eloc + 1] & [elob - 
1] & [eloc - 1] & [vhl - 
1]; 
Formation of Vcb 
complex 
t_117 _trans_117 
 [vcd + 1] & [Cu2 + 1] 
& [vcb - 1] & [Cu2 - 
1]; 
Interaction with Cu2, 
formation of Vcd 
t_118 _trans_118 
 [Hif_ub + 1] & [vcd - 




t_119 degradation1  [Hif_ub - 1]; Degradation of Hif 
	   131	  	  
t_120 _trans_120 
 [_place_205 + 1] & 
[oxa - 1]; 
Uptake of oxalacetate 
for PHD2 inhibition 
t_121 _trans_121 
 [_place_205 + 1] & 
[fum - 1]; 
Uptake of malate for 
PHD2 inhibition 
t_122 _trans_122 
 [_place_205 + 1] & 
[su - 1]; 
Uptake of succinate 
for PHD2 inhibition 
t_123 _trans_123 
 [O2 + 2] & [Et_eff1 - 
1]; 
Creation of oxygen 
by Endothelin effect 
t_124 _trans_124 
 [O2 + 2] & 
[_place_33 - 1]; 
Creation of oxygen 
by VEGF 
t_125 _trans_125 
 [O2 + 2] & 
[_place_59 - 1]; 
Creation of oxygen 
by Vegf 
t_126 _trans_126 
 [O2 + 2] & 
[_place_47 - 1]; 
Creation of oxygen 
by Vegf 
t_127 _trans_127 
 [O2 + 2] & 
[_place_94 - 1]; 
Creation of oxygen 
by EPO 
t_128 _trans_128 
 [O2 + 2] & 
[_place_32 - 1]; 
Creation of oxygen 
by Vegf 
t_129 _trans_129 
 [O2 + 2] & [Et_eff2 - 
1]; 
Creation of oxygen 
by Endothelin 
t_130 _trans_130 
 [O2 + 2] & 
[_place_89 - 1]; 
Creation of oxygen 
by EPO 
t_131 _trans_131 
 [p2 + 1] & [GDP2 + 
1] & [GTP3 - 1]; Breaking of GTP 
t_132 _trans_132 
 [gsk3b_inact + 1] & 
[PKB_AKT + 1] & 
[PKB_AKT - 1] & 
[gsk3b_act - 1]; 
Inactivation of GSK 
by PKB 
t_133 _trans_133 
 [mt + 1] & [tubulin - 




 [nedd_vhl + 1] & 
[nedd8 - 1] & [vcb - 
1]; Neddylation of Vhl 
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t_135 _trans_135 
 [VHL_FN + 1] & [FN 
- 1] & [nedd_vhl - 1]; 
Interaction of Vhl and 
Fibronectin 
t_136 matrix 
 [stable_matrix + 1] & 
[VHL_FN - 1]; Stabilization of ECM 
t_137 _trans_137 
 [FN + 1] & [nedd8 + 
1] & [vcb + 1] & 
[stable_matrix - 1] & 
[MT1MMP - 1]; 
Destabilization of 
ECM by MMP 
t_138 _trans_138 
 [MT1MMP + 1] & 
[_place_218 - 1]; Production of MMP 
t_139 _trans_139 
 [mmp_inact + 1] & 
[_place_221 + 1] & 
[MT1MMP - 1] & 
[timp1 - 1]; 
Inhibition of MMP by 
TIMP 
t_140 _trans_140 
 [timp1 + 1] & 
[_place_221 - 1] & 
[vcb - 1]; 
Activation of TIMP by 
Vhl 
t_141 _trans_141  [insulin - 1]; Elimination of insulin 
t_142 _trans_142 
 [gtp1 + 1] & 
[_place_55 - 1]; Formation of GTP 
t_143 _trans_143 
 [prot_no_ub + 1] & 




t_144 VDU_degr  [_place_227 - 1]; 
VDU degradation by 
VHL 
t_145 _trans_145 
 [_place_227 + 1] & 
[Cu2 + 1] & [Cu2 - 1] 
& [_place_225 - 1]; 
Binding of vcb and 
VDU with Cu2 
t_146 _trans_146 
 [_place_225 + 1] & 
[vcb - 1] & [VDU - 1]; 
Interaction of VDU 
and VHL 
t_147 out_nucleus  [_place_228 - 1]; 
Extrusion of VHL by 
eEF1A 
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t_148 _trans_148 
 [_place_228 + 1] & 
[_place_231 + 1] & 
[eEF1a + 1] & [rpb1 + 
1] & [rpb7 + 1] & 
[eEF1a - 1] & [vhl - 1] 
& [_place_230 - 1]; 
Activation of eEF1A 
by RNA pol II to 
extrude Vhl 
t_149 _trans_149 
 [_place_230 + 1] & 
[_place_231 - 1] & 
[rpb7 - 1] & [rpb1 - 1]; 
Formation of RNA pol 
II  from subunits 
t_150 _trans_150 
 [_place_235 + 1] & 
[card9 - 1] & [nfkb - 
1]; 
Binding of Card9 with 
NFkB 
t_151 _trans_151 
 [tnfa + 1] & [nfkb + 1] 
& [card9 + 1] & 
[_place_236 + 1] & 
[_place_235 - 1] & 
[_place_236 - 1]; 
Stimulation of TNFα 
production 
t_152 _trans_152 
 [_place_238 + 1] & 
[card9 - 1] & [vcb - 1]; 
Binding Vhl and 
Card9 
t_153 _trans_153 
 [_place_240 + 1] & 
[_place_238 - 1] & 




 [card9_p + 1] & [ck2 





 [PHD2_act + 1] & 
[phy_rpb1 + 1] & 
[_place_242 - 1] & 
[PHD2_act - 1]; 
Hydroxylation of 
RPB1 by PDH2 
t_156 _trans_156 
 [Rpb_hy_p + 1] & 
[rpb_kin + 1] & 
[phy_rpb1 - 1] & 





 [ub_moved + 1] & 
[ub + 1] & [ub - 1] & 
[Rpb_hy_p - 1]; 
Movement of RPB1 
to other area of 
nucleus 
t_158 _trans_158 
 [_place_242 + 1] & 
[rpb1 - 1] & [vcb - 1]; 
Binding of Vhl to 
RPB1 
t_159 _trans_159 
 [Rpb7_vhl + 1] & 
[rpb7 - 1] & [vcb - 1]; 
Binding of Vhl to 
RPB7 
t_160 Rpb_degr  [Rpb7_vhl - 1]; Degradation of RPB7 
t_161 _trans_161 
 [stab_complex + 1] & 
[jade1 - 1] & [vhl - 1]; 
Stabilization of Jade1 
by Vhl 
t_162 transcription 
 [proliferation + 1] & 




 [b_cat_P + 1] & 
[_place_258 + 1] & 
[gsk3b_act + 1] & 
[_place_257 + 1] & 
[GSK3B_complex - 1] 






 [ub_jade + 1] & 
[b_cat_P - 1] & 
[stab_complex - 1]; 
Jade bind b-catenin 
for degradation 
t_165 _trans_165 
 [_place_309 + 1] & 
[wnt + 1] & [wnt - 1] & 
[b_catenin - 1]; Activtion of b-catenin 
t_166 _trans_166 
 [GSK3B_complex + 
1] & [gsk3b_act - 1] & 
[_place_257 - 1] & 
[_place_258 - 1]; 
Formation of kinase 
complex from axin, 
APC and GSK 
t_167 _trans_167 
 [pkcz2 + 1] & [sp1_P 
+ 1] & [pkcz2 - 1] & 
[sp1_solo - 1]; 
Phosphorylation of 
Sp1 by PKCζ 
t_168 PKCz2_degr  [_place_318 - 1]; Degradation of PKCζ 
	   135	  	  
t_169 _trans_169 
 [_place_259 + 1] & 
[pkcz2 - 1] & [vcb - 1]; 
Binding of Vhl and 
PKCζ 
t_170 _trans_170 
 [_place_263 + 1] & 
[par6 - 1] & [aPKC - 
1]; 
Activation of aPKC by 
Par6 
t_171 _trans_171 
 [aPKC_act + 1] & 
[_place_263 - 1] & 
[cdc42 - 1]; 
Complete activation 
of aPKC via cdc42 
t_172 _trans_172 
 [par3_P + 1] & 
[cdc42 + 1] & [aPKC 
+ 1] & [aPKC_act - 1] 
& [par3 - 1]; 
Formation of par 
complex 
t_173 _trans_173 
 [tight_j_form + 1] & 
[par3 + 1] & [par6 + 
1] & [par3_P - 1]; 
Formation of tight 
junctions 
t_174 _trans_174 
 [par6_pkcz + 1] & 
[pkcz2 - 1] & [par6 - 
1]; 
Binding par6 and 
PKCζ 
t_175 _trans_175 
 [nur_vhl_hif + 1] & 





 [nur77 + 1] & 
[nur77_mRNA - 1]; 
Translation of Nur77 
mRNA 
t_177 _trans_177 
 [sp1_vhl + 1] & [vhl - 
1] & [sp1_solo - 1]; Binding Sp1 and Vhl 
t_178 _trans_178 
 [vegf_stab + 1] & 
[vegf2 - 1] & [hur - 1]; 
Stabilization of Vegf 
by HuR 
t_179 transcription_2 
 [sp1_P + 1] & [vegf2 
+ 1] & [sp1_P - 1]; 
Transcription of Vegf 
by Sp1 
t_180 _trans_180 
 [nur_vhl + 1] & 
[nur77 - 1] & [vhl - 1]; 




 [no_stab + 1] & [hur - 
1] & [vhl - 1]; 
Inhibition of 
stabilization action by 
Hur via Vhl 
t_182 _trans_182 
 [stabilization + 1] & 
[hur - 1] & 
[_place_315 - 1]; 
Stabilization of IGFR 
mRNA by Hur 
t_183 _trans_183 
 [IGF1R + 1] & [hur + 
1] & [stabilization - 1]; Translation for IGF1R 
t_184 _trans_184 
 [igfr_act + 1] & [IGF1 
+ 1] & [IGF1 - 1] & 
[IGF1R - 1]; 
Activation of receptor 
by IGF1 
t_185 _trans_185 
 [pi3k_act + 1] & 
[IGF1R + 1] & [pi3k - 
1] & [igfr_act - 1]; 
Activation of PI3k by 
IGFR 
t_186 _trans_186 
 [pip3 + 1] & [pi3k + 
1] & [pi3k_act - 1]; Formation of PIP3 
t_187 _trans_187 
 [AKT_mem + 1] & 
[pip3 - 1] & [akt - 1]; 
Movement of AKT to 
membrane 
t_188 _trans_188 
 [AKt_PP + 1] & 
[PDPK1_2 + 1] & 
[mtorc2_1 + 1] & 
[mtorc2_1 - 1] & 
[AKT_mem - 1] & 




 [signal_no_death + 
1] & [akt + 1] & 
[AKt_PP - 1]; 
AKT signaling for 
survival 
t_190 hif_p53_degr  [Ub - 1]; 
Hif degradation via 
p53 
t_191 _trans_191 
 [Ub + 1] & [mdm2 + 
1] & [HIF_mod - 1] & 
[mdm2 - 1]; 
Interaction of Hif with 
mdm2 for 
ubiquitination 
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t_192 _trans_192 
 [HIF_mod + 1] & 
[Hif_IN - 1] & [p53 - 
1]; 
Modification of Hif by 
p53 
t_193 p53_degrad  [_place_295 - 1]; 
P53 degradation by 
mdm2  
t_194 _trans_194 
 [_place_295 + 1] & 
[mdm2 + 1] & [mdm2 
- 1] & [p53 - 1]; 
Binding of mdm2 and 
p53 
t_195 _trans_195 
 [DEATH_signal + 1] 
& [p300_2 + 1] & 
[_place_298 - 1]; 
Signal of p53 for 
Apoptosis 
t_196 _trans_196 
 [_place_298 + 1] & 
[p300_2 - 1] & 




 [_place_300 + 1] & 
[p53 - 1] & [vhl - 1]; Complex p53 and vhl 
t_198 survival 
 [signal_no_death - 
1]; 
Survival signal by 
IGF1 
t_199 _trans_199 
 [sp1_solo + 1] & 
[sp1_P - 1]; 
Dephosphorylation of 
Sp1 
t_200 Apoptosis  [DEATH_signal - 1]; Apoptosis by p53 
t_201 _trans_201  [pkcz2 + 1]; Input for PKCζII 
t_202 _trans_202  [vhl + 1]; Input for Vhl 
t_203 _trans_203 
 [hur + 1] & [rec_act + 
1] & [vegf_stab - 1] & 
[_place_19 - 1]; 
Activation of VEGFR 
by Vegf stabilized by 
HuR 
t_204 _trans_204 
 [dna + 1] & [pomc + 
1] & [nur77 - 1] & 
[dna - 1]; 
Stimulation of 
production of POMC 
by Nur77 
t_205 _trans_205 
 [acth + 1] & [pomc - 
1]; 
Transformation of 
POMC in ACTH 
t_206 acth_action  [acth - 1]; 




 [hur + 1] & [vhl + 1] & 
[no_stab - 1]; 
Breaking of complex 
between HuR and 
Vhl 
t_208 _trans_208 
 [sp1_solo + 1] & [vhl 
+ 1] & [sp1_vhl - 1]; 
Breaking of complex 
between Sp1 and Vhl 
t_209 _trans_209  [jade1 + 1]; Input for Jade1 
t_210 _trans_210 
 [jade_instab + 1] & 
[jade1 - 1]; Instability of Jade1 
t_211 jade_degrad  [jade_instab - 1]; Output for Jade1 
t_212 _trans_212  [b_catenin + 1]; Input for b-catenin 
t_213 _trans_213  [ub_jade - 1]; 
Degradation of b-
catenin 
t_214 _trans_214  [proliferation - 1]; Proliferation signal 
t_215 _trans_215  [lactic_acid - 1]; 
Lactic acid 
elimination 
t_216 _trans_216  [pyr + 1]; 
Input for Pyruvate 
from other metabolic 
pathways 
t_217 _trans_217  [mmp_inact - 1]; 
Output for MMP 
inactive form 
t_218 _trans_218  [glicogen - 1]; Glycogen removal 
t_219 _trans_219  [tnfa - 1]; Output for TNFα 
t_220 _trans_220 
 [card9 + 1] & 
[card9_p - 1]; 
Dephosphorylation of 
card9 
t_221 _trans_221  [ub_moved - 1]; 
Movement of RPB1 
to other areas of 
nucleus 
t_222 _trans_222 
 [pkcz2 + 1] & [par6 + 
1] & [par6_pkcz - 1]; 
Breaking of complex 
between par6 and 
PKCζ 
t_223 _trans_223  [tight_j_form - 1]; 
Tight junction 
formation 
t_224 _trans_224  [H2O - 1]; Output removal 
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t_225 _trans_225  [p53 + 1]; Input p53 
t_226 _trans_226 
 [rpb7 + 1] & [rpb1 + 
1]; 
Input for RPB1 and 
RPB7 




t_228 _trans_228  [prot_ub + 1]; 
Input for ubiquitinated 
proteins 
t_229 _trans_229  [VDU + 1]; Input for VDU 
t_230 _trans_230 
 [nur77_mRNA + 1] & 
[vegf2 + 1] & [Hif_IN 
+ 1] & [vhl + 1] & 
[nur_vhl_hif - 1]; 
Breaking of complex 
between Hif, Nur77 
and Vhl, stimulation 
of production of 
Nur77 and Vegf 
t_231 _trans_231 
 [_place_315 + 1] & 
[sp1_P + 1] & [sp1_P 
- 1]; 
Transcription for 
IGFR mRNA by sp1 
t_232 _trans_232  [_place_315 – 1]; 
Output for excess 
mRNA 
t_233 _trans_233  [IGF1R -1]; 
Output for excess 
IGFR 
t_234 _trans_234 
 [FIH + 1] & [hif + 1] & 
[O2 + 1] & [Hif_IN - 1] 
& [FIH - 1] & [O2 – 1]; 
Inibition HIF by FIH in 
Normoxia 
t_235 _trans_235  [NUR77 + 1]; Input for Nur77 
t_236 _trans_236 
 [_place_318 + 1] & 
[Cu2 + 1] & 
[_place_259 - 1] & 
[Cu2 – 1]; 
Cu2 interaction with 
Vhl and PKCζΙΙ for 
degradation. 
t_237 _trans_237 
[PG2 + 1] & [PGM + 1] 
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Table	  S2:	  List	  of	  all	  model	  places.	  The	  progressive	  ID	  number,	  name	  and	  biological	  meaning	  are	  shown.	  









Table	  	  S3:	  List	  of	  T-­‐invariants	  named	  in	  the	  text	  and	  their	  composition.	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Table	  	  S4:	  Composition	  in	  terms	  of	  invariants	  of	  the	  clusters	  C8,	  C9,	  C10,	  C11.	  
	  
File	  S1	  and	  Video	  S1	  are	  only	  available	  in	  the	  online	  version	  (DOI	  File	  S1:	  10.1371/journal.pone.0096986.s005,	  DOI	  











8.3	   Evaluation	   of	   the	   steric	   impact	   of	   flavin	   adenine	  
dinucleotide	   in	   Drosophila	   melanogaster	   cryptochrome	  
function.	  Supplementary	  Information.	  	  
	  	  
Supplementary	   Material	   1:	   RING	   network	   of	   the	   most	   conserved	   residues	   in	  
cryptochromes.	  	  
Supplementary	  Material	   2:	   Root	  mean	   square	   deviation	   (RMSD)	   plots	   of	  molecular	  
dynamics	   simulations:	   A	   –	   holoprotein,	   B	   –	   Cryptochrome	   without	   FAD,	   C	   –	  
Cryptochrome	  withtout	  both	  FAD	  and	  Mg2+,	  D	  –	  Cryptochrome	  with	  phosphorylated	  
S526.	  	  
Supplementary	  Material	  	  3:	  Root	  mean	  square	  fluctuation	  (RMSF)	  plots	  of	  molecular	  
dynamics	  simulations:	  A	  –	  holoprotein,	  B	  –	  Cryptochrome	  without	  FAD,	  C	  –	  
Cryptochrome	  withtout	  both	  FAD	  and	  Mg2+,	  D	  –	  Cryptochrome	  with	  phosphorylated	  
S526.	  	  
Supplementary	  Material	  	  4:	  BLUUES	  surface	  of	  A	  –	  PL	  and	  B	  –	  dCRY	  	  











Supplementary	  Material	  2	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8.4	   Structural	   protein	   reorganization	   and	   fold	   emergence	  
investigated	   through	   amino	   acid	   sequence	   permutations.	  
Supplementary	  Information.	  	  	  	  
Supplementary	  Figure	  	  1:	  Validation	  of	  ab	  initio	  protocol.	  Graphical	  representation	  of	  structures	  obtained	  with	  the	  ab	  initio	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8.5	  RING	  MD:	   gathering	   time	   into	   structures.	   Supplementary	  
Information.	  	  
	  
RINs	  for	  Molecular	  Dynamics	  
	  A	  protein	  r	  can	  be	  represented	  as	  a	  ℝ!×!	  matrix,	  where	  n	   is	   the	  number	  of	  amino	  acids	  that	  need	  a	  3-­‐dimensional	  representation.	  Let	  ri	  be	  the	   i-­‐th	  residue,	  then	  we	  can	  compute	  the	  so-­‐called	  contact	  map	  𝑚 ∈ 0,1 !×!,	  which	  is	  defined	  as	  follows:	  	   𝑚!" = 1, 𝑖𝑓   ∥ 𝑟! − 𝑟! ∥  < 𝑐0, 𝑜𝑡ℎ𝑒𝑟𝑤𝑖𝑠𝑒 	  	  Where	  ∥  . ∥ 	  is	   the	   well	   known	   euclidean	   norm	   and	   c	   is	   a	   user-­‐defined	   cut-­‐off	  (typically	  set	  to	  6-­‐12Å).	  Contact	  maps	  are	  intimately	  related	  to	  RINs,	  and	  any	  result	  obtained	  in	  the	  former	  can	  be	  immediately	  extended	  to	  the	  latter.	  In	  our	  work,	  we	  introduced	  the	  concept	  of	  Time-­‐Dependent	  Contact-­‐Map	  (TDCM),	  which	  is	  based	  on	  the	  following	  set	  of	  contact	  matrices:	  	   𝑚!"(𝑡) = 1, 𝑖𝑓   ∥ 𝑟!(𝑡)− 𝑟!(𝑡) ∥  < 𝑐0, 𝑜𝑡ℎ𝑒𝑟𝑤𝑖𝑠𝑒 	  	  where	  r(t)	  is	  the	  set	  of	  3-­‐dimensional	  coordinates	  of	  the	  protein	  r	  at	  discrete	  time	  𝑡 ∈ 𝑇 	  of	   MD	   simulation.	   The	   first	   straightforward	   implementation	   of	   TDCM	   is	  proposed	  in	  (169),	  where	  authors	  proposed	  to	  calculate	  the	  mean	  of	  m(t)	  matrices	  to	  easily	  summarize	  the	  MD.	  In	  order	  to	  generalize	  this	  concept,	  we	  represent	  each	  contact-­‐map	  m(t)	  as	  a	  vector	  by	  means	  of	  the	  vectorization	  operator	  vec():	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𝑣𝑒𝑐 𝑚 = [𝑚!,!,… ,𝑚!,!,𝑚!,!,… ,𝑚!,!,…   𝑚!,!,… ,𝑚!,!]! 	  	  and	  use	  the	  concept	  of	  convex	  hull	  to	  denote	  the	  space	  of	  possible	  contact-­‐maps:	  	   𝑐𝑜𝑛𝑣 𝑚 𝑡! ,… ,𝑚 𝑡 ! =    𝑎!𝑣𝑒𝑐 𝑚 𝑡   !∈! ∀𝑡 ∶ 𝑎! ≥ 0   ∧      𝑎!!∈! = 1  }	  	  In	  other	  words,	  the	  space	  of	  conformers	  observed	  during	  the	  MD	  is	  described	  by	  a	  linear	   combination	   of	   the	   contact-­‐maps.	   This	   is	   an	   interesting	   formulation,	   as	   it	  considers	   explicitly	   all	   the	   possible	   states	   of	   the	   protein.	   In	   particular,	   if	   we	   set	  𝑎! = |𝑇|!!∀𝑡 ∈ 𝑇,	  we	  obtain	  the	  formulation	  proposed	  in	  (169).	  On	  the	  other	  hand,	  a	  given	  protein	  of	  interest	  explores	  different	  conformers	  during	  the	  MD,	  and	  none	  of	  them	  will	  be	  described	  accurately	  by	  the	  mean	  contact	  map	  proposed	  in(169).	  To	  overcome	  this	  limitation,	  we	  propose	  to	  use	  clustering	  methods	  to	  better	  represent	  TDCM.	  In	  our	  work,	  we	  used	  k-­‐means	  algorithm	  (165)	  to	  identify	  k	  similar	  contact	  maps:	  
𝑎𝑟𝑔𝑚𝑖𝑛! ∥ 𝑚(𝑡!)− 𝜇! ∥!(!!)∈!!!!!! 	  	  Thus,	  contact-­‐maps	  are	  assigned	  to	  different	  clusters	  in	  S,	  and	  their	  means	  μ1	  ,	  ...,	  μk	  can	   be	   used	   to	   summarize	   states-­‐dependent	   interactions.	   In	   other	   words,	   the	  convex	   hull	   is	   basically	   segmented	   by	   assigning	   a	   coefficient	   of	  𝑎! = |𝑆!|!!	  to	   all	  contact-­‐maps	   that	   belonging	   to	   certain	   cluster	   Sj	   and	   0	   otherwise.	   As	   results,	  we	  obtain	   a	   set	   of	   contact	   maps	   that	   are	   likely	   to	   be	   generated	   from	   similar	  conformers,	  and	  therefore	  good	  representative	  of	  a	  that	  protein	  state.	  The	  number	  
k	  of	  conformers	  has	  been	  estimated	  by	  means	  of	  the	  Bayesian	  information	  criterion	  (BIC)	   (174),	   which	   is	   a	   well-­‐known	   model	   selection	   technique.	   It	   is	   defined	   as	  follows:	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−2 ln(𝑃(𝑚 𝑡 |𝜇, 𝑆))+   𝑘 ⋅ 𝑛! ⋅ ln(|𝑇|)	  	  The	  objective	  function	  is	  dependent	  on	  two	  aspects:	  the	  likelihood	  of	  the	  k-­‐means	  fitting,	   and	   a	   penalty	   related	   to	   the	  𝑘 ⋅ 𝑛!	  number	   of	   parameters	   needed	   for	   k	  clusters.	   Thus,	   BIC	   aims	   to	   select	   a	   model	   representing	   a	   compromise	   between	  fitting	   quality	   and	   its	   complexity.	   In	   order	   to	   speed	   up	   the	   computations,	   we	  simplified	   the	  contact	  map	  representation	  using	  a	  map	   function	  𝑆𝐶𝑀:ℝ!×! → ℝ!.	  This	  function	  transform	  the	  matrix	  m(t)	  into	  a	  a	  vector	  m'(t)	  where:	  	  
𝑚′!(𝑡) = 1, 𝑖𝑓   𝑚!"(𝑡)!!!! > 00, 𝑜𝑡ℎ𝑒𝑟𝑤𝑖𝑠𝑒 	  	  Indeed,	   for	  each	  residue,	  we	  set	   to	  1	   those	  ones	   that	  are	  currently	   involved	   in	  an	  interaction	  (see	  Fig	  S1).	  	  	  	  
	  
Fig	  S1:	  Contact	  map	  and	  simplified	  contact	  map.	  With	  RING,	  we	  can	  label	  interactions	  according	  to	  different	  type	  
of	  bonds,	  like	  hydrogen	  bonds	  (green),	  ionic	  bonds	  (yellow)	  and	  pi-­‐cations	  (red).	  The	  binary	  symmetric	  matrix	  M	  
representing	   the	   contact	  map	   is	   transformed	   into	   a	   binary	   vector	   V.	   Such	   vector	   represents	   the	   existence	   of	   an	  
interaction	  of	  the	   i-­‐th	  amino-­‐acid.	  As	  an	  example,	  the	  bond	  in	  M4,7	   lead	  to	  the	  coloring	  of	  V4	  and	  V7.	  Clearly,	   this	  
lead	  to	  a	  lossy	  compression	  of	  the	  contact	  map.	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This	   is	   a	   critical	   improvement,	   since	   it	   is	   practically	   infeasible	   to	   run	   clustering	  algorithms	  on	   thousands	  of	  protein	   frames	  where	   the	  number	  of	   residues	   is	  high	  (e.g.	  greater	   than	  1,000).	   In	  addition,	   it	   is	  common	  to	   focus	  only	  on	  contact	  maps	  with	  main	  chain-­‐side	  chain	  and	  side	  chain-­‐side	  chain	   interactions,	  as	   they	  are	  the	  most	   informative	  bonds	  (175).	  These	  contact	  maps	  are	  highly	  sparse	  matrices,	  so	  the	  information	  lost	  by	  means	  of	  our	  function	  f	  is	  very	  limited.	  Finally,	  this	  has	  also	  an	  impact	  in	  the	  BIC	  model	  selection	  process,	  as	  it	  reduces	  the	  penalty	  term	  related	  to	   the	   model	   complexity	   and	   allowing	   the	   discovery	   of	   additional	   useful	  conformers.	  It	  should	  be	  noted	  that	  the	  parameters	  obtained	  from	  clustering	  can	  be	  interpreted	   as	   a	  mixture	  model.	   Therefore,	   one	   can	   use	   such	   a	  model	   to	   test	   if	   a	  different	  MD	  of	  the	  same	  protein	  is	  generated	  from	  the	  same	  stochastic	  process.	  A	  clear	   instance	   of	   this	   idea	   is	   the	   evaluation	   of	   mutations	   impact	   in	   the	   protein	  dynamic	  or	  in	  its	  stability.	  
	  
Validation	  
	  In	   order	   to	   validate	   ring	   MD	   clustering	   methodology,	   we	   used	   and	   idea	   from	  CoDNaS	  (181),	  a	  database	  of	  known	  experimental	  conformations	  for	  thousands	  of	  proteins.	  In	  their	  work,	  the	  authors	  suggested	  to	  use	  hierarchical	  clustering	  on	  the	  protein	   structure	   coordinates	   to	   determine	   PDB	   similarities.	   Such	   an	   approach	  enables	   the	   detection	   of	   largely	   different	   conformers	   describing	   diverse	   native	  states.	   Ideally,	   we	   expect	   to	   observe	   agreement	   between	   ring	   MD	   and	   CoDNaS-­‐based	  clustering	  for	  MD	  simulated	  conformers.	  In	  agreement	  to	  CoDNaS	  definition,	  we	   computed	   the	   pairwise	   distance	   of	   MD	   frame	   coordinates	   using	   the	   Bio3D	  package	  (185),	  and	  calculated	  a	  dendrogram.	  Using	  in-­‐house	  code,	  we	  obtained	  the	  conformers	  dendrogram	  represented	  from	  simplified	  contact	  maps	  (SCM).	  In	  Table	  1,	   the	   clustering	   similarity	   is	   evaluated	   by	  means	   of	   Cophenetic	   correlation.	   For	  Glutaredoxin,	   inter-­‐atomic	   contacts	   seems	   the	   main	   cause	   of	   tridimensional	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conformation	   switch,	   while	   the	   changes	   observed	   for	   hydrogen	   bonds	   in	   both	  Ubiquitin	  and	  Lysozyme	  better	  explain	  the	  different	  conformers.	  Ionic	  contacts	  also	  play	  a	  role	  in	  two	  situations.	  The	  joint	  combination	  of	  multiple	  types	  of	  interactions	  (denoted	  as	  all)	  has	  a	   correlation	  value	  of	   almost	  0.5,	   and	  demonstrates	   the	  high	  explanatory	   power	   of	   RINs	   in	   the	   detection	   of	   different	   protein	   native	   states.	   A	  second	  appealing	   strength	  of	  RINs	   is	   their	   ability	   to	   spot	   the	   type	  of	   interactions	  promoting	   conformational	   changes.	   This	   is	   a	   clear	   abstraction	   of	   the	   whole	  dynamics,	   and	   enables	   the	  quick	  detection	  of	   key	   factors	   for	   the	  protein	   stability	  and	   its	   fluctuations.	   A	   last	   important	   consideration	   arises	  when	  we	   compare	   the	  average	   number	   of	   interactions	   for	   a	   given	   residue	   during	   the	   MD	  with	   its	   root	  mean	  square	  fluctuation.	  As	  shown	  in	  Table	  2,	   the	  inter-­‐atomic	  contacts	  explain	  a	  significant	   part	   of	   the	   amino-­‐acid	   degree	   of	   freedom.	   This	   is	   obvious	   in	   practice,	  and	  is	  also	  well	  modeled	  by	  our	  RIN-­‐based	  MD	  representation.	  	  
  Ubiquitin	   Lysozyme	   Glutaredoxin	  H-­‐bond	   0.423	   0.350	   0.213	  Van-­‐der-­‐Waals	   0.176	   0.153	   0.604	  π	  -­‐cation	   0.061	   0.033	   0.233	  
π	  -­‐ π	  stack	   0.046	   0.179	   0.196	  Ionic	   0.098	   0.323	   0.314	  All	   0.460	   0.500	   0.474 
Table	   1:	   Cophenetic	   correlation	   of	   PDB	   clustering	   and	   RING	   MD	   average	   clustering.	   In	   general,	   there	   is	   good	  
agreement	  between	   the	  dendrograms	  produced	   from	  the	  different	   type	  of	  protein	  representations.	  The	   “All”	   row	  







	   173	  	  
 Ubiquitin	   Lysozyme	   Glutaredoxin	  H-­‐bond	   -­‐0.042	   -­‐0.056	   -­‐0.064	  Van-­‐der-­‐Waals	   -­‐0.619	   -­‐0.439	   -­‐0.294	  π	  -­‐cation	   -­‐0.066	   -­‐0.031	   -­‐0.246	  
π	  -­‐ π	  stack	   -­‐0.050	   -­‐0.013	   -­‐0.179	  Ionic	   -­‐0.058	   -­‐0.030	   -­‐0.190	  All	   -­‐0.074	   -­‐0.043	   -­‐0.282 
 
Table	  2:	  Correlation	  of	  RING	  MD	  mean	  number	  of	  interactions	  of	  a	  residue	  with	  respect	  to	  amino	  acid	  RMSF.	  Total	  




Ubiquitin	   is	   a	   protein	   involved	   in	   posttranslational	   modifications	   driving	  intracellular	  signaling	  events	  (186).	  	  
Ionic E1 E2 β1 β2 L1 L2 L3 L4 
Cluster 1 K27-(D52) 
E34-(K11) 
R54-(E51) K11-(E34) R72-(D39) Few int.  D39-(R72) D52-(K27) 
E51-(R54) 
Few int. 
Cluster 2 K27-(D52) 
E34-(K11) 
D58-(R54) K11-(E34) R72-(D39) 
R42-(D39) 




Few int.  
Cluster 3 K27-(D52) 
E34-(K11) 
D58-(R54) K11-(E34) Few int. Few int. Few int.  D52-(K27)   
R54-(D58) 
Few int.  
Cluster 4 K27-(D52) 
E34-(K11) 
R54-(E51) K11-(E34) Few int. Few int.  Few int.  D52-(K27) 
E51-(R54) 
Few int.  Table	  3:	  Ionic	  interactions	  differences	  between	  the	  four	  conformational	  clusters.	  	  K11,	   as	   demonstrated	   in	   	   (42),	   appears	   to	   play	   a	   key	   role	   in	   Ubiquitin	  structural	   stability,	   and	   our	   results	   confirm	   this	   finding,	   as	   the	   residue	   is	  involved	   in	   interactions	   in	   all	   the	   clusters	   (see	   Table	   3).	   The	   key	   residues	  involved	   in	   conformational	   changes	   appear	   to	   be	   D39,	   R42,	   E51,	   D58	   and	  R72	  [Sup.	  Fig.	  1].	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Supplementary	  Figure	  1:	  Ionic	  interactions	  Ubiquitin	  driven	  clusterization.	  
	  
H-bonds E1 E2 β1 β2 L1 L2 L3 L4 










Few int.  I36 Few int. Q62 












I36 Few int. Q62  













E18 Few int.  Few int.  Q62  










Few int.  P38 Few int. Q62  
Table	  4:	  H-­‐bonds	  differences	  between	  the	  four	  conformational	  clusters.	  	  The	   main	   H	   bond	   performing	   characters	   for	   structural	   maintenance	   are,	  according	   to	   Table	   4,	   E1,	   β1	   and	   β2,	   and	   E2.	   E1	   N25	   and	   K27	   perform	  constant	  H	  bond	  networks	  during	  all	  the	  simulation,	  as	  well	  as	  T55	  and	  D58	  for	   E2.	   β1	   and	   β2	   domains	   are	   held	   by	   T7	   and	   K11,	   and	   Q41	   and	   S65	  respectively.	   Considering	   loops,	   L1	   performs	   switching	   interactions,	   which	  are	  present	  only	  in	  clusters	  2	  and	  3	  and	  are	  performed	  by	  E18	  and	  D21.	  On	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the	   other	   hand,	   L4	   contains	   a	   crucial	   H	   bond	   performing	   residue,	   Q62.	  Residues	   involved	   in	   H-­‐bonds	   and	   assuming	   a	   key	   role	   in	   conformational	  transitions	  are	  E16,	  E18,	  D21,	  Q40	  and	  L73	  [Sup.	  Fig.	  2].	  	  	  
	  
Supplementary	  Figure	  2:	  H-­‐bond	  interactions	  Ubiquitin	  driven	  clusterization.	  Considering	   all	   the	   computed	   interaction	   and	   all	   the	   obtained	   clusters,	   the	  key	  residues	   involved	   in	  conformational	   transitions	   for	  Ubiquitin	  appear	   to	  be	   D39,	   Q40,	   R42,	   R72	   and	   L73.	   These	   residues	   appear	   to	   be	   involved	   in	  every	  clustering	  as	  driving	  conformational	  changes	  residues	  [Sup.	  Fig.	  3].	  In	  2011,	  Ralat	  et	  al.	  highlighted	  R72	  as	  one	  of	  the	  second	  phase	  cleavage	  sites	  for	  human	  Insulin-­‐degrading	  enzyme	  (IDE)	  (179),	  and	  according	  to	  RING	  MD	  analysis	   this	   residue	   appears	   to	   play	   also	   a	   major	   structural	   role,	   being	  involved	  in	  conformational	  transitions.	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Supplementary	  Figure	  3:	  All	  interactions	  Ubiquitin	  driven	  clusterization.	  
	  
Lysozyme	  
As	  mentioned	  formerly,	  the	  second	  target	  was	  T4	  Lysozyme.	  This	  enzyme	  is	  involved	  in	  host	  peptidoglycan	  degradation	  and	  cell	  lysis	  (182).	  	  
Ionic E1 E2 E3 E4 E5 E6 E7 E8 E9 E10 β1 












































































Few int.  



























Table	  5:	  Ionic	  interactions	  differences	  between	  the	  four	  conformational	  clusters.	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As	   shown	   in	   Table	   5,	   structural	   domains	   apparently	   being	   involved	   in	  conformational	  changes	  are	  E4,	  E5,	  E9	  and	  β1.	  Helix	  10	  shows,	  together	  with	  E3,	   to	   perform	   the	   highest	   number	   and	   more	   stable	   interactions.	   On	   the	  contrary,	   E1	   shows	   a	   plethora	   of	   different	   interactions	   scenarios,	   ranging	  from	  one	  ionic	  interaction	  in	  cluster	  3	  to	  four	  in	  cluster	  1.	  E11,	  which	  shown	  to	  perform	  ionic	  interactions	  in	  clusters	  1,	  2	  and	  4,	  belongs	  also	  to	  the	  active	  site	  of	  the	  enzyme	  (173).	  Our	  analysis	  could	  thus	  provide	  a	  different	  role	  for	  this	   residue,	   highlighting	   its	   importance	   in	   both	   structure	   and	   function	   of	  Lysozyme.	  Furthermore,	  E45	  is	  shown	  to	  be	  a	  mutation	  spot	  that	  whenever	  mutated	  provides	  structural	  differences	  (184).	  
	  
Supplementary	  Figure	  4:	  Ionic	  interactions	  Lysozyme	  driven	  clusterization.	  	  	  	  	  	  	  
	  178	  
	  	  	  
H-bonds E1 E2 E3 E4 E5 E6 E7 E8 E9 E10 β1 







































































































































































Table	  6:	  H-­‐bonds	  differences	  between	  the	  four	  conformational	  clusters.	  	  Table	  6	   lists	  all	   the	  residues	   involved	   in	  H	  bond	  network	   formations	   in	   the	  four	   clusters.	   Mutations	   occurring	   in	   some	   of	   these	   residues,	   in	   particular	  S44F,	   S44E,	   S44W,	   S117V,	   and	   R96A	   Lysozyme	   mutants	   have	   been	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previously	   demonstrated	   to	   provide	   different	   enzyme	   conformations	  when	  compared	   to	   the	  WT	   (184).	   The	   H-­‐bond	   performing	   residues	   allowing	   the	  conformational	   switching	   are	   D10,	   Y18,	   G30,	   D47,	   N55,	   P86,	   V87,	   N101,	  E108,	  S117,	  Q122,	  K124,	  E128,	  R145,	  D159	  and	  Y161	  [Sup.	  Fig.	  5].	  	  	  
	  




	  	  Supplementary	  Figure	  6:	  All	  interactions	  Lysozyme	  driven	  clusterization.	  	  	  
	  
Glutaredoxin	  
	  The	   third	   target	   of	   this	   work	   was	   T4	   Glutaredoxin,	   a	   reducing	   agent	   for	  phage-­‐induced	  ribonucleotide	  reductase	  (183).	  Like	  the	  former	  two	  targets,	  this	   has	   been	   chosen	   for	   both	   its	   dimensions	   and	   for	   the	   presence	   of	   an	  active	   site	   to	   investigate	   on.	   	   As	   for	   the	   other	   two	   simulations,	   the	   first	  analysis	  dealt	  with	  ionic	  interactions.	  In	  table	  7,	  the	  peculiar	  interactions	  per	  cluster	  driving	  the	  folding	  of	  the	  secondary	  structure	  are	  highlighted.	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Ionic E1 E2 E3 β1 
Cluster 1 D18-K21 D44-K47 Few int. K3-E32 
Cluster 2 D18-K21 E50-(K3) D80-R83 K3-(E50) 
Cluster 3 Few int. D44-K47 
E50-K54 
D80-R83 K3-E32 
Cluster 4 D18-R22 D44-K47 
E50-K54 
E50-(K3) 
Few int. K3-(E50) 
Table	  7:	  Ionic	  interactions	  differences	  between	  the	  four	  conformational	  clusters.	  	  	  K21	  and	  D80	  are,	   interestingly,	   two	  residues	  known	   to	  undergo	  mutations,	  the	   former	   causing	   loss	   of	   ability	   by	   the	   protein	   to	   get	   reduced	   by	  thioredoxin	   reductase	   and	   the	   latter	   known	   to	   provide	   an	   opposite	  effect(183).	   By	   the	   fast	   RING	  MD	   analysis,	   we	   were	   able	   to	   identify	   these	  residues	   without	   carrying	   out	   mutation	   analysis,	   and	   just	   identifying	   the	  node	  centrality	  during	  the	  entire	  MD	  simulation.	  	  The	  first	  residue	  leading	  to	  conformational	   changes	   due	   to	   ionic	   interactions	   was	   found	   to	   be	   E32,	  involved	   in	   conformational	   transition	   between	   cluster	   1-­‐2	   and	   3-­‐4.	   In	  clusters	  1	  and	  3,	  E32	  interacts	  with	  K3.	  On	  the	  other	  hand,	  in	  clusters	  2	  and	  4	  it	  performs	  no	   interactions.	  D44	  appears	   to	  be	  an	   ionic	  switch	  required	   for	  clusters	  3	  and	  4,	  having	  K47	  as	  a	  positive	  counterpart.	  E50,	  belonging	  to	  E2,	  interacts	  with	  β1	  K3	  in	  clusters	  2	  and	  4	  and	  switches	  the	  interaction	  towards	  K54	   in	   clusters	   3	   and	   4.	   Thus	   cluster	   4	   seems	   to	   be	   characterized	   by	   a	  transient	  ionic	  switch.	  D80	  and	  R83	  are,	  at	  the	  end,	  the	  driving	  force	  leading	  to	   clusters	   2	   and	   3	   formation.	   The	   main	   secondary	   structure	   elements	  driving	   conformational	   change	   appear	   to	   be,	   at	   the	   end,	   E3	   and	   β1,	   with	  some	  biases	  coming	  from	  E2	  [Sup.	  Fig.	  7].	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Supplementary	  Figure	  7:	  Ionic	  interactions	  Glutaredoxin	  driven	  clusterization.	  
	  
H-bonds E1 E2 E3 β1 L1 L2 L3 L4 L5 











Few int. Few int. Few int. 














































N35 Few int. 
 
Few int. 
 Table	  8:	  H-­‐bonds	  differences	  between	  the	  four	  conformational	  clusters.	  	  	  As	  noticeable	  by	  table	  8,	  two	  key	  residues	  involved	  in	  H	  bond	  formation	  are	  K21	   and	   T25,	   which	   are	   crucial	   for	   E1.	   In	   E2,	   A49	   and	   T53	   are	   always	  present,	   and	   they	   appear	   to	   have	   a	   structural	   role	   for	   helix	   maintenance.	  Loops,	   as	   one	   could	   expect,	   are	  not	  performing	  H	  bonds	   frequently,	   except	  for	   L5	   in	   cluster	   4	   and	   L3	   in	   clusters	   3	   and	   4.	   The	   overall	   H-­‐bond	   driven	  conformational	   changes	   are	   switched	   by	   Y5,	   E50,	   D72,	   S74,	   G78	   and	   Q81	  [Sup.	  Fig.	  8].	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Supplementary	  Figure	  8:	  H-­‐bond	  interactions	  Glutaredoxin	  driven	  clusterization.	  	  Coming	  to	  the	  final	  analysis,	  a	  comprehensive	  evaluation	  of	  the	  whole	  set	  of	  the	  considered	  interaction	  lead	  to	  identify	  Y5,	  D18,	  R22,	  E32,	  N35,	  F43,	  T64,	  Q67,	   D72,	   S74,	   D80	   and	   Y85	   as	   key	   residues	   for	   overall	   conformational	  transitions	  during	  the	  entire	  50	  ns	  MD	  simulation	  [Sup.	  Fig.	  9].	  Moreover,	  as	  previously	   mentioned,	   the	   functional	   importance	   of	   K21	   added	   to	   the	  structural	  role	  highlighted	  by	  RING	  MD	  analysis	  suggests	  the	  central	  role	  of	  this	  residue	  for	  this	  protein.	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Supplementary	  Figure	  9:	  All	  interactions	  Glutaredoxin	  driven	  clusterization.	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